country,term,count
AF,ASTHENIA,1
AF,BLOOD CHOLESTEROL INCREASED,1
AF,BREAST MALFORMATION,1
AF,DRUG INEFFECTIVE,1
AF,DRUG PRESCRIBING ERROR,1
AF,FATIGUE,1
AF,INJECTION SITE BRUISING,1
AF,INJECTION SITE PRURITUS,1
AF,MUSCULOSKELETAL STIFFNESS,1
AF,PYREXIA,1
DZ,HYPERPHAGIA,1
DZ,OBESITY,1
DZ,PRODUCT USE ISSUE,1
AR,BRONCHOSPASM,4
AR,DRUG INEFFECTIVE,3
AR,PNEUMONIA,3
AR,PRODUCT USE ISSUE,3
AR,BONE DECALCIFICATION,2
AR,COUGH,2
AR,GAIT DISTURBANCE,2
AR,PNEUMONITIS,2
AR,PRODUCT QUALITY ISSUE,2
AR,RASH,2
AR,AGITATION,1
AR,ARRHYTHMIA,1
AR,ARTHRALGIA,1
AR,ASPHYXIA,1
AR,ASTHMATIC CRISIS,1
AR,ATRIAL FIBRILLATION,1
AR,BACK PAIN,1
AR,BLOOD POTASSIUM DECREASED,1
AR,BONE PAIN,1
AR,BREATH SOUNDS ABNORMAL,1
AR,BRONCHIOLITIS,1
AR,CARDIAC FAILURE,1
AR,CARDIAC FIBRILLATION,1
AR,CARDIOVERSION,1
AR,CHEST DISCOMFORT,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COELIAC DISEASE,1
AR,COMPLETED SUICIDE,1
AR,DIABETES MELLITUS,1
AR,DRUG ADMINISTRATION ERROR,1
AR,DUST ALLERGY,1
AR,DYSPNOEA,1
AR,DYSSTASIA,1
AR,EYE PRURITUS,1
AR,HEADACHE,1
AR,HYPOKALAEMIA,1
AR,INFLUENZA,1
AR,INSOMNIA,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,LARYNGEAL OEDEMA,1
AR,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
AR,MALAISE,1
AR,MOBILITY DECREASED,1
AR,MUSCLE SPASMS,1
AR,MYOCARDIAL INFARCTION,1
AR,NASAL DISCOMFORT,1
AR,NERVOUSNESS,1
AR,OSTEOARTHRITIS,1
AR,OXYGEN SATURATION DECREASED,1
AR,PRODUCT USE IN UNAPPROVED INDICATION,1
AR,PULMONARY OEDEMA,1
AR,PYREXIA,1
AR,SECRETION DISCHARGE,1
AR,SUDDEN DEATH,1
AR,SUFFOCATION FEELING,1
AR,SYNCOPE,1
AR,THROAT IRRITATION,1
AR,TONGUE DISCOLOURATION,1
AR,TONGUE ERUPTION,1
AR,TRACHEOSTOMY,1
AR,WEIGHT INCREASED,1
AU,DYSPNOEA,43
AU,ASTHMA,31
AU,DRUG INEFFECTIVE,25
AU,DIARRHOEA,22
AU,LOWER RESPIRATORY TRACT INFECTION,22
AU,NAUSEA,21
AU,FATIGUE,16
AU,MALAISE,16
AU,PNEUMONIA,16
AU,VOMITING,16
AU,DIZZINESS,14
AU,BACK PAIN,13
AU,PAIN,13
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,12
AU,COUGH,12
AU,FALL,12
AU,INSOMNIA,12
AU,PYREXIA,12
AU,ARTHRALGIA,10
AU,DEATH,10
AU,HEADACHE,10
AU,NEUTROPENIA,10
AU,URINARY TRACT INFECTION,9
AU,WHEEZING,9
AU,ANAPHYLACTIC REACTION,8
AU,CONFUSIONAL STATE,8
AU,FEELING ABNORMAL,8
AU,ANXIETY,7
AU,BALANCE DISORDER,7
AU,CONDITION AGGRAVATED,7
AU,DEPRESSION,7
AU,INFLUENZA LIKE ILLNESS,7
AU,OEDEMA PERIPHERAL,7
AU,PRODUCT QUALITY ISSUE,7
AU,RASH,7
AU,SEPSIS,7
AU,UPPER RESPIRATORY TRACT INFECTION,7
AU,URTICARIA,7
AU,WEIGHT INCREASED,7
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,6
AU,CARDIAC FAILURE,6
AU,CHEST DISCOMFORT,6
AU,CHEST PAIN,6
AU,CONSTIPATION,6
AU,HYPERTENSION,6
AU,LUNG INFECTION,6
AU,MOBILITY DECREASED,6
AU,MUSCULOSKELETAL PAIN,6
AU,NECK PAIN,6
AU,OSTEOARTHRITIS,6
AU,PAIN IN EXTREMITY,6
AU,RHABDOMYOLYSIS,6
AU,ANAEMIA,5
AU,ANGIOEDEMA,5
AU,ARTHROPATHY,5
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
AU,BLOOD CREATININE INCREASED,5
AU,BLOOD PRESSURE INCREASED,5
AU,CARDIAC FAILURE CONGESTIVE,5
AU,FEBRILE NEUTROPENIA,5
AU,GASTROOESOPHAGEAL REFLUX DISEASE,5
AU,HYPOTENSION,5
AU,LOSS OF CONSCIOUSNESS,5
AU,LUNG DISORDER,5
AU,MUSCLE SPASMS,5
AU,PANCREATITIS,5
AU,PSYCHOTIC DISORDER,5
AU,PULMONARY EMBOLISM,5
AU,RESPIRATORY FAILURE,5
AU,RHEUMATOID ARTHRITIS,5
AU,SUICIDAL IDEATION,5
AU,ABDOMINAL PAIN,4
AU,ACUTE KIDNEY INJURY,4
AU,AGGRESSION,4
AU,ANGINA PECTORIS,4
AU,BLOOD GLUCOSE INCREASED,4
AU,BLOOD PHOSPHORUS INCREASED,4
AU,CARDIAC DISORDER,4
AU,CEREBROVASCULAR ACCIDENT,4
AU,CHOKING,4
AU,CHOLELITHIASIS,4
AU,DECREASED APPETITE,4
AU,DRUG DOSE OMISSION,4
AU,DRY EYE,4
AU,EPISTAXIS,4
AU,EXPOSURE DURING PREGNANCY,4
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
AU,GASTROINTESTINAL HAEMORRHAGE,4
AU,GLOMERULAR FILTRATION RATE DECREASED,4
AU,HERPES ZOSTER,4
AU,HYPERSENSITIVITY,4
AU,HYPOAESTHESIA,4
AU,LETHARGY,4
AU,MALIGNANT NEOPLASM PROGRESSION,4
AU,MOOD SWINGS,4
AU,MUSCULAR WEAKNESS,4
AU,OROPHARYNGEAL PAIN,4
AU,PALPITATIONS,4
AU,PERIPHERAL SWELLING,4
AU,PRURITUS,4
AU,RESPIRATION ABNORMAL,4
AU,SKIN ULCER,4
AU,TACHYCARDIA,4
AU,VIRAL INFECTION,4
AU,ABNORMAL BEHAVIOUR,3
AU,ABORTION SPONTANEOUS,3
AU,ACUTE MYOCARDIAL INFARCTION,3
AU,ADVERSE DRUG REACTION,3
AU,ANGINA UNSTABLE,3
AU,APATHY,3
AU,ASCITES,3
AU,ASPARTATE AMINOTRANSFERASE INCREASED,3
AU,ATRIAL FIBRILLATION,3
AU,BASAL CELL CARCINOMA,3
AU,BLOOD ALBUMIN DECREASED,3
AU,C-REACTIVE PROTEIN INCREASED,3
AU,CARDIAC ARREST,3
AU,CELLULITIS,3
AU,CHILLS,3
AU,CONGESTIVE CARDIOMYOPATHY,3
AU,DEEP VEIN THROMBOSIS,3
AU,DEHYDRATION,3
AU,DEVICE ISSUE,3
AU,DRUG ADMINISTRATION ERROR,3
AU,DRUG DEPENDENCE,3
AU,DRY MOUTH,3
AU,DYSPEPSIA,3
AU,DYSPHONIA,3
AU,EAR PAIN,3
AU,ELECTROCARDIOGRAM QT PROLONGED,3
AU,FIBRIN D DIMER INCREASED,3
AU,FLUSHING,3
AU,GENERAL PHYSICAL HEALTH DETERIORATION,3
AU,HAEMOPTYSIS,3
AU,HALLUCINATION,3
AU,HEART RATE INCREASED,3
AU,HERNIA,3
AU,HUMERUS FRACTURE,3
AU,HYPERHIDROSIS,3
AU,HYPERTHYROIDISM,3
AU,HYPOKALAEMIA,3
AU,HYPONATRAEMIA,3
AU,IMPAIRED HEALING,3
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,3
AU,INTRACRANIAL ANEURYSM,3
AU,JOINT SWELLING,3
AU,LYMPHOPENIA,3
AU,MALIGNANT BOWEL OBSTRUCTION,3
AU,MENORRHAGIA,3
AU,MITRAL VALVE INCOMPETENCE,3
AU,MYOCARDIAL INFARCTION,3
AU,MYOCARDIAL ISCHAEMIA,3
AU,OSTEOPOROSIS,3
AU,OXYGEN SATURATION DECREASED,3
AU,PANIC ATTACK,3
AU,PERTUSSIS,3
AU,PULMONARY MASS,3
AU,RECTAL HAEMORRHAGE,3
AU,RENAL IMPAIRMENT,3
AU,RESPIRATORY DISTRESS,3
AU,RESPIRATORY TRACT INFECTION BACTERIAL,3
AU,SUICIDE ATTEMPT,3
AU,SYNCOPE,3
AU,TREMOR,3
AU,VISION BLURRED,3
AU,VISUAL IMPAIRMENT,3
AU,WEIGHT DECREASED,3
AU,ABASIA,2
AU,ABDOMINAL DISCOMFORT,2
AU,ABDOMINAL TENDERNESS,2
AU,ACCIDENTAL UNDERDOSE,2
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
AU,ALANINE AMINOTRANSFERASE INCREASED,2
AU,ANION GAP INCREASED,2
AU,ANKLE FRACTURE,2
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
AU,APHASIA,2
AU,APPENDIX DISORDER,2
AU,ASTHENIA,2
AU,BLINDNESS,2
AU,BLOOD BILIRUBIN ABNORMAL,2
AU,BLOOD CREATININE DECREASED,2
AU,BLOOD POTASSIUM DECREASED,2
AU,BLOOD POTASSIUM INCREASED,2
AU,BLOOD UREA DECREASED,2
AU,BLOOD UREA INCREASED,2
AU,BODY TEMPERATURE INCREASED,2
AU,BONE PAIN,2
AU,BREAST CANCER,2
AU,BRONCHITIS,2
AU,BRONCHOSPASM,2
AU,CARDIOMYOPATHY,2
AU,CIRCULATORY COLLAPSE,2
AU,COGNITIVE DISORDER,2
AU,CONVULSION,2
AU,CORONARY ARTERY OCCLUSION,2
AU,CRYING,2
AU,DELIRIUM,2
AU,DELUSION,2
AU,DEPENDENCE,2
AU,DEPRESSED MOOD,2
AU,DERMATITIS ATOPIC,2
AU,DIABETIC KETOACIDOSIS,2
AU,DISEASE PROGRESSION,2
AU,DISTURBANCE IN ATTENTION,2
AU,DIVERTICULITIS,2
AU,DRUG EFFECT INCOMPLETE,2
AU,DRUG ERUPTION,2
AU,DRUG THERAPEUTIC INCOMPATIBILITY,2
AU,DYSARTHRIA,2
AU,DYSMENORRHOEA,2
AU,DYSPHAGIA,2
AU,DYSPNOEA EXERTIONAL,2
AU,DYSSTASIA,2
AU,ELECTROCARDIOGRAM T WAVE INVERSION,2
AU,EMPHYSEMA,2
AU,EXERCISE TOLERANCE DECREASED,2
AU,EYE PAIN,2
AU,EYE SWELLING,2
AU,FLAT AFFECT,2
AU,FLUID OVERLOAD,2
AU,FOETAL DEATH,2
AU,FOREIGN BODY,2
AU,GASTRITIS,2
AU,GLAUCOMA,2
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
AU,HAEMOGLOBIN DECREASED,2
AU,HAEMORRHAGE INTRACRANIAL,2
AU,HEMIPLEGIA,2
AU,HIP FRACTURE,2
AU,HYPERCHOLESTEROLAEMIA,2
AU,HYPERGLYCAEMIA,2
AU,HYPERPARATHYROIDISM,2
AU,INCORRECT DOSE ADMINISTERED,2
AU,INFECTION,2
AU,INFECTIVE EXACERBATION OF BRONCHIECTASIS,2
AU,INFLUENZA,2
AU,INTERSTITIAL LUNG DISEASE,2
AU,INTESTINAL OBSTRUCTION,2
AU,IRRITABILITY,2
AU,KNEE ARTHROPLASTY,2
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
AU,LEFT VENTRICULAR FAILURE,2
AU,LIMB INJURY,2
AU,LOCALISED INFECTION,2
AU,MELAENA,2
AU,MENTAL DISORDER,2
AU,MOTOR DYSFUNCTION,2
AU,MOUTH ULCERATION,2
AU,MYALGIA,2
AU,NASOPHARYNGITIS,2
AU,NEURALGIA,2
AU,NIGHT SWEATS,2
AU,NO THERAPEUTIC RESPONSE,2
AU,OCULAR HYPERAEMIA,2
AU,OESOPHAGITIS,2
AU,ORAL CANDIDIASIS,2
AU,ORTHOSTATIC HYPOTENSION,2
AU,OSTEITIS DEFORMANS,2
AU,OSTEOMYELITIS,2
AU,OVERDOSE,2
AU,PANCREATIC CARCINOMA,2
AU,PANCREATIC CARCINOMA METASTATIC,2
AU,PANCYTOPENIA,2
AU,PARAESTHESIA,2
AU,PARANOIA,2
AU,PERICARDIAL EFFUSION,2
AU,PERSONALITY DISORDER,2
AU,PLEURAL EFFUSION,2
AU,PNEUMONIA MYCOPLASMAL,2
AU,POLYURIA,2
AU,POST PROCEDURAL HAEMORRHAGE,2
AU,PRODUCTIVE COUGH,2
AU,PULMONARY ARTERIAL HYPERTENSION,2
AU,PULMONARY OEDEMA,2
AU,QUALITY OF LIFE DECREASED,2
AU,RED BLOOD CELL COUNT DECREASED,2
AU,RENAL FAILURE,2
AU,RETCHING,2
AU,SCHIZOPHRENIA,2
AU,SEBACEOUS CARCINOMA,2
AU,SENSORY LOSS,2
AU,SINUS CONGESTION,2
AU,SLEEP DISORDER,2
AU,SNEEZING,2
AU,SOFT TISSUE INJURY,2
AU,SOMNOLENCE,2
AU,SPEECH DISORDER,2
AU,SPLENIC INFARCTION,2
AU,SPUTUM DISCOLOURED,2
AU,SPUTUM INCREASED,2
AU,SQUAMOUS CELL CARCINOMA OF SKIN,2
AU,SWELLING,2
AU,SWOLLEN TONGUE,2
AU,TEARFULNESS,2
AU,TENDERNESS,2
AU,THROMBOCYTOPENIA,2
AU,TRANSFUSION,2
AU,TROPONIN T INCREASED,2
AU,VERTIGO,2
AU,VITAMIN D DECREASED,2
AU,VITAMIN D DEFICIENCY,2
AU,WOUND SECRETION,2
AU,ABDOMINAL DISTENSION,1
AU,ABDOMINAL PAIN UPPER,1
AU,ACANTHOSIS NIGRICANS,1
AU,ACIDOSIS,1
AU,ACTINIC KERATOSIS,1
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AU,ACUTE CORONARY SYNDROME,1
AU,ACUTE LUNG INJURY,1
AU,ACUTE RESPIRATORY FAILURE,1
AU,ADENOCARCINOMA PANCREAS,1
AU,ADRENAL INSUFFICIENCY,1
AU,AFFECT LABILITY,1
AU,AGITATION,1
AU,AGRANULOCYTOSIS,1
AU,ALANINE AMINOTRANSFERASE ABNORMAL,1
AU,ALOPECIA,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ALVEOLAR OSTEITIS,1
AU,AMNESIA,1
AU,ANAEMIA OF CHRONIC DISEASE,1
AU,ANAL PRURITUS,1
AU,ANAL SQUAMOUS CELL CARCINOMA,1
AU,ANAPHYLACTOID REACTION,1
AU,ANASTOMOTIC LEAK,1
AU,ANEURYSM,1
AU,ANGER,1
AU,ANION GAP DECREASED,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,APLASTIC ANAEMIA,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTHRITIS,1
AU,ASPIRATION,1
AU,ATELECTASIS,1
AU,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
AU,ATROPHIC VULVOVAGINITIS,1
AU,AUTOANTIBODY POSITIVE,1
AU,AUTOIMMUNE HEPATITIS,1
AU,AUTOIMMUNE PANCREATITIS,1
AU,AUTOIMMUNE THYROIDITIS,1
AU,B-CELL LYMPHOMA,1
AU,BACK INJURY,1
AU,BASE EXCESS INCREASED,1
AU,BEDRIDDEN,1
AU,BILIARY COLIC,1
AU,BILIARY SEPSIS,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BLISTER,1
AU,BLOOD BICARBONATE DECREASED,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD CALCIUM INCREASED,1
AU,BLOOD CHLORIDE DECREASED,1
AU,BLOOD CHLORIDE INCREASED,1
AU,BLOOD CHOLESTEROL INCREASED,1
AU,BLOOD FIBRINOGEN INCREASED,1
AU,BLOOD IRON DECREASED,1
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD MAGNESIUM INCREASED,1
AU,BLOOD OSMOLARITY DECREASED,1
AU,BLOOD OSMOLARITY INCREASED,1
AU,BLOOD PH DECREASED,1
AU,BLOOD PRESSURE ABNORMAL,1
AU,BLOOD SODIUM DECREASED,1
AU,BLOOD SODIUM INCREASED,1
AU,BLOOD TEST ABNORMAL,1
AU,BLOOD THYROID STIMULATING HORMONE INCREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BLOOD UREA NITROGEN/CREATININE RATIO DECREASED,1
AU,BLOOD URIC ACID INCREASED,1
AU,BODY MASS INDEX INCREASED,1
AU,BODY TEMPERATURE DECREASED,1
AU,BONE CANCER METASTATIC,1
AU,BRADYCARDIA,1
AU,BRONCHIECTASIS,1
AU,BRONCHOPULMONARY ASPERGILLOSIS,1
AU,BURNING SENSATION,1
AU,CALCINOSIS,1
AU,CALCIUM IONISED DECREASED,1
AU,CARDIAC FAILURE ACUTE,1
AU,CARDIAC MURMUR,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOMEGALY,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CAROTID BRUIT,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CATARACT,1
AU,CENTRAL OBESITY,1
AU,CEREBRAL HAEMORRHAGE,1
AU,CEREBRAL INFARCTION,1
AU,CHOLANGITIS,1
AU,CHOLANGITIS SCLEROSING,1
AU,CHOLECYSTECTOMY,1
AU,CHROMATURIA,1
AU,CHRONIC KIDNEY DISEASE,1
AU,CLAVICLE FRACTURE,1
AU,COLECTOMY,1
AU,COLITIS,1
AU,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
AU,CONTUSION,1
AU,CORONARY ARTERIAL STENT INSERTION,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CUSHINGOID,1
AU,CYSTIC FIBROSIS LUNG,1
AU,CYSTITIS,1
AU,CYTOMEGALOVIRUS INFECTION,1
AU,DEAFNESS,1
AU,DECREASED INTEREST,1
AU,DECUBITUS ULCER,1
AU,DEMENTIA WITH LEWY BODIES,1
AU,DENTAL CARIES,1
AU,DEPENDENCE ON OXYGEN THERAPY,1
AU,DERMATITIS CONTACT,1
AU,DERMATITIS EXFOLIATIVE,1
AU,DERMATOMYOSITIS,1
AU,DEVICE USE ERROR,1
AU,DIABETES MELLITUS,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DILATATION VENTRICULAR,1
AU,DISCOMFORT,1
AU,DISEASE RECURRENCE,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG DIVERSION,1
AU,DRUG HYPERSENSITIVITY,1
AU,DRUG RESISTANCE,1
AU,DRUG TOLERANCE DECREASED,1
AU,DRUG WITHDRAWAL SYNDROME,1
AU,DRUG-INDUCED LIVER INJURY,1
AU,DUODENAL OBSTRUCTION,1
AU,DYSPHEMIA,1
AU,DYSURIA,1
AU,ECHOCARDIOGRAM ABNORMAL,1
AU,ECZEMA,1
AU,ECZEMA NUMMULAR,1
AU,EJECTION FRACTION DECREASED,1
AU,ELECTROCARDIOGRAM Q WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
AU,ENDOTRACHEAL INTUBATION COMPLICATION,1
AU,EOSINOPHIL COUNT DECREASED,1
AU,EOSINOPHIL COUNT INCREASED,1
AU,EOSINOPHILIA,1
AU,EPSTEIN-BARR VIRUS INFECTION,1
AU,ERUCTATION,1
AU,ERYTHEMA,1
AU,EXPIRED PRODUCT ADMINISTERED,1
AU,EXTRA DOSE ADMINISTERED,1
AU,EXTRAPYRAMIDAL DISORDER,1
AU,EYE PRURITUS,1
AU,EYELASH THICKENING,1
AU,FACE OEDEMA,1
AU,FACIAL PARESIS,1
AU,FACTOR VIII INHIBITION,1
AU,FAECALOMA,1
AU,FEAR,1
AU,FEELING DRUNK,1
AU,FEELING HOT,1
AU,FEELING JITTERY,1
AU,FEELING OF DESPAIR,1
AU,FIBROSIS,1
AU,FOETAL EXPOSURE DURING PREGNANCY,1
AU,FOETAL MACROSOMIA,1
AU,FOLLICULITIS,1
AU,FOREARM FRACTURE,1
AU,GAIT DISTURBANCE,1
AU,GALACTORRHOEA,1
AU,GALLBLADDER DISORDER,1
AU,GALLBLADDER ENLARGEMENT,1
AU,GASTRIC DILATATION,1
AU,GASTRIC HAEMORRHAGE,1
AU,GASTRIC ULCER,1
AU,GASTRIC ULCER PERFORATION,1
AU,GASTROENTERITIS RADIATION,1
AU,GASTROINTESTINAL CARCINOMA,1
AU,GASTROINTESTINAL DISORDER,1
AU,GASTROINTESTINAL INFLAMMATION,1
AU,GASTROINTESTINAL STOMA COMPLICATION,1
AU,GASTROINTESTINAL TUBE INSERTION,1
AU,GENITAL NEOPLASM MALIGNANT FEMALE,1
AU,GINGIVAL BLEEDING,1
AU,GINGIVAL DISORDER,1
AU,GINGIVAL SWELLING,1
AU,GLIOSIS,1
AU,GLOBULINS DECREASED,1
AU,GOUT,1
AU,HAEMANGIOMA OF BONE,1
AU,HAEMATEMESIS,1
AU,HAEMATOMA,1
AU,HAEMATURIA,1
AU,HAEMORRHAGE,1
AU,HAEMORRHOIDS,1
AU,HEAD INJURY,1
AU,HEMIANOPIA,1
AU,HEPATIC CYST,1
AU,HEPATIC ENCEPHALOPATHY,1
AU,HEPATIC ENZYME INCREASED,1
AU,HEPATIC FAILURE,1
AU,HODGKIN^S DISEASE,1
AU,HOSPITALISATION,1
AU,HUMAN METAPNEUMOVIRUS TEST POSITIVE,1
AU,HYPERCALCAEMIA,1
AU,HYPERLIPIDAEMIA,1
AU,HYPERPHOSPHATAEMIA,1
AU,HYPOAESTHESIA ORAL,1
AU,HYPOCALCAEMIA,1
AU,HYPOCHONDRIASIS,1
AU,HYPOMAGNESAEMIA,1
AU,HYPOMANIA,1
AU,HYPOPHAGIA,1
AU,HYPOPNOEA,1
AU,HYPOTHYROIDISM,1
AU,HYPOXIA,1
AU,HYSTERECTOMY,1
AU,IMMUNODEFICIENCY COMMON VARIABLE,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INCONTINENCE,1
AU,INCORRECT DOSE ADMINISTERED BY DEVICE,1
AU,INCORRECT DRUG ADMINISTRATION DURATION,1
AU,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AU,INCREASED UPPER AIRWAY SECRETION,1
AU,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,1
AU,INFLAMMATORY MARKER INCREASED,1
AU,INFUSION SITE REACTION,1
AU,INGUINAL HERNIA,1
AU,INHALATION THERAPY,1
AU,INJECTION SITE URTICARIA,1
AU,INTENTIONAL OVERDOSE,1
AU,INTENTIONAL PRODUCT MISUSE,1
AU,INTENTIONAL PRODUCT USE ISSUE,1
AU,INTENTIONAL SELF-INJURY,1
AU,INTERVERTEBRAL DISC PROTRUSION,1
AU,INTESTINAL DILATATION,1
AU,INTESTINAL ISCHAEMIA,1
AU,INTRAOCULAR PRESSURE INCREASED,1
AU,IRON DEFICIENCY,1
AU,JOINT INJURY,1
AU,LACTIC ACIDOSIS,1
AU,LAPAROTOMY,1
AU,LARGE INTESTINAL OBSTRUCTION,1
AU,LARGE INTESTINE POLYP,1
AU,LARYNGECTOMY,1
AU,LEUKOPENIA,1
AU,LIGAMENT SPRAIN,1
AU,LIP SWELLING,1
AU,LIVE BIRTH,1
AU,LIVER FUNCTION TEST ABNORMAL,1
AU,LIVER FUNCTION TEST INCREASED,1
AU,LIVER INJURY,1
AU,LOOSE TOOTH,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LOWER GASTROINTESTINAL HAEMORRHAGE,1
AU,LUNG ADENOCARCINOMA,1
AU,LUNG CANCER METASTATIC,1
AU,LUNG INFILTRATION,1
AU,LUNG NEOPLASM MALIGNANT,1
AU,LYMPHADENOPATHY,1
AU,LYMPHOCYTE COUNT DECREASED,1
AU,MALIGNANT MELANOMA,1
AU,MANIA,1
AU,MATERNAL EXPOSURE DURING PREGNANCY,1
AU,MEAN CELL VOLUME INCREASED,1
AU,MEDICATION ERROR,1
AU,MEDICATION RESIDUE PRESENT,1
AU,MEMORY IMPAIRMENT,1
AU,MENINGITIS,1
AU,MESOTHELIOMA,1
AU,METASTASES TO BONE,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,METASTASES TO LIVER,1
AU,METASTASES TO LUNG,1
AU,METASTASES TO LYMPH NODES,1
AU,METASTATIC SQUAMOUS CELL CARCINOMA,1
AU,METRORRHAGIA,1
AU,MICROALBUMINURIA,1
AU,MIGRAINE,1
AU,MOVEMENT DISORDER,1
AU,MUCINOUS ADENOCARCINOMA OF APPENDIX,1
AU,MUCINOUS CYSTADENOCARCINOMA OVARY,1
AU,MUCOSAL INFLAMMATION,1
AU,MUCOUS MEMBRANE DISORDER,1
AU,MULTI-ORGAN FAILURE,1
AU,MULTIPLE FRACTURES,1
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AU,MULTIPLE SCLEROSIS RELAPSE,1
AU,MUSCLE CONTRACTIONS INVOLUNTARY,1
AU,MUSCLE DISORDER,1
AU,MUSCLE FATIGUE,1
AU,MUSCLE INJURY,1
AU,MUSCLE SPASTICITY,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MUSCULOSKELETAL DISCOMFORT,1
AU,MUSCULOSKELETAL DISORDER,1
AU,MUSCULOSKELETAL STIFFNESS,1
AU,MYOCLONUS,1
AU,MYOPATHY,1
AU,NASAL DISCOMFORT,1
AU,NECROSIS,1
AU,NEOPLASM,1
AU,NEOPLASM MALIGNANT,1
AU,NEOPLASM PROSTATE,1
AU,NEPHROLITHIASIS,1
AU,NEUROLOGIC NEGLECT SYNDROME,1
AU,NEUROLOGICAL SYMPTOM,1
AU,NEUROPATHY PERIPHERAL,1
AU,NEUTROPHIL COUNT ABNORMAL,1
AU,NEUTROPHILIA,1
AU,NON-SMALL CELL LUNG CANCER,1
AU,OBSTRUCTIVE AIRWAYS DISORDER,1
AU,OEDEMA,1
AU,OESOPHAGEAL PERFORATION,1
AU,OESOPHAGEAL ULCER,1
AU,OLIGODENDROGLIOMA,1
AU,OPTIC NEURITIS,1
AU,ORAL HERPES,1
AU,ORAL PAIN,1
AU,ORGAN FAILURE,1
AU,ORTHOPNOEA,1
AU,OSTEOPOROTIC FRACTURE,1
AU,OXYGEN SATURATION INCREASED,1
AU,PAIN IN JAW,1
AU,PAIN OF SKIN,1
AU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
AU,PANCREATITIS ACUTE,1
AU,PAPILLOMA VIRAL INFECTION,1
AU,PARAESTHESIA ORAL,1
AU,PARATHYROID DISORDER,1
AU,PCO2 INCREASED,1
AU,PELVIC FRACTURE,1
AU,PELVIC PAIN,1
AU,PERFORMANCE STATUS DECREASED,1
AU,PERIPHERAL ARTERY STENOSIS,1
AU,PERIPHERAL COLDNESS,1
AU,PERIPHERAL VASCULAR DISORDER,1
AU,PERITONECTOMY,1
AU,PHARYNGITIS,1
AU,PHOTOPHOBIA,1
AU,PLANTAR FASCIITIS,1
AU,PLASMA CELL MYELOMA,1
AU,PLEURAL FIBROSIS,1
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AU,PNEUMONIA ASPIRATION,1
AU,PNEUMONIA PSEUDOMONAL,1
AU,PNEUMONITIS,1
AU,PNEUMOTHORAX,1
AU,PO2 INCREASED,1
AU,POLLAKIURIA,1
AU,POLYCYSTIC OVARIES,1
AU,POST PROCEDURAL INFECTION,1
AU,POSTPARTUM HAEMORRHAGE,1
AU,PRE-EXISTING CONDITION IMPROVED,1
AU,PRESCRIBED UNDERDOSE,1
AU,PROCTALGIA,1
AU,PRODUCT USE ISSUE,1
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
AU,PROTEIN TOTAL DECREASED,1
AU,PROTEIN TOTAL INCREASED,1
AU,PROTHROMBIN TIME PROLONGED,1
AU,PSORIATIC ARTHROPATHY,1
AU,PSYCHOMOTOR HYPERACTIVITY,1
AU,PULMONARY CONGESTION,1
AU,PULMONARY FUNCTION TEST DECREASED,1
AU,PULMONARY VALVE INCOMPETENCE,1
AU,PULMONARY VASCULAR DISORDER,1
AU,PULSE ABSENT,1
AU,PURPURA,1
AU,RADIUS FRACTURE,1
AU,RASH FOLLICULAR,1
AU,RASH MACULAR,1
AU,RASH PRURITIC,1
AU,RECTAL CANCER,1
AU,RECTOSIGMOID CANCER,1
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AU,RENAL CANCER,1
AU,RENAL DISORDER,1
AU,RESPIRATORY ARREST,1
AU,RESPIRATORY DISORDER,1
AU,RESPIRATORY SYMPTOM,1
AU,RESPIRATORY TRACT CONGESTION,1
AU,RESPIRATORY TRACT INFECTION,1
AU,RETINAL ARTERY OCCLUSION,1
AU,RHINORRHOEA,1
AU,RHINOVIRUS INFECTION,1
AU,RIB FRACTURE,1
AU,RIGHT ATRIAL DILATATION,1
AU,RIGHT VENTRICULAR FAILURE,1
AU,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,1
AU,ROSACEA,1
AU,SALIVARY HYPERSECRETION,1
AU,SCHIZOPHRENIA_ PARANOID TYPE,1
AU,SCIATICA,1
AU,SEDATION,1
AU,SEIZURE,1
AU,SEPTIC SHOCK,1
AU,SEROTONIN SYNDROME,1
AU,SEXUALLY TRANSMITTED DISEASE,1
AU,SINUS TACHYCARDIA,1
AU,SINUSITIS,1
AU,SKIN BURNING SENSATION,1
AU,SKIN DISCOLOURATION,1
AU,SKIN DISORDER,1
AU,SKIN EXFOLIATION,1
AU,SKIN FISSURES,1
AU,SKIN GRAFT,1
AU,SKIN INFECTION,1
AU,SKIN LESION,1
AU,SKIN NEOPLASM EXCISION,1
AU,SKIN STRIAE,1
AU,SLEEP APNOEA SYNDROME,1
AU,SMALL INTESTINAL OBSTRUCTION,1
AU,SMEAR CERVIX ABNORMAL,1
AU,SOLAR LENTIGO,1
AU,SPINAL COLUMN STENOSIS,1
AU,SPINAL OPERATION,1
AU,SPINAL OSTEOARTHRITIS,1
AU,SPONDYLOLISTHESIS,1
AU,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
AU,STERNAL FRACTURE,1
AU,STRIDOR,1
AU,SUBDURAL HAEMATOMA,1
AU,SUDDEN CARDIAC DEATH,1
AU,SUDDEN DEATH,1
AU,SUPRAVENTRICULAR TACHYCARDIA,1
AU,TENDONITIS,1
AU,THALAMUS HAEMORRHAGE,1
AU,THERAPEUTIC RESPONSE UNEXPECTED,1
AU,THERAPY NON-RESPONDER,1
AU,THIRST DECREASED,1
AU,THROAT IRRITATION,1
AU,THROAT TIGHTNESS,1
AU,THYROID MASS,1
AU,TIC,1
AU,TONGUE DISORDER,1
AU,TOOTH ABSCESS,1
AU,TOOTH DISORDER,1
AU,TOOTH LOSS,1
AU,TOXIC NODULAR GOITRE,1
AU,TOXICITY TO VARIOUS AGENTS,1
AU,TRAUMATIC HAEMORRHAGE,1
AU,TRAUMATIC LUNG INJURY,1
AU,TREATMENT NONCOMPLIANCE,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,UNDERDOSE,1
AU,UNRESPONSIVE TO STIMULI,1
AU,UPPER LIMB FRACTURE,1
AU,URINARY INCONTINENCE,1
AU,URINARY RETENTION,1
AU,URINARY TRACT INFECTION ENTEROCOCCAL,1
AU,URINE OUTPUT DECREASED,1
AU,UROSEPSIS,1
AU,UVEITIS,1
AU,VARICOSE VEIN,1
AU,VENOUS PRESSURE INCREASED,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VENTRICULAR FIBRILLATION,1
AU,VENTRICULAR HYPOKINESIA,1
AU,VERTIGO POSITIONAL,1
AU,VESTIBULAR NEURONITIS,1
AU,VIITH NERVE PARALYSIS,1
AU,VISUAL ACUITY REDUCED,1
AU,VITAMIN B12 DEFICIENCY,1
AU,VULVOVAGINAL PRURITUS,1
AU,WAIST CIRCUMFERENCE INCREASED,1
AU,WHEELCHAIR USER,1
AU,WHITE BLOOD CELL COUNT DECREASED,1
AU,WOUND ABSCESS,1
AU,WRIST FRACTURE,1
AU,WRONG DRUG ADMINISTERED,1
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BD,ANAEMIA OF CHRONIC DISEASE,1
BD,BLOOD ALBUMIN DECREASED,1
BD,DEAFNESS,1
BD,DECREASED APPETITE,1
BD,DYSPNOEA EXERTIONAL,1
BD,ELECTROLYTE IMBALANCE,1
BD,HAEMOPTYSIS,1
BD,HYPOCALCAEMIA,1
BD,INTENTIONAL PRODUCT USE ISSUE,1
BD,MYOCARDIAL ISCHAEMIA,1
BD,VOMITING,1
BE,FOETAL EXPOSURE DURING PREGNANCY,12
BE,DYSPNOEA,6
BE,FOETAL MALFORMATION,6
BE,PREMATURE BABY,6
BE,RESPIRATORY DISTRESS,6
BE,TRISOMY 18,5
BE,ABORTION INDUCED,4
BE,EXPOSURE DURING PREGNANCY,4
BE,ASTHMA,3
BE,DRUG INEFFECTIVE,3
BE,GAIT DISTURBANCE,3
BE,MYALGIA,3
BE,AGITATION,2
BE,ALOPECIA,2
BE,CAESAREAN SECTION,2
BE,CARDIAC FAILURE,2
BE,COMA,2
BE,CONDITION AGGRAVATED,2
BE,CONGENITAL ANOMALY IN OFFSPRING,2
BE,DIARRHOEA,2
BE,FATIGUE,2
BE,FEBRILE NEUTROPENIA,2
BE,GENERAL PHYSICAL HEALTH DETERIORATION,2
BE,HEADACHE,2
BE,IRRITABILITY,2
BE,LYMPHOEDEMA,2
BE,MATERNAL DRUGS AFFECTING FOETUS,2
BE,MATERNAL EXPOSURE DURING PREGNANCY,2
BE,NAUSEA,2
BE,OVERDOSE,2
BE,PREMATURE DELIVERY,2
BE,SOMNOLENCE,2
BE,ABASIA,1
BE,ABNORMAL BEHAVIOUR,1
BE,ACUTE KIDNEY INJURY,1
BE,AGGRESSION,1
BE,ALCOHOL ABUSE,1
BE,ALOPECIA TOTALIS,1
BE,AMNESIA,1
BE,ANAEMIA,1
BE,ANAPHYLACTIC REACTION,1
BE,ANKLE FRACTURE,1
BE,APHTHOUS ULCER,1
BE,ARRHYTHMIA,1
BE,ARTHRALGIA,1
BE,ARTHRITIS,1
BE,ATRIAL FIBRILLATION,1
BE,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
BE,BLOOD CHOLESTEROL INCREASED,1
BE,BONE DISORDER,1
BE,BRONCHOSPASM,1
BE,CARDIAC ARREST,1
BE,CENTRAL NERVOUS SYSTEM LESION,1
BE,CHOLECYSTITIS,1
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BE,CLUSTER HEADACHE,1
BE,COMPLEX PARTIAL SEIZURES,1
BE,CONCOMITANT DISEASE PROGRESSION,1
BE,CONVULSION,1
BE,CUSHING^S SYNDROME,1
BE,CUTANEOUS LUPUS ERYTHEMATOSUS,1
BE,DEATH,1
BE,DECREASED APPETITE,1
BE,DEPRESSION,1
BE,DERMATITIS ACNEIFORM,1
BE,DYSARTHRIA,1
BE,DYSGEUSIA,1
BE,ECZEMA,1
BE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
BE,EPIDIDYMITIS,1
BE,EPILEPSY,1
BE,ERYSIPELAS,1
BE,FACE OEDEMA,1
BE,FALL,1
BE,FEELING ABNORMAL,1
BE,FLATULENCE,1
BE,GASTROINTESTINAL DISORDER,1
BE,GENERALISED ERYTHEMA,1
BE,HAEMOLYTIC URAEMIC SYNDROME,1
BE,HEMIPARESIS,1
BE,HEPATIC FUNCTION ABNORMAL,1
BE,HYDROCEPHALUS,1
BE,HYPERAMMONAEMIA,1
BE,HYPERCHOLESTEROLAEMIA,1
BE,HYPEREOSINOPHILIC SYNDROME,1
BE,HYPERNATRAEMIA,1
BE,HYPERTENSION,1
BE,HYPONATRAEMIA,1
BE,HYPOTENSION,1
BE,HYPOTHERMIA,1
BE,HYPOTHYROIDISM,1
BE,ILL-DEFINED DISORDER,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INSOMNIA,1
BE,INSULIN RESISTANCE,1
BE,LIVE BIRTH,1
BE,LOCALISED OEDEMA,1
BE,LOSS OF CONSCIOUSNESS,1
BE,LOW DENSITY LIPOPROTEIN INCREASED,1
BE,LUNG INFECTION,1
BE,LYMPHANGITIS,1
BE,MENINGIOMA,1
BE,MENINGITIS ASEPTIC,1
BE,METABOLIC DISORDER,1
BE,MOOD ALTERED,1
BE,MUSCLE TIGHTNESS,1
BE,MUSCULOSKELETAL DISORDER,1
BE,MYOPATHY,1
BE,NAIL DISORDER,1
BE,NECK PAIN,1
BE,NEONATAL RESPIRATORY DISTRESS,1
BE,NERVE INJURY,1
BE,NERVOUS SYSTEM DISORDER,1
BE,OBSTRUCTIVE AIRWAYS DISORDER,1
BE,ODYNOPHAGIA,1
BE,OEDEMA PERIPHERAL,1
BE,ORCHITIS,1
BE,OROPHARYNGEAL PAIN,1
BE,OSTEITIS,1
BE,OSTEONECROSIS OF JAW,1
BE,PAIN,1
BE,PAIN IN EXTREMITY,1
BE,PAIN IN JAW,1
BE,PARONYCHIA,1
BE,PERIPHERAL MOTOR NEUROPATHY,1
BE,PERIPHERAL SENSORY NEUROPATHY,1
BE,PERONEAL NERVE PALSY,1
BE,PHARYNGEAL INFLAMMATION,1
BE,PHARYNGEAL OEDEMA,1
BE,PNEUMONIA,1
BE,POISONING,1
BE,POLYARTHRITIS,1
BE,PRESYNCOPE,1
BE,PRODUCT QUALITY ISSUE,1
BE,PRODUCT USE ISSUE,1
BE,PRODUCTIVE COUGH,1
BE,PULMONARY EMBOLISM,1
BE,PYREXIA,1
BE,RADIOALLERGOSORBENT TEST POSITIVE,1
BE,RASH MACULAR,1
BE,RESPIRATORY DEPRESSION,1
BE,RESPIRATORY TRACT INFECTION,1
BE,RHEUMATIC DISORDER,1
BE,SINUSITIS,1
BE,SKIN PLAQUE,1
BE,SKIN STRIAE,1
BE,STATUS EPILEPTICUS,1
BE,SUDDEN DEATH,1
BE,SUICIDE ATTEMPT,1
BE,SWOLLEN TONGUE,1
BE,TACHYCARDIA,1
BE,THERAPY NON-RESPONDER,1
BE,THROAT TIGHTNESS,1
BE,THROMBOCYTOPENIA,1
BE,THROMBOPHLEBITIS SUPERFICIAL,1
BE,TOOTH DISORDER,1
BE,TOOTHACHE,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,URTICARIA,1
BE,VOMITING,1
BE,WEIGHT INCREASED,1
BZ,PREGNANCY,1
BA,DIARRHOEA,1
BA,EPISTAXIS,1
BA,OBSTRUCTIVE AIRWAYS DISORDER,1
BA,THERAPY NON-RESPONDER,1
BR,PNEUMONIA,3
BR,ASTHMA,2
BR,CHEST PAIN,2
BR,DYSPNOEA,2
BR,HYPERTENSION,2
BR,ABDOMINAL PAIN,1
BR,ANGINA PECTORIS,1
BR,ANTIPHOSPHOLIPID SYNDROME,1
BR,APATHY,1
BR,APHASIA,1
BR,ARTHRALGIA,1
BR,BLOOD PRESSURE FLUCTUATION,1
BR,BRONCHITIS,1
BR,CARDIAC ARREST,1
BR,CARDIAC DISORDER,1
BR,CARDIO-RESPIRATORY ARREST,1
BR,CEREBROVASCULAR ACCIDENT,1
BR,CHEST DISCOMFORT,1
BR,COUGH,1
BR,DIZZINESS,1
BR,EAR INFECTION,1
BR,GAIT DISTURBANCE,1
BR,HAEMATOCHEZIA,1
BR,HYPERSENSITIVITY,1
BR,INFLUENZA,1
BR,LOSS OF CONSCIOUSNESS,1
BR,MALAISE,1
BR,MEMORY IMPAIRMENT,1
BR,MOUTH HAEMORRHAGE,1
BR,MYOCARDIAL INFARCTION,1
BR,NEPHROLITHIASIS,1
BR,PAIN,1
BR,PARAESTHESIA,1
BR,PNEUMOTHORAX,1
BR,PRODUCT USE ISSUE,1
BR,PSORIASIS,1
BR,PSORIATIC ARTHROPATHY,1
BR,PULMONARY EMBOLISM,1
BR,RENAL PAIN,1
BR,RESPIRATORY ARREST,1
BR,SEIZURE,1
BR,SNORING,1
BR,SPUTUM DISCOLOURED,1
BR,SYNCOPE,1
BR,TUBERCULOSIS,1
BR,URINARY TRACT INFECTION,1
BR,VACCINATION FAILURE,1
BG,ACCIDENTAL OVERDOSE,2
BG,ASTHMA,2
BG,BLOOD CREATININE INCREASED,2
BG,CRYING,2
BG,HEART RATE INCREASED,2
BG,HEPATITIS C,2
BG,HYPERKALAEMIA,2
BG,OVERDOSE,2
BG,ACCIDENTAL EXPOSURE TO PRODUCT,1
BG,COLITIS ULCERATIVE,1
BG,COUGH,1
BG,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BG,DISCOMFORT,1
BG,DYSPNOEA,1
BG,ELECTROCARDIOGRAM QT PROLONGED,1
BG,EPILEPSY,1
BG,HAEMATURIA,1
BG,HYPERTENSION,1
BG,HYPOXIA,1
BG,MUSCLE SPASMS,1
BG,NERVOUSNESS,1
BG,NODAL RHYTHM,1
BG,PNEUMONITIS,1
BG,POISONING,1
BG,PROSTATE CANCER,1
BG,TACHYCARDIA,1
BG,TELANGIECTASIA,1
KH,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
KH,DRUG RESISTANCE,1
KH,INJECTION SITE HAEMORRHAGE,1
CM,CONDITION AGGRAVATED,1
CM,DRUG INEFFECTIVE,1
CM,GASTROINTESTINAL DISORDER,1
CM,HEADACHE,1
CM,INFECTION,1
CM,MOBILITY DECREASED,1
CM,NAUSEA,1
CM,PNEUMOTHORAX,1
CM,SPINAL FRACTURE,1
CM,VOMITING,1
CA,DYSPNOEA,907
CA,ASTHMA,906
CA,COUGH,653
CA,MALAISE,579
CA,FATIGUE,544
CA,PNEUMONIA,508
CA,NASOPHARYNGITIS,505
CA,BLOOD PRESSURE INCREASED,420
CA,DRUG INEFFECTIVE,417
CA,WHEEZING,410
CA,HEADACHE,388
CA,PRODUCTIVE COUGH,379
CA,WEIGHT DECREASED,372
CA,INFLUENZA,342
CA,PAIN,326
CA,HEART RATE INCREASED,321
CA,NAUSEA,290
CA,DIZZINESS,268
CA,LOWER RESPIRATORY TRACT INFECTION,264
CA,PYREXIA,261
CA,ASTHENIA,258
CA,WEIGHT INCREASED,258
CA,BRONCHITIS,254
CA,FORCED EXPIRATORY VOLUME DECREASED,254
CA,LUNG INFECTION,243
CA,BLOOD PRESSURE SYSTOLIC INCREASED,240
CA,SINUSITIS,237
CA,FALL,228
CA,CHEST DISCOMFORT,223
CA,ARTHRALGIA,219
CA,DIARRHOEA,217
CA,HYPERSENSITIVITY,217
CA,OROPHARYNGEAL PAIN,214
CA,PAIN IN EXTREMITY,208
CA,VOMITING,207
CA,SPUTUM DISCOLOURED,197
CA,INSOMNIA,177
CA,NASAL CONGESTION,176
CA,BACK PAIN,172
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,167
CA,HYPERTENSION,164
CA,RESPIRATORY RATE INCREASED,160
CA,DYSPNOEA EXERTIONAL,159
CA,PRURITUS,159
CA,BODY TEMPERATURE DECREASED,158
CA,OBSTRUCTIVE AIRWAYS DISORDER,153
CA,OXYGEN SATURATION DECREASED,149
CA,RESPIRATORY DISORDER,142
CA,CONTUSION,138
CA,CHEST PAIN,135
CA,ANXIETY,130
CA,LUNG DISORDER,130
CA,MIDDLE INSOMNIA,130
CA,FEELING ABNORMAL,129
CA,RHINORRHOEA,127
CA,INFECTION,125
CA,PERIPHERAL SWELLING,125
CA,RASH,125
CA,STRESS,115
CA,RESPIRATORY TRACT CONGESTION,112
CA,URTICARIA,111
CA,DEATH,110
CA,ABDOMINAL PAIN,108
CA,DECREASED APPETITE,105
CA,ABDOMINAL PAIN UPPER,103
CA,ERYTHEMA,103
CA,CONDITION AGGRAVATED,102
CA,GAIT DISTURBANCE,102
CA,MYALGIA,99
CA,DYSPHONIA,97
CA,BLOOD PRESSURE DECREASED,94
CA,HYPOAESTHESIA,90
CA,INJECTION SITE PAIN,90
CA,ARTHRITIS,85
CA,URINARY TRACT INFECTION,85
CA,DIABETES MELLITUS,84
CA,INFLUENZA LIKE ILLNESS,84
CA,MYOCARDIAL INFARCTION,82
CA,SOMNOLENCE,81
CA,CHILLS,80
CA,HYPOVENTILATION,80
CA,BREATH SOUNDS ABNORMAL,76
CA,JOINT SWELLING,75
CA,RESPIRATORY TRACT INFECTION,74
CA,GENERAL PHYSICAL HEALTH DETERIORATION,73
CA,UPPER RESPIRATORY TRACT INFECTION,73
CA,OEDEMA PERIPHERAL,72
CA,MIGRAINE,71
CA,MUSCLE SPASMS,71
CA,RALES,71
CA,TREMOR,71
CA,INFUSION RELATED REACTION,70
CA,SENSITIVITY TO WEATHER CHANGE,70
CA,VIRAL INFECTION,70
CA,LOSS OF CONSCIOUSNESS,69
CA,HYPOTENSION,68
CA,SEASONAL ALLERGY,68
CA,MUSCULOSKELETAL STIFFNESS,67
CA,PULMONARY CONGESTION,67
CA,PRODUCT USE ISSUE,64
CA,HYPERHIDROSIS,63
CA,RHEUMATOID ARTHRITIS,63
CA,DEPRESSION,62
CA,SECRETION DISCHARGE,62
CA,THROAT IRRITATION,62
CA,DYSPEPSIA,61
CA,PALPITATIONS,61
CA,ABDOMINAL DISCOMFORT,60
CA,SINUS CONGESTION,60
CA,BRONCHOSPASM,59
CA,GASTROOESOPHAGEAL REFLUX DISEASE,59
CA,MUSCULAR WEAKNESS,59
CA,PARAESTHESIA,57
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,57
CA,HAEMOGLOBIN DECREASED,56
CA,PULMONARY FUNCTION TEST DECREASED,56
CA,CARDIAC DISORDER,55
CA,ECZEMA,55
CA,BODY TEMPERATURE INCREASED,54
CA,HOT FLUSH,52
CA,SWELLING,52
CA,APHONIA,51
CA,DRY MOUTH,50
CA,CELLULITIS,49
CA,CONFUSIONAL STATE,49
CA,EAR INFECTION,49
CA,HEART RATE DECREASED,49
CA,TACHYCARDIA,49
CA,MUSCULOSKELETAL PAIN,48
CA,BLOOD IMMUNOGLOBULIN E INCREASED,47
CA,MOBILITY DECREASED,46
CA,PRODUCT QUALITY ISSUE,46
CA,DISCOMFORT,45
CA,LOWER RESPIRATORY TRACT CONGESTION,45
CA,OSTEOARTHRITIS,45
CA,PRURITUS GENERALISED,45
CA,ATRIAL FIBRILLATION,44
CA,ANAEMIA,43
CA,CATARACT,43
CA,EAR PAIN,43
CA,FEELING HOT,42
CA,SEPSIS,42
CA,DRUG DOSE OMISSION,41
CA,LIMB DISCOMFORT,41
CA,OSTEOPOROSIS,41
CA,SEIZURE,41
CA,BLOOD PRESSURE DIASTOLIC DECREASED,40
CA,CHOKING,40
CA,CONSTIPATION,40
CA,CROHN^S DISEASE,40
CA,DYSPHAGIA,40
CA,HERPES ZOSTER,40
CA,INJECTION SITE ERYTHEMA,39
CA,OVERDOSE,39
CA,VISION BLURRED,39
CA,ANAPHYLACTIC REACTION,38
CA,BALANCE DISORDER,38
CA,FORCED VITAL CAPACITY DECREASED,38
CA,GASTROINTESTINAL DISORDER,38
CA,LIMB INJURY,38
CA,SINUS DISORDER,38
CA,SYNCOPE,38
CA,DRUG HYPERSENSITIVITY,37
CA,ROAD TRAFFIC ACCIDENT,37
CA,SLEEP APNOEA SYNDROME,37
CA,ABDOMINAL DISTENSION,36
CA,ARTHROPATHY,36
CA,CARDIAC FAILURE CONGESTIVE,36
CA,DEHYDRATION,36
CA,EMPHYSEMA,36
CA,GASTROENTERITIS VIRAL,36
CA,HEART RATE IRREGULAR,36
CA,PULMONARY OEDEMA,36
CA,RESPIRATORY FAILURE,36
CA,SNEEZING,36
CA,DRY SKIN,35
CA,NECK PAIN,35
CA,PULMONARY MASS,35
CA,BLOOD CHOLESTEROL INCREASED,34
CA,BLOOD PRESSURE FLUCTUATION,34
CA,EPISTAXIS,34
CA,NERVOUSNESS,34
CA,PLEURAL EFFUSION,34
CA,RIB FRACTURE,34
CA,WHITE BLOOD CELL COUNT INCREASED,34
CA,BLOOD GLUCOSE INCREASED,33
CA,LUNG NEOPLASM MALIGNANT,33
CA,RESPIRATORY DISTRESS,33
CA,VISUAL IMPAIRMENT,33
CA,BURNING SENSATION,32
CA,CYSTITIS,32
CA,HAEMOPTYSIS,32
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,32
CA,LOCALISED INFECTION,32
CA,PULMONARY EMBOLISM,32
CA,RASH ERYTHEMATOUS,32
CA,SLEEP DISORDER,32
CA,THERAPEUTIC RESPONSE DECREASED,32
CA,THROMBOSIS,32
CA,ALOPECIA,31
CA,ILL-DEFINED DISORDER,31
CA,INFLAMMATION,31
CA,MEMORY IMPAIRMENT,31
CA,NASAL POLYPS,31
CA,THROAT TIGHTNESS,31
CA,WOUND,31
CA,HAEMATOCHEZIA,30
CA,HAEMORRHAGE,30
CA,NEPHROLITHIASIS,30
CA,PRODUCT USE IN UNAPPROVED INDICATION,30
CA,PULMONARY FUNCTION TEST ABNORMAL,30
CA,SPEECH DISORDER,30
CA,FIBROMYALGIA,29
CA,INCORRECT DOSE ADMINISTERED,29
CA,INJECTION SITE BRUISING,29
CA,CREPITATIONS,28
CA,EYE PRURITUS,28
CA,RHONCHI,28
CA,UPPER LIMB FRACTURE,28
CA,ACNE,27
CA,CEREBROVASCULAR ACCIDENT,27
CA,CONCOMITANT DISEASE AGGRAVATED,27
CA,NEOPLASM MALIGNANT,27
CA,SWELLING FACE,27
CA,TYPE 2 DIABETES MELLITUS,27
CA,DIVERTICULITIS,26
CA,FOOD ALLERGY,26
CA,FUNGAL INFECTION,26
CA,GASTROENTERITIS,26
CA,HYPOXIA,26
CA,INJECTION SITE PRURITUS,26
CA,INTESTINAL OBSTRUCTION,26
CA,JOINT INJURY,26
CA,NIGHT SWEATS,26
CA,RECTAL HAEMORRHAGE,26
CA,VERTIGO,26
CA,ANAPHYLACTIC SHOCK,25
CA,DRUG INTOLERANCE,25
CA,FOOT FRACTURE,25
CA,HYPERAESTHESIA,25
CA,INJECTION SITE SWELLING,25
CA,LYMPHADENOPATHY,25
CA,POOR QUALITY SLEEP,25
CA,PSORIASIS,25
CA,RENAL FAILURE,25
CA,BLOOD COUNT ABNORMAL,24
CA,BRONCHIECTASIS,24
CA,EOSINOPHIL COUNT INCREASED,24
CA,PALLOR,24
CA,PHARYNGEAL OEDEMA,24
CA,UPPER-AIRWAY COUGH SYNDROME,24
CA,BLOOD GLUCOSE DECREASED,23
CA,BONE DISORDER,23
CA,BONE PAIN,23
CA,CARDIAC FAILURE,23
CA,CHOLELITHIASIS,23
CA,DISTURBANCE IN ATTENTION,23
CA,DRY THROAT,23
CA,INCREASED UPPER AIRWAY SECRETION,23
CA,MOVEMENT DISORDER,23
CA,PHARYNGITIS,23
CA,AMNESIA,22
CA,ASTHMATIC CRISIS,22
CA,CYSTIC FIBROSIS,22
CA,HIP FRACTURE,22
CA,INCREASED BRONCHIAL SECRETION,22
CA,LACERATION,22
CA,LACRIMATION INCREASED,22
CA,LIGAMENT SPRAIN,22
CA,NASAL DISCHARGE DISCOLOURATION,22
CA,PULMONARY PAIN,22
CA,FLUSHING,21
CA,HEPATIC ENZYME INCREASED,21
CA,HIATUS HERNIA,21
CA,INTERVERTEBRAL DISC PROTRUSION,21
CA,RHINITIS,21
CA,COMA,20
CA,DRUG EFFECT DECREASED,20
CA,EYE SWELLING,20
CA,FLUID RETENTION,20
CA,GASTRIC DISORDER,20
CA,HYPOPHAGIA,20
CA,RESTRICTIVE PULMONARY DISEASE,20
CA,SPINAL FRACTURE,20
CA,TOOTH ABSCESS,20
CA,BACTERIAL INFECTION,19
CA,DUST ALLERGY,19
CA,IMPAIRED HEALING,19
CA,INJECTION SITE REACTION,19
CA,MUSCULOSKELETAL CHEST PAIN,19
CA,MUSCULOSKELETAL DISCOMFORT,19
CA,SEPTIC SHOCK,19
CA,SKIN DISCOLOURATION,19
CA,SKIN LESION,19
CA,ACCIDENT,18
CA,ADVERSE EVENT,18
CA,AGITATION,18
CA,ANGINA PECTORIS,18
CA,ANGIOEDEMA,18
CA,BLOOD IRON DECREASED,18
CA,BLOOD POTASSIUM DECREASED,18
CA,DRUG EFFECT INCOMPLETE,18
CA,EAR DISCOMFORT,18
CA,EYE PAIN,18
CA,LARYNGITIS,18
CA,OEDEMA,18
CA,POST PROCEDURAL COMPLICATION,18
CA,TINNITUS,18
CA,WOUND INFECTION,18
CA,ADRENAL INSUFFICIENCY,17
CA,BLOOD PRESSURE DIASTOLIC INCREASED,17
CA,BRONCHIAL DISORDER,17
CA,CYST,17
CA,DECREASED ACTIVITY,17
CA,DELIRIUM,17
CA,EXERCISE TOLERANCE DECREASED,17
CA,FEEDING DISORDER,17
CA,FEELING COLD,17
CA,HYPOKINESIA,17
CA,MUSCLE SPASTICITY,17
CA,ORAL CANDIDIASIS,17
CA,PANIC ATTACK,17
CA,PERFUME SENSITIVITY,17
CA,PNEUMOTHORAX,17
CA,PULMONARY FIBROSIS,17
CA,STAPHYLOCOCCAL INFECTION,17
CA,TOTAL LUNG CAPACITY DECREASED,17
CA,WHITE BLOOD CELL COUNT DECREASED,17
CA,ANKLE FRACTURE,16
CA,CYANOSIS,16
CA,DYSGEUSIA,16
CA,EYE DISORDER,16
CA,FREQUENT BOWEL MOVEMENTS,16
CA,JOINT STIFFNESS,16
CA,KIDNEY INFECTION,16
CA,LOCAL SWELLING,16
CA,RESPIRATION ABNORMAL,16
CA,SCRATCH,16
CA,SWOLLEN TONGUE,16
CA,ABDOMINAL PAIN LOWER,15
CA,ANOSMIA,15
CA,BURSITIS,15
CA,EOSINOPHILIA,15
CA,HYPOTHYROIDISM,15
CA,INJECTION SITE HAEMORRHAGE,15
CA,INJURY,15
CA,MATERNAL EXPOSURE DURING PREGNANCY,15
CA,MUSCLE STRAIN,15
CA,POOR VENOUS ACCESS,15
CA,RASH PRURITIC,15
CA,RENAL DISORDER,15
CA,STOMATITIS,15
CA,TENDONITIS,15
CA,TRANSIENT ISCHAEMIC ATTACK,15
CA,ARRHYTHMIA,14
CA,BASAL CELL CARCINOMA,14
CA,BRONCHIAL OBSTRUCTION,14
CA,CARPAL TUNNEL SYNDROME,14
CA,DYSURIA,14
CA,HYPERGLYCAEMIA,14
CA,INCREASED VISCOSITY OF BRONCHIAL SECRETION,14
CA,MOUTH ULCERATION,14
CA,OBESITY,14
CA,OCULAR HYPERAEMIA,14
CA,PHARYNGITIS STREPTOCOCCAL,14
CA,RED BLOOD CELL COUNT DECREASED,14
CA,RESTLESSNESS,14
CA,SPUTUM RETENTION,14
CA,SUICIDAL IDEATION,14
CA,TOOTH INFECTION,14
CA,ABASIA,13
CA,ABORTION SPONTANEOUS,13
CA,ACUTE KIDNEY INJURY,13
CA,ALLERGY TO ANIMAL,13
CA,BLINDNESS,13
CA,BLOOD URINE PRESENT,13
CA,BRAIN INJURY,13
CA,DYSPNOEA AT REST,13
CA,FACE OEDEMA,13
CA,FEAR OF INJECTION,13
CA,GASTROINTESTINAL INFLAMMATION,13
CA,IMMUNODEFICIENCY,13
CA,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,13
CA,INJECTION SITE WARMTH,13
CA,MENTAL DISORDER,13
CA,PANCREATITIS,13
CA,PARAESTHESIA ORAL,13
CA,PNEUMONITIS,13
CA,SMOKE SENSITIVITY,13
CA,SURGERY,13
CA,TEMPERATURE INTOLERANCE,13
CA,THYROID DISORDER,13
CA,TREATMENT NONCOMPLIANCE,13
CA,UNDERDOSE,13
CA,ABSCESS,12
CA,BLOOD PRESSURE ABNORMAL,12
CA,BREAST CANCER,12
CA,CHOKING SENSATION,12
CA,CLOSTRIDIUM DIFFICILE INFECTION,12
CA,DEEP VEIN THROMBOSIS,12
CA,DISEASE PROGRESSION,12
CA,DISORIENTATION,12
CA,FRACTURE,12
CA,HAEMATOMA,12
CA,HYPOGLYCAEMIA,12
CA,LETHARGY,12
CA,MUSCLE TIGHTNESS,12
CA,NEUTROPHIL COUNT INCREASED,12
CA,ORAL DISCOMFORT,12
CA,ORAL HERPES,12
CA,ORAL PAIN,12
CA,POST PROCEDURAL INFECTION,12
CA,PRODUCT SUBSTITUTION ISSUE,12
CA,PROSTATE CANCER,12
CA,PULMONARY HYPERTENSION,12
CA,SKIN EXFOLIATION,12
CA,SKIN ULCER,12
CA,SPUTUM INCREASED,12
CA,AGEUSIA,11
CA,BLOOD PRESSURE SYSTOLIC DECREASED,11
CA,BLOOD TEST ABNORMAL,11
CA,CANDIDA INFECTION,11
CA,CARDIAC ARREST,11
CA,DIABETES MELLITUS INADEQUATE CONTROL,11
CA,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,11
CA,EYE INFECTION,11
CA,FOOT DEFORMITY,11
CA,HEAD INJURY,11
CA,HERNIA,11
CA,JOINT DISLOCATION,11
CA,LOWER LIMB FRACTURE,11
CA,MALIGNANT NEOPLASM PROGRESSION,11
CA,MULTIPLE ALLERGIES,11
CA,PAIN IN JAW,11
CA,PARANASAL SINUS DISCOMFORT,11
CA,PEAK EXPIRATORY FLOW RATE DECREASED,11
CA,PHARYNGEAL DISORDER,11
CA,PNEUMONIA ASPIRATION,11
CA,POLLAKIURIA,11
CA,SCAR,11
CA,TACHYPNOEA,11
CA,TOOTH DISORDER,11
CA,TOOTHACHE,11
CA,UMBILICAL HERNIA,11
CA,WEIGHT FLUCTUATION,11
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,11
CA,ARTHROPOD BITE,10
CA,ATELECTASIS,10
CA,BLOOD CREATININE INCREASED,10
CA,BREAST MASS,10
CA,BRONCHITIS CHRONIC,10
CA,CRYING,10
CA,DISABILITY,10
CA,DRUG ADMINISTRATION ERROR,10
CA,EMOTIONAL DISTRESS,10
CA,FEAR,10
CA,FLANK PAIN,10
CA,GASTROINTESTINAL HAEMORRHAGE,10
CA,GLAUCOMA,10
CA,GOUT,10
CA,HAEMATURIA,10
CA,HOSPITALISATION,10
CA,HYPOACUSIS,10
CA,HYPOPNOEA,10
CA,IMMUNE SYSTEM DISORDER,10
CA,INTERSTITIAL LUNG DISEASE,10
CA,IRRITABILITY,10
CA,KNEE ARTHROPLASTY,10
CA,LIP SWELLING,10
CA,MASS,10
CA,NEUTROPENIA,10
CA,OSTEOMYELITIS,10
CA,PAINFUL RESPIRATION,10
CA,POSTOPERATIVE WOUND INFECTION,10
CA,PRESYNCOPE,10
CA,RHINITIS ALLERGIC,10
CA,SINUS HEADACHE,10
CA,SKIN ABRASION,10
CA,SKIN DISORDER,10
CA,SNORING,10
CA,VITAL CAPACITY DECREASED,10
CA,ABDOMINAL HERNIA,9
CA,ALANINE AMINOTRANSFERASE INCREASED,9
CA,ASPARTATE AMINOTRANSFERASE INCREASED,9
CA,ASPERGILLUS INFECTION,9
CA,ASPHYXIA,9
CA,ASPIRATION,9
CA,BACK INJURY,9
CA,BLISTER,9
CA,BLOOD DISORDER,9
CA,C-REACTIVE PROTEIN INCREASED,9
CA,COELIAC DISEASE,9
CA,COGNITIVE DISORDER,9
CA,DEPRESSED MOOD,9
CA,DYSSTASIA,9
CA,EYE IRRITATION,9
CA,FAECES DISCOLOURED,9
CA,FEBRILE NEUTROPENIA,9
CA,FLATULENCE,9
CA,GENERAL PHYSICAL CONDITION ABNORMAL,9
CA,HAEMATEMESIS,9
CA,HEPATIC CIRRHOSIS,9
CA,HUMIDITY INTOLERANCE,9
CA,HYPERSOMNIA,9
CA,INCREASED APPETITE,9
CA,MENISCUS INJURY,9
CA,NEURALGIA,9
CA,PERICARDIAL EFFUSION,9
CA,PERIPHERAL COLDNESS,9
CA,PLEURISY,9
CA,PULMONARY THROMBOSIS,9
CA,RASH GENERALISED,9
CA,RED BLOOD CELL COUNT INCREASED,9
CA,RED CELL DISTRIBUTION WIDTH INCREASED,9
CA,RESPIRATORY RATE DECREASED,9
CA,SCIATICA,9
CA,SINUS PAIN,9
CA,SKIN CANCER,9
CA,SKIN PLAQUE,9
CA,SPINAL PAIN,9
CA,TENDON RUPTURE,9
CA,THROMBOCYTOPENIA,9
CA,TOOTH LOSS,9
CA,UPPER RESPIRATORY TRACT CONGESTION,9
CA,VAGINAL HAEMORRHAGE,9
CA,VOCAL CORD DISORDER,9
CA,AGGRESSION,8
CA,BACK DISORDER,8
CA,BIPOLAR DISORDER,8
CA,BLINDNESS TRANSIENT,8
CA,BLOOD GLUCOSE ABNORMAL,8
CA,BRONCHIAL HYPERREACTIVITY,8
CA,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,8
CA,CHRONIC SINUSITIS,8
CA,COLD SWEAT,8
CA,CONJUNCTIVITIS,8
CA,CORONARY ARTERY OCCLUSION,8
CA,CUSHING^S SYNDROME,8
CA,DERMATITIS ATOPIC,8
CA,DISEASE RECURRENCE,8
CA,FEMUR FRACTURE,8
CA,FOOD POISONING,8
CA,FRUSTRATION TOLERANCE DECREASED,8
CA,GENERALISED ERYTHEMA,8
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
CA,HAND FRACTURE,8
CA,INJECTION SITE HYPERSENSITIVITY,8
CA,INJECTION SITE RASH,8
CA,LIGAMENT RUPTURE,8
CA,LIVER FUNCTION TEST ABNORMAL,8
CA,LUNG INFILTRATION,8
CA,MACULAR DEGENERATION,8
CA,NASAL DISORDER,8
CA,NODULE,8
CA,ORTHOSTATIC HYPOTENSION,8
CA,PERICARDITIS,8
CA,PLASMA CELL MYELOMA,8
CA,POLYP,8
CA,PSEUDOMONAS INFECTION,8
CA,PYELONEPHRITIS,8
CA,RENAL IMPAIRMENT,8
CA,RENAL PAIN,8
CA,SCOLIOSIS,8
CA,SKIN IRRITATION,8
CA,SPIROMETRY ABNORMAL,8
CA,STREPTOCOCCAL INFECTION,8
CA,THERAPY NON-RESPONDER,8
CA,URINARY INCONTINENCE,8
CA,ABDOMINAL ABSCESS,7
CA,ABNORMAL BEHAVIOUR,7
CA,ACCIDENTAL OVERDOSE,7
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,7
CA,APPARENT DEATH,7
CA,ARTHRITIS INFECTIVE,7
CA,BRONCHOPULMONARY ASPERGILLOSIS,7
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,7
CA,CARDIAC MURMUR,7
CA,CARDIO-RESPIRATORY ARREST,7
CA,CARDIOVASCULAR DISORDER,7
CA,COLITIS,7
CA,COLITIS ULCERATIVE,7
CA,CORTISOL DECREASED,7
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,7
CA,DIABETIC KETOACIDOSIS,7
CA,DIARRHOEA HAEMORRHAGIC,7
CA,DIZZINESS POSTURAL,7
CA,EPILEPSY,7
CA,EYELID DISORDER,7
CA,EYELID OEDEMA,7
CA,FACIAL PAIN,7
CA,FISTULA,7
CA,FORCED EXPIRATORY FLOW DECREASED,7
CA,FURUNCLE,7
CA,GALLBLADDER DISORDER,7
CA,GASTRITIS,7
CA,HAEMATOCRIT DECREASED,7
CA,HEAD DISCOMFORT,7
CA,HEPATIC FAILURE,7
CA,HYPOAESTHESIA ORAL,7
CA,HYPONATRAEMIA,7
CA,INJECTION SITE URTICARIA,7
CA,INTESTINAL PERFORATION,7
CA,IRRITABLE BOWEL SYNDROME,7
CA,JOINT EFFUSION,7
CA,LABYRINTHITIS,7
CA,LIVER DISORDER,7
CA,LUNG HYPERINFLATION,7
CA,MECHANICAL URTICARIA,7
CA,MENTAL IMPAIRMENT,7
CA,MOOD ALTERED,7
CA,MYCOBACTERIUM AVIUM COMPLEX INFECTION,7
CA,NEUROPATHY PERIPHERAL,7
CA,ORAL DISORDER,7
CA,ORAL FUNGAL INFECTION,7
CA,PARALYSIS,7
CA,PARANOIA,7
CA,PIGMENTATION DISORDER,7
CA,PLATELET COUNT DECREASED,7
CA,QUALITY OF LIFE DECREASED,7
CA,RASH MACULAR,7
CA,RENAL CANCER,7
CA,RESPIRATORY SYNCYTIAL VIRUS INFECTION,7
CA,RESTLESS LEGS SYNDROME,7
CA,RUBBER SENSITIVITY,7
CA,SALIVARY HYPERSECRETION,7
CA,SARCOIDOSIS,7
CA,SCAB,7
CA,SENSORY LOSS,7
CA,SKIN INFECTION,7
CA,SUPRAVENTRICULAR TACHYCARDIA,7
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,7
CA,THERAPY CESSATION,7
CA,THINKING ABNORMAL,7
CA,TOXICITY TO VARIOUS AGENTS,7
CA,VISUAL ACUITY REDUCED,7
CA,WEIGHT LOSS POOR,7
CA,WRIST FRACTURE,7
CA,ACUTE SINUSITIS,6
CA,ANGER,6
CA,ANIMAL SCRATCH,6
CA,AORTIC ANEURYSM,6
CA,ARTERIOSCLEROSIS CORONARY ARTERY,6
CA,ASCITES,6
CA,ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME,6
CA,BACTERIAL TEST POSITIVE,6
CA,BLOOD BILIRUBIN INCREASED,6
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
CA,BLOOD SODIUM DECREASED,6
CA,BRONCHITIS BACTERIAL,6
CA,CATARACT OPERATION,6
CA,CEREBRAL HAEMORRHAGE,6
CA,CHOLECYSTECTOMY,6
CA,DENTAL CARIES,6
CA,DIASTOLIC DYSFUNCTION,6
CA,DRY EYE,6
CA,EAR CONGESTION,6
CA,EATING DISORDER,6
CA,EMOTIONAL DISORDER,6
CA,ENDOTRACHEAL INTUBATION,6
CA,EUPHORIC MOOD,6
CA,GINGIVAL PAIN,6
CA,HEPATITIS B,6
CA,HIP ARTHROPLASTY,6
CA,HYPOKALAEMIA,6
CA,HYPOSMIA,6
CA,HYSTERECTOMY,6
CA,INJECTION SITE INDURATION,6
CA,INTENTIONAL PRODUCT MISUSE,6
CA,INTERNATIONAL NORMALISED RATIO INCREASED,6
CA,LIGAMENT DISORDER,6
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,6
CA,LUNG ABSCESS,6
CA,LYMPHOMA,6
CA,MICTURITION URGENCY,6
CA,MITE ALLERGY,6
CA,MOOD SWINGS,6
CA,MUSCLE ATROPHY,6
CA,NASAL SEPTUM DEVIATION,6
CA,NEOPLASM,6
CA,NERVE COMPRESSION,6
CA,ODYNOPHAGIA,6
CA,OSTEONECROSIS,6
CA,PHOTOSENSITIVITY REACTION,6
CA,PULSE PRESSURE INCREASED,6
CA,RHINALGIA,6
CA,SKIN ATROPHY,6
CA,SKIN REACTION,6
CA,SPINAL COMPRESSION FRACTURE,6
CA,SUICIDE ATTEMPT,6
CA,TRACHEAL OEDEMA,6
CA,TRACHEOMALACIA,6
CA,ULCER,6
CA,UNEVALUABLE EVENT,6
CA,UNRESPONSIVE TO STIMULI,6
CA,ABNORMAL DREAMS,5
CA,ACUTE MYOCARDIAL INFARCTION,5
CA,ADVERSE DRUG REACTION,5
CA,ANEURYSM,5
CA,ANKYLOSING SPONDYLITIS,5
CA,APHASIA,5
CA,ARTERIAL OCCLUSIVE DISEASE,5
CA,ATYPICAL PNEUMONIA,5
CA,BENIGN PROSTATIC HYPERPLASIA,5
CA,BLEEDING VARICOSE VEIN,5
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,5
CA,BLOOD CORTISOL DECREASED,5
CA,BLOOD GLUCOSE FLUCTUATION,5
CA,BLOOD PHOSPHORUS DECREASED,5
CA,BRADYCARDIA,5
CA,BRONCHIAL SECRETION RETENTION,5
CA,CARDIAC PACEMAKER INSERTION,5
CA,CENTRAL NERVOUS SYSTEM LESION,5
CA,CHROMATURIA,5
CA,DEAFNESS,5
CA,DECREASED IMMUNE RESPONSIVENESS,5
CA,DEMENTIA,5
CA,DERMATITIS ALLERGIC,5
CA,DERMATITIS CONTACT,5
CA,DEVICE MALFUNCTION,5
CA,DEVICE RELATED INFECTION,5
CA,DIPLOPIA,5
CA,DRUG DEPENDENCE,5
CA,ELECTROCARDIOGRAM QT PROLONGED,5
CA,ENVIRONMENTAL EXPOSURE,5
CA,FINGER AMPUTATION,5
CA,FULL BLOOD COUNT DECREASED,5
CA,GAIT INABILITY,5
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
CA,GASTRIC ULCER,5
CA,GRUNTING,5
CA,H1N1 INFLUENZA,5
CA,HAEMATOCRIT INCREASED,5
CA,HALLUCINATION,5
CA,HEPATOMEGALY,5
CA,HYPERCHOLESTEROLAEMIA,5
CA,HYPERVENTILATION,5
CA,IMMOBILE,5
CA,IMPAIRED QUALITY OF LIFE,5
CA,INFECTED CYST,5
CA,INFECTION SUSCEPTIBILITY INCREASED,5
CA,INJECTION RELATED REACTION,5
CA,INJECTION SITE DISCOMFORT,5
CA,INJECTION SITE MASS,5
CA,INJECTION SITE OEDEMA,5
CA,INNER EAR DISORDER,5
CA,INTESTINAL RESECTION,5
CA,JOINT RANGE OF MOTION DECREASED,5
CA,LIP DISCOLOURATION,5
CA,LUNG INFECTION PSEUDOMONAL,5
CA,LYMPHOCYTE COUNT DECREASED,5
CA,MALNUTRITION,5
CA,MEAN CELL HAEMOGLOBIN INCREASED,5
CA,MEAN CELL VOLUME INCREASED,5
CA,MEDICATION ERROR,5
CA,MENINGITIS VIRAL,5
CA,MIDDLE EAR EFFUSION,5
CA,MONOCYTE COUNT INCREASED,5
CA,MUCOSAL DISCOLOURATION,5
CA,MUCOUS STOOLS,5
CA,MULTIPLE SCLEROSIS RELAPSE,5
CA,NASAL DRYNESS,5
CA,NERVOUS SYSTEM DISORDER,5
CA,NEUROGENIC SHOCK,5
CA,NIGHTMARE,5
CA,NOCTURNAL DYSPNOEA,5
CA,NON-CARDIAC CHEST PAIN,5
CA,NOSOCOMIAL INFECTION,5
CA,OESOPHAGEAL ULCER,5
CA,ORAL PRURITUS,5
CA,ORTHOSIS USER,5
CA,OVARIAN CYST,5
CA,PANCYTOPENIA,5
CA,PANIC REACTION,5
CA,PELVIC FRACTURE,5
CA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
CA,PHOTOPHOBIA,5
CA,POST PROCEDURAL HAEMORRHAGE,5
CA,PROCEDURAL COMPLICATION,5
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
CA,PROSTATOMEGALY,5
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
CA,RESPIRATORY ARREST,5
CA,RESPIRATORY SYMPTOM,5
CA,RESPIRATORY TRACT INFLAMMATION,5
CA,SENSATION OF FOREIGN BODY,5
CA,SENSE OF OPPRESSION,5
CA,SENSORY DISTURBANCE,5
CA,SINUS OPERATION,5
CA,SKIN DEPIGMENTATION,5
CA,SKIN HAEMORRHAGE,5
CA,SKIN NECROSIS,5
CA,SMALL INTESTINAL OBSTRUCTION,5
CA,SPINAL COLUMN STENOSIS,5
CA,SPLENOMEGALY,5
CA,STENT PLACEMENT,5
CA,SUBCUTANEOUS EMPHYSEMA,5
CA,SUFFOCATION FEELING,5
CA,SYNOVIAL CYST,5
CA,TENDON PAIN,5
CA,THERAPEUTIC REACTION TIME DECREASED,5
CA,THERAPEUTIC RESPONSE SHORTENED,5
CA,TONSILLITIS,5
CA,TOOTH FRACTURE,5
CA,TRANSFUSION,5
CA,TYPE 1 DIABETES MELLITUS,5
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,5
CA,VASODILATATION,5
CA,VISUAL FIELD DEFECT,5
CA,ABDOMINAL INFECTION,4
CA,ACUTE RESPIRATORY FAILURE,4
CA,ADRENAL DISORDER,4
CA,AMYOTROPHIC LATERAL SCLEROSIS,4
CA,ANGINA UNSTABLE,4
CA,ANTINUCLEAR ANTIBODY POSITIVE,4
CA,APATHY,4
CA,APHAGIA,4
CA,ATYPICAL MYCOBACTERIAL INFECTION,4
CA,BLADDER DISORDER,4
CA,BLOOD IMMUNOGLOBULIN E DECREASED,4
CA,BLOOD LACTIC ACID INCREASED,4
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,4
CA,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
CA,BLOOD TRIGLYCERIDES INCREASED,4
CA,BONE DENSITY DECREASED,4
CA,CARDIAC FLUTTER,4
CA,CARDIAC OPERATION,4
CA,CARDIOMEGALY,4
CA,CARDIOMYOPATHY,4
CA,CARTILAGE INJURY,4
CA,CHEILITIS,4
CA,CHEST X-RAY ABNORMAL,4
CA,CHRONIC KIDNEY DISEASE,4
CA,CIRCULATORY COLLAPSE,4
CA,CLAUSTROPHOBIA,4
CA,COMPRESSION FRACTURE,4
CA,CONCUSSION,4
CA,CONJUNCTIVAL HYPERAEMIA,4
CA,CONTRAINDICATED PRODUCT ADMINISTERED,4
CA,CUSHINGOID,4
CA,DEVICE BREAKAGE,4
CA,DEVICE FAILURE,4
CA,DROOLING,4
CA,DYSARTHRIA,4
CA,DYSLIPIDAEMIA,4
CA,ECCHYMOSIS,4
CA,EJECTION FRACTION DECREASED,4
CA,ELECTROLYTE IMBALANCE,4
CA,EOSINOPHILIC PNEUMONIA,4
CA,EPIGASTRIC DISCOMFORT,4
CA,ERYTHEMA NODOSUM,4
CA,EXOSTOSIS,4
CA,EXPIRATORY RESERVE VOLUME DECREASED,4
CA,EXPOSURE DURING PREGNANCY,4
CA,EXTRASYSTOLES,4
CA,EYE DISCHARGE,4
CA,EYE HAEMORRHAGE,4
CA,EYELID PTOSIS,4
CA,FACIAL BONES FRACTURE,4
CA,FOOT PROSTHESIS USER,4
CA,FORCED EXPIRATORY VOLUME ABNORMAL,4
CA,FOREIGN BODY,4
CA,FUNCTIONAL RESIDUAL CAPACITY DECREASED,4
CA,GASTRIC DILATATION,4
CA,GASTROINTESTINAL INFECTION,4
CA,GINGIVITIS,4
CA,GLOSSODYNIA,4
CA,GLUCOSE TOLERANCE IMPAIRED,4
CA,GRANULOMA,4
CA,GRANULOMATOSIS WITH POLYANGIITIS,4
CA,GROIN PAIN,4
CA,GUILLAIN-BARRE SYNDROME,4
CA,HAEMOLYTIC ANAEMIA,4
CA,HAEMORRHOIDS,4
CA,HALLUCINATION_ VISUAL,4
CA,HANGOVER,4
CA,HELICOBACTER INFECTION,4
CA,HEPATIC STEATOSIS,4
CA,HEPATITIS,4
CA,HUNGER,4
CA,HYPERKERATOSIS,4
CA,IMPAIRED WORK ABILITY,4
CA,INCISION SITE INFECTION,4
CA,INCISIONAL HERNIA,4
CA,INCOHERENT,4
CA,INFUSION SITE BRUISING,4
CA,INJECTION SITE DISCOLOURATION,4
CA,INJECTION SITE EXTRAVASATION,4
CA,INTENTIONAL OVERDOSE,4
CA,INTRA-ABDOMINAL HAEMORRHAGE,4
CA,INTRACARDIAC THROMBUS,4
CA,INTRACRANIAL ANEURYSM,4
CA,JOINT SURGERY,4
CA,LEG AMPUTATION,4
CA,LEUKOPENIA,4
CA,LIPASE INCREASED,4
CA,LIVER FUNCTION TEST INCREASED,4
CA,LOWER RESPIRATORY TRACT INFECTION VIRAL,4
CA,LYMPH NODE PAIN,4
CA,MALIGNANT MELANOMA,4
CA,MELANOCYTIC NAEVUS,4
CA,MITRAL VALVE INCOMPETENCE,4
CA,MULTIPLE SCLEROSIS,4
CA,MUSCLE DISORDER,4
CA,MUSCULOSKELETAL DISORDER,4
CA,NAIL DISCOLOURATION,4
CA,NASAL INFLAMMATION,4
CA,NASAL OBSTRUCTION,4
CA,NEUROLOGICAL SYMPTOM,4
CA,NONSPECIFIC REACTION,4
CA,OCCUPATIONAL EXPOSURE TO DUST,4
CA,OPTIC NEURITIS,4
CA,ORAL MUCOSAL ERUPTION,4
CA,OROPHARYNGEAL DISCOMFORT,4
CA,OTITIS MEDIA,4
CA,PANCREATIC DISORDER,4
CA,PERIPHERAL VENOUS DISEASE,4
CA,PHOTOPSIA,4
CA,POLYURIA,4
CA,POST HERPETIC NEURALGIA,4
CA,POST-TRAUMATIC NECK SYNDROME,4
CA,PROCEDURAL PAIN,4
CA,PSYCHOTIC DISORDER,4
CA,PURPURA,4
CA,RASH PUSTULAR,4
CA,RESPIRATORY FUME INHALATION DISORDER,4
CA,RESPIRATORY TRACT OEDEMA,4
CA,RETCHING,4
CA,RHABDOMYOLYSIS,4
CA,RHEUMATOID FACTOR INCREASED,4
CA,SEDATION,4
CA,SINUS POLYP,4
CA,SINUS TACHYCARDIA,4
CA,SKIN INJURY,4
CA,SKIN WARM,4
CA,SLUGGISHNESS,4
CA,SPINAL DISORDER,4
CA,SPINAL OSTEOARTHRITIS,4
CA,STRESS FRACTURE,4
CA,SUNBURN,4
CA,SUPERINFECTION,4
CA,TENDERNESS,4
CA,THIRST,4
CA,THYROID CANCER,4
CA,TONGUE DISCOLOURATION,4
CA,TOOTH EXTRACTION,4
CA,TREATMENT FAILURE,4
CA,TRICUSPID VALVE INCOMPETENCE,4
CA,TROPONIN INCREASED,4
CA,TYMPANIC MEMBRANE PERFORATION,4
CA,URINARY RETENTION,4
CA,URINARY TRACT DISORDER,4
CA,UROSEPSIS,4
CA,VAGINAL INFECTION,4
CA,VASCULITIS,4
CA,VEIN DISORDER,4
CA,WALKING AID USER,4
CA,WEIGHT BEARING DIFFICULTY,4
CA,ABDOMINAL ADHESIONS,3
CA,ACCIDENTAL EXPOSURE TO PRODUCT,3
CA,ACUTE CORONARY SYNDROME,3
CA,ADDISON^S DISEASE,3
CA,ADRENAL MASS,3
CA,AFFECTIVE DISORDER,3
CA,ALCOHOL INTOLERANCE,3
CA,ALLERGIC GRANULOMATOUS ANGIITIS,3
CA,ALLERGY TO PLANTS,3
CA,ANAL ABSCESS,3
CA,ANGIOPATHY,3
CA,AORTIC VALVE REPAIR,3
CA,ARM AMPUTATION,3
CA,ARRHYTHMIA SUPRAVENTRICULAR,3
CA,ARTERIOSCLEROSIS,3
CA,ARTHRODESIS,3
CA,ARTHROPOD STING,3
CA,ATAXIA,3
CA,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,3
CA,AUTOIMMUNE DISORDER,3
CA,BACTERAEMIA,3
CA,BILE DUCT STONE,3
CA,BLADDER DISCOMFORT,3
CA,BLADDER NEOPLASM,3
CA,BLINDNESS UNILATERAL,3
CA,BLOOD CALCIUM INCREASED,3
CA,BLOOD IMMUNOGLOBULIN G DECREASED,3
CA,BLOOD POTASSIUM INCREASED,3
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,3
CA,BONE LOSS,3
CA,BONE MARROW FAILURE,3
CA,BOWEL MOVEMENT IRREGULARITY,3
CA,BREAST ABSCESS,3
CA,BREAST OPERATION,3
CA,BREAST PAIN,3
CA,BRONCHITIS VIRAL,3
CA,CANDIDIASIS,3
CA,CARDIAC FIBRILLATION,3
CA,CARDIAC VALVE DISEASE,3
CA,CATAPLEXY,3
CA,CENTRAL OBESITY,3
CN,DRUG INEFFECTIVE,25
CN,ASTHMA,22
CN,OVERDOSE,16
CN,DYSPNOEA,14
CN,TREMOR,13
CN,PRODUCT USE ISSUE,12
CN,CHEST DISCOMFORT,11
CN,PALPITATIONS,11
CN,PRODUCT QUALITY ISSUE,10
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,8
CN,COUGH,7
CN,DISEASE RECURRENCE,7
CN,NASOPHARYNGITIS,7
CN,DRUG ADMINISTRATION ERROR,6
CN,PNEUMONIA,6
CN,PRODUCT USE IN UNAPPROVED INDICATION,5
CN,CONDITION AGGRAVATED,4
CN,HEART RATE INCREASED,4
CN,INTENTIONAL PRODUCT MISUSE,4
CN,WEIGHT DECREASED,4
CN,WHEEZING,4
CN,ASTHENIA,3
CN,BLOOD PRESSURE INCREASED,3
CN,CARDIAC FAILURE,3
CN,CHEST PAIN,3
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
CN,DEATH,3
CN,DRUG DEPENDENCE,3
CN,PYREXIA,3
CN,TACHYCARDIA,3
CN,ANAPHYLACTIC SHOCK,2
CN,ARRHYTHMIA,2
CN,ASPHYXIA,2
CN,BREATH SOUNDS ABNORMAL,2
CN,BRONCHIECTASIS,2
CN,CARDIAC DISORDER,2
CN,CEREBRAL THROMBOSIS,2
CN,COMA,2
CN,CONCOMITANT DISEASE AGGRAVATED,2
CN,COR PULMONALE,2
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
CN,DRUG EFFECT INCOMPLETE,2
CN,FLUSHING,2
CN,HYPERSENSITIVITY,2
CN,HYPOKALAEMIA,2
CN,MEDICATION ERROR,2
CN,MENTAL DISORDER,2
CN,OBSTRUCTIVE AIRWAYS DISORDER,2
CN,OSTEOPOROSIS,2
CN,PNEUMONITIS,2
CN,PROSTATITIS,2
CN,PULMONARY TUBERCULOSIS,2
CN,RASH,2
CN,SUFFOCATION FEELING,2
CN,UNDERDOSE,2
CN,VISION BLURRED,2
CN,VOMITING,2
CN,ACCIDENTAL UNDERDOSE,1
CN,ACUTE CORONARY SYNDROME,1
CN,ADENOIDAL HYPERTROPHY,1
CN,AGITATION,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,AMNESIA,1
CN,ANAPHYLACTIC REACTION,1
CN,ANAPHYLACTOID REACTION,1
CN,ANGINA PECTORIS,1
CN,AORTIC DISORDER,1
CN,APNOEA,1
CN,ASPIRATION,1
CN,ATRIAL FIBRILLATION,1
CN,BACK PAIN,1
CN,BLINDNESS,1
CN,BLOOD ALBUMIN DECREASED,1
CN,BLOOD GLUCOSE INCREASED,1
CN,BRONCHITIS,1
CN,CANDIDA INFECTION,1
CN,CARDIAC ARREST,1
CN,CARDIAC DISCOMFORT,1
CN,CARDIOVASCULAR INSUFFICIENCY,1
CN,CHILLS,1
CN,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
CN,CONFUSIONAL STATE,1
CN,CONSTIPATION,1
CN,CONVULSION,1
CN,CORONARY ARTERY DISEASE,1
CN,CUSHING^S SYNDROME,1
CN,CYANOSIS,1
CN,DIABETES MELLITUS,1
CN,DISCOMFORT,1
CN,DISEASE PROGRESSION,1
CN,DIZZINESS,1
CN,DRUG DOSE OMISSION,1
CN,DRUG TOLERANCE,1
CN,DYSGEUSIA,1
CN,DYSKINESIA,1
CN,DYSPEPSIA,1
CN,EMPHYSEMA,1
CN,EXPIRED PRODUCT ADMINISTERED,1
CN,EYE DISORDER,1
CN,FACE OEDEMA,1
CN,FEAR,1
CN,FEELING ABNORMAL,1
CN,FEELING COLD,1
CN,FEELING JITTERY,1
CN,FOREIGN BODY,1
CN,FUNGAL OESOPHAGITIS,1
CN,GAIT DISTURBANCE,1
CN,GASTRITIS ATROPHIC,1
CN,GASTROINTESTINAL DISORDER,1
CN,GROWTH RETARDATION,1
CN,HAEMATOCHEZIA,1
CN,HEART RATE ABNORMAL,1
CN,HYPERHIDROSIS,1
CN,HYPOTENSION,1
CN,HYPOXIA,1
CN,ILEUS,1
CN,IMMUNE SYSTEM DISORDER,1
CN,IMMUNODEFICIENCY,1
CN,INCORRECT DOSE ADMINISTERED,1
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CN,INTENTIONAL OVERDOSE,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,LACRIMATION INCREASED,1
CN,LIMB DISCOMFORT,1
CN,LOCALISED INFECTION,1
CN,LOSS OF CONSCIOUSNESS,1
CN,LUNG ADENOCARCINOMA,1
CN,LUNG CANCER METASTATIC,1
CN,LUNG DISORDER,1
CN,LUNG INFECTION,1
CN,MACULOPATHY,1
CN,MENINGITIS,1
CN,MUSCLE SPASTICITY,1
CN,MUSCLE TIGHTNESS,1
CN,MUSCULOSKELETAL PAIN,1
CN,MYOCARDIAL ISCHAEMIA,1
CN,NASOPHARYNGEAL CANCER,1
CN,OEDEMA PERIPHERAL,1
CN,ORAL DISORDER,1
CN,ORGANISING PNEUMONIA,1
CN,OROPHARYNGEAL DISCOMFORT,1
CN,OROPHARYNGEAL PAIN,1
CN,OXYGEN SATURATION DECREASED,1
CN,PAPILLOEDEMA,1
CN,PARKINSONISM,1
CN,PERITONSILLAR ABSCESS,1
CN,PHARYNGEAL OEDEMA,1
CN,PIGMENTATION DISORDER,1
CN,PRESCRIBED OVERDOSE,1
CN,PRODUCT AVAILABILITY ISSUE,1
CN,PRURITUS,1
CN,PRURITUS GENERALISED,1
CN,PSEUDOMONAS INFECTION,1
CN,PULMONARY EMBOLISM,1
CN,PULMONARY PAIN,1
CN,RASH GENERALISED,1
CN,RASH MACULAR,1
CN,REGURGITATION,1
CN,RENAL DISORDER,1
CN,RESPIRATORY FAILURE,1
CN,RESPIRATORY RATE INCREASED,1
CN,RESPIRATORY TRACT CONGESTION,1
CN,RESTLESSNESS,1
CN,RHINITIS,1
CN,RHINORRHOEA,1
CN,SALIVA DISCOLOURATION,1
CN,SEIZURE,1
CN,SHOCK,1
CN,SINUS DISORDER,1
CN,SINUS TACHYCARDIA,1
CN,SNEEZING,1
CN,SNORING,1
CN,SPEECH DISORDER,1
CN,STATUS ASTHMATICUS,1
CN,STRESS,1
CN,STRIDOR,1
CN,SUPRAVENTRICULAR TACHYCARDIA,1
CN,SUSPECTED COUNTERFEIT PRODUCT,1
CN,TACHYPNOEA,1
CN,TEMPERATURE INTOLERANCE,1
CN,TENDERNESS,1
CN,TONGUE DISCOLOURATION,1
CN,TONSILLITIS BACTERIAL,1
CN,TREATMENT NONCOMPLIANCE,1
CN,TUBERCULOSIS,1
CN,UPPER RESPIRATORY TRACT CONGESTION,1
CN,URINARY INCONTINENCE,1
CN,URTICARIA,1
CN,VENTRICULAR TACHYCARDIA,1
CN,WEIGHT INCREASED,1
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CO,DYSPNOEA,2
CO,PNEUMONIA,2
CO,ANAEMIA,1
CO,ASTHENIA,1
CO,ASTHMATIC CRISIS,1
CO,BRONCHITIS,1
CO,CHILLS,1
CO,DRUG HYPERSENSITIVITY,1
CO,DYSPHONIA,1
CO,FATIGUE,1
CO,HEADACHE,1
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CO,INCREASED UPPER AIRWAY SECRETION,1
CO,LUNG INFILTRATION,1
CO,PRODUCTIVE COUGH,1
CO,PULMONARY CONGESTION,1
CO,PYREXIA,1
CO,RASH GENERALISED,1
CO,SPUTUM PURULENT,1
CO,TREATMENT FAILURE,1
CR,BRONCHIOLITIS,2
CR,ASTHMATIC CRISIS,1
CR,CYANOSIS,1
CR,EXTRASYSTOLES,1
CR,INTENTIONAL OVERDOSE,1
CR,OEDEMA,1
CR,PAIN IN EXTREMITY,1
CR,PERIPHERAL ISCHAEMIA,1
CR,PERIPHERAL PULSE DECREASED,1
CR,PRODUCT USE ISSUE,1
CR,RHEUMATIC DISORDER,1
CR,VENTRICULAR ARRHYTHMIA,1
HR,DYSPNOEA,4
HR,COUGH,3
HR,INTENTIONAL OVERDOSE,3
HR,SOMNOLENCE,3
HR,SUICIDE ATTEMPT,3
HR,ASPHYXIA,2
HR,BACK PAIN,2
HR,BLOOD PRESSURE INCREASED,2
HR,CHILLS,2
HR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
HR,DEATH,2
HR,DRUG INEFFECTIVE,2
HR,ERYTHEMA,2
HR,MALAISE,2
HR,NAUSEA,2
HR,PALLOR,2
HR,PRURITUS,2
HR,PULMONARY HYPERTENSION,2
HR,ALANINE AMINOTRANSFERASE INCREASED,1
HR,ALTERED STATE OF CONSCIOUSNESS,1
HR,ANAPHYLACTIC REACTION,1
HR,ANAPHYLACTIC SHOCK,1
HR,ANURIA,1
HR,ARTHRALGIA,1
HR,ASPARTATE AMINOTRANSFERASE INCREASED,1
HR,ASTHENIA,1
HR,ASTHMA,1
HR,AZOTAEMIA,1
HR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HR,BLOOD URIC ACID INCREASED,1
HR,BODY TEMPERATURE INCREASED,1
HR,CARDIAC FAILURE CHRONIC,1
HR,CHRONIC KIDNEY DISEASE,1
HR,CONNECTIVE TISSUE DISORDER,1
HR,DECREASED APPETITE,1
HR,DISEASE PROGRESSION,1
HR,DRUG DEPENDENCE,1
HR,DRUG INTOLERANCE,1
HR,DYSPHAGIA,1
HR,ERYTHEMA MULTIFORME,1
HR,FATIGUE,1
HR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HR,GENERALISED ERYTHEMA,1
HR,HAEMATEMESIS,1
HR,HAEMATURIA,1
HR,HAEMOPTYSIS,1
HR,HALLUCINATION_ AUDITORY,1
HR,HEMIPLEGIA,1
HR,HYPERCHOLESTEROLAEMIA,1
HR,HYPERTENSION,1
HR,HYPERTRIGLYCERIDAEMIA,1
HR,HYPOTENSION,1
HR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
HR,INCARCERATED HIATUS HERNIA,1
HR,INCREASED VISCOSITY OF BRONCHIAL SECRETION,1
HR,INSOMNIA,1
HR,JOINT RANGE OF MOTION DECREASED,1
HR,JOINT SWELLING,1
HR,LUNG DISORDER,1
HR,MELAENA,1
HR,MOBILITY DECREASED,1
HR,MOUTH ULCERATION,1
HR,MUCOSAL DRYNESS,1
HR,NASOPHARYNGITIS,1
HR,ORAL DISORDER,1
HR,PALPITATIONS,1
HR,PNEUMOCOCCAL SEPSIS,1
HR,PNEUMONIA PNEUMOCOCCAL,1
HR,PRODUCTIVE COUGH,1
HR,PRURITUS GENERALISED,1
HR,PULMONARY FIBROSIS,1
HR,RASH,1
HR,RASH PAPULAR,1
HR,RESPIRATORY DEPRESSION,1
HR,RESTLESSNESS,1
HR,RHEUMATOID ARTHRITIS,1
HR,SKIN REACTION,1
HR,SPUTUM DISCOLOURED,1
HR,SPUTUM PURULENT,1
HR,THIRST,1
HR,TONGUE OEDEMA,1
HR,URTICARIA,1
HR,VOMITING,1
HR,WEIGHT DECREASED,1
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
CZ,COUGH,3
CZ,RESPIRATORY TRACT INFECTION,3
CZ,ASTHMA,2
CZ,ATRIAL FIBRILLATION,2
CZ,DRY MOUTH,2
CZ,DYSGEUSIA,2
CZ,DYSPNOEA,2
CZ,ERYTHEMA,2
CZ,FATIGUE,2
CZ,LIP SWELLING,2
CZ,LUNG NEOPLASM MALIGNANT,2
CZ,ORAL MUCOSAL ERYTHEMA,2
CZ,PNEUMONIA,2
CZ,TONGUE DISCOMFORT,2
CZ,TONGUE OEDEMA,2
CZ,ACCIDENTAL OVERDOSE,1
CZ,ACUTE RESPIRATORY FAILURE,1
CZ,ALOPECIA,1
CZ,ANAEMIA,1
CZ,ANGINA UNSTABLE,1
CZ,AORTIC ARTERIOSCLEROSIS,1
CZ,ARTHRALGIA,1
CZ,ASTHENIA,1
CZ,BLOOD GLUCOSE INCREASED,1
CZ,BRONCHITIS,1
CZ,CALCULUS PROSTATIC,1
CZ,CHILLS,1
CZ,CONDITION AGGRAVATED,1
CZ,DECREASED APPETITE,1
CZ,DIABETES MELLITUS,1
CZ,DRUG INEFFECTIVE,1
CZ,DYSPEPSIA,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,FACE OEDEMA,1
CZ,GENE MUTATION,1
CZ,HYPERGLYCAEMIA,1
CZ,HYPERHIDROSIS,1
CZ,HYPERKALAEMIA,1
CZ,IMMOBILE,1
CZ,INCONTINENCE,1
CZ,LIPOMA,1
CZ,MATERNAL EXPOSURE DURING PREGNANCY,1
CZ,MUSCLE TWITCHING,1
CZ,MYALGIA,1
CZ,MYOCARDIAL ISCHAEMIA,1
CZ,NASOPHARYNGITIS,1
CZ,NEPHROLITHIASIS,1
CZ,NON-SMALL CELL LUNG CANCER,1
CZ,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CZ,POST PROCEDURAL HAEMORRHAGE,1
CZ,PRURITUS,1
CZ,PULMONARY EMBOLISM,1
CZ,PYREXIA,1
CZ,RASH,1
CZ,SEASONAL ALLERGY,1
CZ,SEIZURE,1
CZ,SLEEP DISORDER,1
CZ,SPINAL ANAESTHESIA,1
CZ,SPINAL PAIN,1
CZ,SQUAMOUS CELL CARCINOMA OF LUNG,1
CZ,TRACHEOBRONCHITIS,1
CZ,URETERIC OBSTRUCTION,1
CZ,URINARY TRACT INFECTION,1
CZ,VENOUS THROMBOSIS,1
CZ,VENTRICULAR FIBRILLATION,1
CZ,VISION BLURRED,1
CZ,VISUAL IMPAIRMENT,1
CZ,WEIGHT DECREASED,1
DK,PYREXIA,2
DK,ACCIDENTAL OVERDOSE,1
DK,ALTERED STATE OF CONSCIOUSNESS,1
DK,ANAEMIA,1
DK,ANAPHYLACTIC REACTION,1
DK,ANXIETY,1
DK,ARTHRALGIA,1
DK,BLOOD PRESSURE IMMEASURABLE,1
DK,BRADYCARDIA,1
DK,CARDIAC FAILURE ACUTE,1
DK,DECREASED APPETITE,1
DK,DRUG DISPENSING ERROR,1
DK,DRUG LEVEL INCREASED,1
DK,DYSPNOEA,1
DK,HALLUCINATION,1
DK,HEADACHE,1
DK,HEPATIC FUNCTION ABNORMAL,1
DK,HYPERGLYCAEMIA,1
DK,HYPONATRAEMIA,1
DK,HYPOTENSION,1
DK,INTRA-ABDOMINAL HAEMORRHAGE,1
DK,KETOACIDOSIS,1
DK,LOSS OF CONSCIOUSNESS,1
DK,MENTAL DISORDER,1
DK,METABOLIC ACIDOSIS,1
DK,MYALGIA,1
DK,OTITIS MEDIA,1
DK,RASH,1
DK,RENAL IMPAIRMENT,1
DK,SWOLLEN TONGUE,1
DK,TONSILLITIS,1
DK,WEIGHT DECREASED,1
EC,ASPIRATION BRONCHIAL,1
EC,BRONCHOSPASM,1
EC,CYANOSIS,1
EC,DEATH,1
EC,EMOTIONAL DISTRESS,1
EC,HYPOAESTHESIA,1
EC,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
EC,OVERDOSE,1
EC,PAIN,1
EC,PYREXIA,1
EC,SEIZURE,1
EC,TACHYCARDIA,1
EC,VOMITING,1
EG,MYASTHENIA GRAVIS,1
SV,TACHYCARDIA,3
SV,CRYING,2
SV,COLD SWEAT,1
SV,COUGH,1
SV,FEELING OF DESPAIR,1
SV,HAEMODYNAMIC INSTABILITY,1
SV,LIVEDO RETICULARIS,1
SV,MUSCLE TIGHTNESS,1
SV,SKIN DISORDER,1
EE,CEREBROVASCULAR ACCIDENT,1
FI,PYREXIA,3
FI,ANAPHYLACTIC SHOCK,2
FI,ASTHMA,2
FI,ATRIAL FIBRILLATION,2
FI,CARDIAC FAILURE,2
FI,DEEP VEIN THROMBOSIS,2
FI,DYSPNOEA,2
FI,ERYTHEMA,2
FI,HYPERSENSITIVITY,2
FI,MALAISE,2
FI,PRURITUS,2
FI,URTICARIA,2
FI,ABDOMINAL PAIN,1
FI,ANAPHYLACTIC REACTION,1
FI,ANDROGEN DEFICIENCY,1
FI,ANGINA BULLOSA HAEMORRHAGICA,1
FI,AORTIC STENOSIS,1
FI,BONE FISTULA,1
FI,BURNING SENSATION,1
FI,C-REACTIVE PROTEIN INCREASED,1
FI,CARDIAC DISORDER,1
FI,CARDIOMEGALY,1
FI,CHEST DISCOMFORT,1
FI,CHILLS,1
FI,CONDITION AGGRAVATED,1
FI,DIARRHOEA,1
FI,DIZZINESS,1
FI,EJECTION FRACTION DECREASED,1
FI,ENCEPHALOMYELITIS,1
FI,EOSINOPHILIA,1
FI,EXOSTOSIS,1
FI,EXPOSED BONE IN JAW,1
FI,FATIGUE,1
FI,FEAR,1
FI,FEELING ABNORMAL,1
FI,FLUSHING,1
FI,GAIT DISTURBANCE,1
FI,GASTROENTERITIS,1
FI,HAEMATOMA,1
FI,HEART RATE INCREASED,1
FI,HERPES SIMPLEX MENINGOENCEPHALITIS,1
FI,HERPES ZOSTER,1
FI,HYPERTENSION,1
FI,HYPOAESTHESIA ORAL,1
FI,HYPOKALAEMIA,1
FI,HYPOTENSION,1
FI,LOSS OF CONSCIOUSNESS,1
FI,LYMPHOPENIA,1
FI,MUSCULAR WEAKNESS,1
FI,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
FI,NASAL CONGESTION,1
FI,NAUSEA,1
FI,OSTEONECROSIS OF JAW,1
FI,OXYGEN SATURATION DECREASED,1
FI,PALLOR,1
FI,PALPITATIONS,1
FI,PARAESTHESIA,1
FI,PARAESTHESIA ORAL,1
FI,PERIPHERAL EMBOLISM,1
FI,PLASMA CELL MYELOMA,1
FI,PRIMARY SEQUESTRUM,1
FI,PRODUCT QUALITY ISSUE,1
FI,PRODUCT USE ISSUE,1
FI,PULMONARY EMBOLISM,1
FI,PURULENT DISCHARGE,1
FI,RASH,1
FI,RASH MACULAR,1
FI,RESTLESS LEGS SYNDROME,1
FI,RETCHING,1
FI,SKIN IRRITATION,1
FI,SNEEZING,1
FI,SPEECH DISORDER,1
FI,SYNCOPE,1
FI,THROAT IRRITATION,1
FI,THROMBOCYTOPENIA,1
FI,ULCER,1
FI,UPPER RESPIRATORY TRACT INFECTION,1
FI,VIRAL INFECTION,1
FI,VOMITING,1
FR,ACUTE KIDNEY INJURY,14
FR,DYSPNOEA,11
FR,RESPIRATORY DISTRESS,9
FR,NAUSEA,8
FR,RESPIRATORY FAILURE,8
FR,DRUG INEFFECTIVE,7
FR,ASTHMA,6
FR,CARDIAC FAILURE,6
FR,HEADACHE,6
FR,ISCHAEMIC STROKE,6
FR,CONFUSIONAL STATE,5
FR,FATIGUE,5
FR,HYPERKALAEMIA,5
FR,MALAISE,5
FR,OEDEMA PERIPHERAL,5
FR,PYREXIA,5
FR,ARTHRALGIA,4
FR,ASTHENIA,4
FR,ATRIAL FIBRILLATION,4
FR,CEREBRAL ARTERY THROMBOSIS,4
FR,COUGH,4
FR,DIARRHOEA,4
FR,INFUSION RELATED REACTION,4
FR,INTERSTITIAL LUNG DISEASE,4
FR,NEUTROPENIA,4
FR,PALPITATIONS,4
FR,PANCREATITIS ACUTE,4
FR,PNEUMONIA,4
FR,PULMONARY EMBOLISM,4
FR,SOMNOLENCE,4
FR,THROMBOCYTOPENIA,4
FR,VOMITING,4
FR,ABNORMAL BEHAVIOUR,3
FR,ANAEMIA,3
FR,CARDIAC ARREST,3
FR,CHEST PAIN,3
FR,DIZZINESS,3
FR,EOSINOPHILIA,3
FR,ERYTHEMA,3
FR,FALL,3
FR,HEPATOCELLULAR INJURY,3
FR,HOT FLUSH,3
FR,INSOMNIA,3
FR,LEUKOPENIA,3
FR,MUSCLE SPASMS,3
FR,PAIN,3
FR,PANCYTOPENIA,3
FR,PARAESTHESIA,3
FR,PRURITUS,3
FR,TOXIC SKIN ERUPTION,3
FR,VERTIGO,3
FR,ABDOMINAL PAIN UPPER,2
FR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
FR,ALTERED STATE OF CONSCIOUSNESS,2
FR,ANAPHYLACTIC SHOCK,2
FR,ANGINA PECTORIS,2
FR,ARRHYTHMIA,2
FR,ARTHROPATHY,2
FR,ASTHMATIC CRISIS,2
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
FR,CARDIO-RESPIRATORY ARREST,2
FR,CELL DEATH,2
FR,CHEST INJURY,2
FR,CHOLESTASIS,2
FR,CONDITION AGGRAVATED,2
FR,CONGESTIVE CARDIOMYOPATHY,2
FR,CRYING,2
FR,DEPRESSION,2
FR,DIABETES MELLITUS,2
FR,DIAPHRAGMATIC RUPTURE,2
FR,DRUG PRESCRIBING ERROR,2
FR,DRUG-INDUCED LIVER INJURY,2
FR,ECCHYMOSIS,2
FR,ELECTROCARDIOGRAM QT PROLONGED,2
FR,FACIAL PARALYSIS,2
FR,FEELING ABNORMAL,2
FR,FEELING COLD,2
FR,FOETAL EXPOSURE DURING PREGNANCY,2
FR,GAIT DISTURBANCE,2
FR,GASTROINTESTINAL DISORDER,2
FR,GENERAL PHYSICAL HEALTH DETERIORATION,2
FR,GENERALISED OEDEMA,2
FR,HAEMATURIA,2
FR,HEPATIC ENZYME INCREASED,2
FR,HEPATITIS,2
FR,HYPERTENSION,2
FR,HYPERTHYROIDISM,2
FR,HYPOFIBRINOGENAEMIA,2
FR,HYPOTENSION,2
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FR,INFLAMMATION,2
FR,INTENTIONAL PRODUCT MISUSE,2
FR,JAUNDICE,2
FR,JOINT SWELLING,2
FR,LACTIC ACIDOSIS,2
FR,LUNG DISORDER,2
FR,LUNG INFECTION,2
FR,MYALGIA,2
FR,MYOCLONUS,2
FR,NASOPHARYNGITIS,2
FR,PAIN IN EXTREMITY,2
FR,PEMPHIGOID,2
FR,PERIPHERAL COLDNESS,2
FR,PLEURAL EFFUSION,2
FR,PRODUCTIVE COUGH,2
FR,PULMONARY ARTERIAL HYPERTENSION,2
FR,PYELONEPHRITIS,2
FR,RASH,2
FR,RENAL FAILURE,2
FR,SHOCK HAEMORRHAGIC,2
FR,SLEEP DISORDER,2
FR,TACHYCARDIA,2
FR,URINARY RETENTION,2
FR,URTICARIA,2
FR,VIRAL PERICARDITIS,2
FR,WEIGHT INCREASED,2
FR,WHEEZING,2
FR,ABDOMINAL INJURY,1
FR,ACCIDENTAL EXPOSURE TO PRODUCT,1
FR,ACTINIC KERATOSIS,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ADRENAL INSUFFICIENCY,1
FR,ADRENOMEGALY,1
FR,AFFECTIVE DISORDER,1
FR,AGGRESSION,1
FR,AGRANULOCYTOSIS,1
FR,ALLERGIC GRANULOMATOUS ANGIITIS,1
FR,ALOPECIA,1
FR,AMENORRHOEA,1
FR,ANAPHYLACTOID REACTION,1
FR,ANEURYSM,1
FR,ANTINUCLEAR ANTIBODY POSITIVE,1
FR,APPENDICECTOMY,1
FR,AREFLEXIA,1
FR,ARTERIAL THROMBOSIS,1
FR,ARTERIOSCLEROSIS CORONARY ARTERY,1
FR,ASPARTATE AMINOTRANSFERASE INCREASED,1
FR,ASPERGILLOMA,1
FR,ASTERIXIS,1
FR,ATELECTASIS,1
FR,ATRIAL FLUTTER,1
FR,B-CELL LYMPHOMA,1
FR,BASAL CELL CARCINOMA,1
FR,BENIGN NEOPLASM OF LACRIMAL GLAND,1
FR,BILIRUBIN CONJUGATED INCREASED,1
FR,BLADDER TRANSITIONAL CELL CARCINOMA,1
FR,BLOOD CORTISOL DECREASED,1
FR,BLOOD CREATININE INCREASED,1
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BONE FISSURE,1
FR,BOWEN^S DISEASE,1
FR,BRAIN SCAN ABNORMAL,1
FR,BREATH SOUNDS ABNORMAL,1
FR,BRONCHIAL DISORDER,1
FR,BRONCHITIS,1
FR,BRONCHOPULMONARY ASPERGILLOSIS,1
FR,CARDIAC DISORDER,1
FR,CARDIOGENIC SHOCK,1
FR,CARDIOMYOPATHY,1
FR,CARDIOVASCULAR DISORDER,1
FR,CAUDA EQUINA SYNDROME,1
FR,CEREBRAL HAEMORRHAGE,1
FR,CEREBROVASCULAR ACCIDENT,1
FR,CHEST DISCOMFORT,1
FR,CHRONIC KIDNEY DISEASE,1
FR,COMA,1
FR,CONSTIPATION,1
FR,CONTUSION,1
FR,CONVULSION,1
FR,COORDINATION ABNORMAL,1
FR,COR PULMONALE ACUTE,1
FR,CORONARY ARTERY STENOSIS,1
FR,CUSHING^S SYNDROME,1
FR,CYANOSIS,1
FR,DEAFNESS,1
FR,DEATH,1
FR,DEEP VEIN THROMBOSIS,1
FR,DEHYDRATION,1
FR,DELIRIUM,1
FR,DIABETIC KETOACIDOSIS,1
FR,DIARRHOEA HAEMORRHAGIC,1
FR,DIASTOLIC DYSFUNCTION,1
FR,DIFFUSE ALOPECIA,1
FR,DISEASE RECURRENCE,1
FR,DISTURBANCE IN ATTENTION,1
FR,DRUG DEPENDENCE,1
FR,DRUG DOSE OMISSION,1
FR,DRUG WITHDRAWAL CONVULSIONS,1
FR,DRUG WITHDRAWAL SYNDROME NEONATAL,1
FR,DYSACUSIS,1
FR,DYSGEUSIA,1
FR,DYSPHONIA,1
FR,DYSURIA,1
FR,EAR HAEMORRHAGE,1
FR,ELECTROENCEPHALOGRAM ABNORMAL,1
FR,EMBOLISM ARTERIAL,1
FR,EPILEPSY,1
FR,ERYSIPELAS,1
FR,EXTRASYSTOLES,1
FR,EXTREMITY NECROSIS,1
FR,EYE MOVEMENT DISORDER,1
FR,EYELID OEDEMA,1
FR,FEBRILE BONE MARROW APLASIA,1
FR,FEBRILE NEUTROPENIA,1
FR,FEEDING DISORDER,1
FR,FEELING HOT,1
FR,FORCED EXPIRATORY VOLUME DECREASED,1
FR,FOREIGN BODY,1
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FR,GASTROENTERITIS EOSINOPHILIC,1
FR,GASTROINTESTINAL HAEMORRHAGE,1
FR,GINGIVAL BLEEDING,1
FR,GOUT,1
FR,GROWTH RETARDATION,1
FR,HAEMATOCHEZIA,1
FR,HAEMATOMA,1
FR,HAEMATOTOXICITY,1
FR,HAEMOPTYSIS,1
FR,HAEMORRHAGE,1
FR,HALLUCINATION_ VISUAL,1
FR,HEART RATE DECREASED,1
FR,HEMIPARESIS,1
FR,HEMIPLEGIA,1
FR,HEPATIC FAILURE,1
FR,HYPERCAPNIA,1
FR,HYPERGLYCAEMIA,1
FR,HYPERHIDROSIS,1
FR,HYPERPLASIA,1
FR,HYPERTENSIVE CARDIOMYOPATHY,1
FR,HYPERTHERMIA,1
FR,HYPERTRIGLYCERIDAEMIA,1
FR,HYPERVOLAEMIA,1
FR,HYPOCAPNIA,1
FR,HYPOGLYCAEMIA,1
FR,HYPOGLYCAEMIC COMA,1
FR,HYPOGLYCAEMIC SEIZURE,1
FR,HYPOMAGNESAEMIA,1
FR,HYPOXIA,1
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
FR,IMPAIRED WORK ABILITY,1
FR,INCORRECT DOSE ADMINISTERED,1
FR,INCREASED APPETITE,1
FR,INFLUENZA,1
FR,INJURY,1
FR,INTENTIONAL DRUG MISUSE,1
FR,INTENTIONAL OVERDOSE,1
FR,INTERNATIONAL NORMALISED RATIO INCREASED,1
FR,INTERVERTEBRAL DISC DEGENERATION,1
FR,IRRITABILITY,1
FR,LEFT VENTRICULAR FAILURE,1
FR,LEUKOCYTOSIS,1
FR,LIGAMENT SPRAIN,1
FR,LIPASE INCREASED,1
FR,LOOSE TOOTH,1
FR,LOSS OF CONSCIOUSNESS,1
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
FR,LUNG INFECTION PSEUDOMONAL,1
FR,LUNG NEOPLASM MALIGNANT,1
FR,LYMPHADENOPATHY,1
FR,LYMPHOCYTE COUNT DECREASED,1
FR,LYMPHOCYTE COUNT INCREASED,1
FR,LYMPHOCYTOSIS,1
FR,LYMPHOMA TRANSFORMATION,1
FR,LYMPHOPENIA,1
FR,MALNUTRITION,1
FR,MATERNAL EXPOSURE DURING PREGNANCY,1
FR,MEDICATION ERROR,1
FR,MEMORY IMPAIRMENT,1
FR,MENTAL DISORDER,1
FR,METABOLIC ACIDOSIS,1
FR,METABOLIC ALKALOSIS,1
FR,MICROCYTOSIS,1
FR,MONOPLEGIA,1
FR,MUSCULAR WEAKNESS,1
FR,MUSCULOSKELETAL PAIN,1
FR,MYOCARDIAL INFARCTION,1
FR,NECK PAIN,1
FR,NEPHROTIC SYNDROME,1
FR,NERVOUSNESS,1
FR,NEUROPATHY PERIPHERAL,1
FR,OSTEOPOROSIS,1
FR,OSTEOPOROTIC FRACTURE,1
FR,OVERDOSE,1
FR,PAIN IN JAW,1
FR,PALATAL OEDEMA,1
FR,PALLOR,1
FR,PANCREATITIS,1
FR,PERIPHERAL ISCHAEMIA,1
FR,PERONEAL NERVE PALSY,1
FR,PHARYNGEAL OEDEMA,1
FR,PHARYNGITIS,1
FR,PLEURISY,1
FR,POLLAKIURIA,1
FR,POST PROCEDURAL HAEMATOMA,1
FR,PRESYNCOPE,1
FR,PROCTALGIA,1
FR,PRODUCT FORMULATION ISSUE,1
FR,PRODUCT QUALITY ISSUE,1
FR,PRODUCT SUBSTITUTION ISSUE,1
FR,PRODUCT USE IN UNAPPROVED INDICATION,1
FR,PRODUCT USE ISSUE,1
FR,PROTEIN URINE PRESENT,1
FR,PRURIGO,1
FR,PSYCHOMOTOR HYPERACTIVITY,1
FR,PSYCHOMOTOR SKILLS IMPAIRED,1
FR,PULMONARY ARTERY STENOSIS CONGENITAL,1
FR,PURPURA,1
FR,QUADRIPLEGIA,1
FR,RASH MACULO-PAPULAR,1
FR,RENAL FAILURE ACUTE,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL IMPAIRMENT,1
FR,RESPIRATORY ARREST,1
FR,RESPIRATORY DISORDER,1
FR,RESPIRATORY MONILIASIS,1
FR,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,1
FR,RHABDOMYOLYSIS,1
FR,RHINITIS,1
FR,SEGMENTED HYALINISING VASCULITIS,1
FR,SELF-MEDICATION,1
FR,SENSORY LOSS,1
FR,SEPTIC SHOCK,1
FR,SINUS TACHYCARDIA,1
FR,SKIN ATROPHY,1
FR,SKIN DISCOLOURATION,1
FR,SKIN TEST NEGATIVE,1
FR,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
FR,SPEECH DISORDER,1
FR,SPINAL COMPRESSION FRACTURE,1
FR,SPINAL CORD COMPRESSION,1
FR,SPLENIC INFARCTION,1
FR,SPLENOMEGALY,1
FR,STATUS ASTHMATICUS,1
FR,STEREOTYPY,1
FR,SUICIDE ATTEMPT,1
FR,SUPRAVENTRICULAR TACHYCARDIA,1
FR,SWELLING,1
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FR,TACHYPNOEA,1
FR,THIRST,1
FR,THROMBOTIC MICROANGIOPATHY,1
FR,TINNITUS,1
FR,TONGUE DISCOLOURATION,1
FR,TOTAL LUNG CAPACITY DECREASED,1
FR,TOXICITY TO VARIOUS AGENTS,1
FR,TRANSAMINASES INCREASED,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TREMOR,1
FR,TUBERCULOSIS,1
FR,TUMOUR FLARE,1
FR,VENTRICULAR EXTRASYSTOLES,1
FR,VIITH NERVE PARALYSIS,1
FR,VISUAL ACUITY REDUCED,1
FR,VOCAL CORD DISORDER,1
FR,WEIGHT DECREASE NEONATAL,1
FR,WEIGHT DECREASED,1
FR,WHITE BLOOD CELL COUNT INCREASED,1
FR,WITHDRAWAL SYNDROME,1
FR,WOUND COMPLICATION,1
FR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
DE,DYSPNOEA,2
DE,FOETAL EXPOSURE DURING PREGNANCY,2
DE,ACUTE KIDNEY INJURY,1
DE,ACUTE MYOCARDIAL INFARCTION,1
DE,ADVERSE EVENT,1
DE,ALBUMINURIA,1
DE,ALCOHOL WITHDRAWAL SYNDROME,1
DE,ALOPECIA,1
DE,ANAPHYLACTIC REACTION,1
DE,ANGIOEDEMA,1
DE,ASPIRATION,1
DE,BREAST FEEDING,1
DE,CONDITION AGGRAVATED,1
DE,CONGENITAL INGUINAL HERNIA,1
DE,COUGH,1
DE,CRYPTORCHISM,1
DE,DEATH,1
DE,DERMATITIS EXFOLIATIVE,1
DE,DISTURBANCE IN ATTENTION,1
DE,DIZZINESS,1
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,1
DE,EXPOSURE DURING BREAST FEEDING,1
DE,FEBRILE NEUTROPENIA,1
DE,GENERAL PHYSICAL CONDITION ABNORMAL,1
DE,GESTATIONAL DIABETES,1
DE,HEART RATE IRREGULAR,1
DE,KAPOSI^S SARCOMA,1
DE,LACTIC ACIDOSIS,1
DE,MATERNAL EXPOSURE DURING PREGNANCY,1
DE,MULTI-ORGAN FAILURE,1
DE,NEONATAL RESPIRATORY FAILURE,1
DE,OBSTRUCTION,1
DE,ORAL DISCOMFORT,1
DE,ORAL DISORDER,1
DE,ORAL PAIN,1
DE,OROPHARYNGEAL PAIN,1
DE,PARAESTHESIA ORAL,1
DE,PATENT DUCTUS ARTERIOSUS,1
DE,PERIPHERAL VASCULAR DISORDER,1
DE,PERSISTENT FOETAL CIRCULATION,1
DE,PRE-ECLAMPSIA,1
DE,PRODUCT USE IN UNAPPROVED INDICATION,1
DE,PRODUCT USE ISSUE,1
DE,PROTEINURIA,1
DE,RENAL FAILURE,1
DE,RESPIRATORY DISTRESS,1
DE,RHABDOMYOLYSIS,1
DE,RHINITIS,1
DE,SKIN DISORDER,1
DE,SNEEZING,1
DE,SPIROCHAETAL INFECTION,1
DE,SWOLLEN TONGUE,1
DE,TACHYPNOEA,1
DE,THROAT IRRITATION,1
DE,TREMOR,1
DE,TRUNCUS ARTERIOSUS PERSISTENT,1
DE,TUNNEL VISION,1
DE,UNDERDOSE,1
DE,VENTRICULAR SEPTAL DEFECT,1
DE,VERTIGO,1
DE,VIRAL INFECTION,1
DE,WEIGHT DECREASED,1
HN,TACHYCARDIA,1
HK,ACUTE KIDNEY INJURY,2
HK,DEHYDRATION,2
HK,DYSPNOEA,2
HK,PNEUMONIA,2
HK,VOMITING,2
HK,ABDOMINAL DISTENSION,1
HK,ABDOMINAL PAIN UPPER,1
HK,BLOOD CREATININE INCREASED,1
HK,BLOOD UREA INCREASED,1
HK,CARDIAC ARREST,1
HK,CARDIOMEGALY,1
HK,DECREASED APPETITE,1
HK,DIARRHOEA,1
HK,ECZEMA,1
HK,EROSIVE DUODENITIS,1
HK,GASTRITIS,1
HK,HAEMATEMESIS,1
HK,HYPERBILIRUBINAEMIA,1
HK,HYPOKALAEMIA,1
HK,MALAISE,1
HK,NAUSEA,1
HK,OEDEMA PERIPHERAL,1
HK,OESOPHAGITIS HAEMORRHAGIC,1
HK,ORTHOPNOEA,1
HK,PLEURAL EFFUSION,1
HK,PULMONARY CONGESTION,1
HK,RENAL DISORDER,1
HK,RESPIRATORY FAILURE,1
HK,URINARY RETENTION,1
HK,WEIGHT DECREASED,1
HU,DYSPNOEA,11
HU,DYSPNOEA EXERTIONAL,7
HU,DIARRHOEA,5
HU,ASTHMA,4
HU,BRONCHITIS,4
HU,MOBILITY DECREASED,4
HU,MYOCARDIAL ISCHAEMIA,4
HU,PERIPHERAL ARTERY OCCLUSION,4
HU,URINARY TRACT INFECTION BACTERIAL,4
HU,ANGINA PECTORIS,3
HU,ARRHYTHMIA,3
HU,NASOPHARYNGITIS,3
HU,NAUSEA,3
HU,PNEUMONIA,3
HU,RESPIRATORY FAILURE,3
HU,VOMITING,3
HU,ASTHENIA,2
HU,BACK PAIN,2
HU,BLOOD PRESSURE INCREASED,2
HU,DRUG INEFFECTIVE,2
HU,FALL,2
HU,FATIGUE,2
HU,HAEMOPTYSIS,2
HU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
HU,INFLUENZA,2
HU,INJURY,2
HU,MALAISE,2
HU,OVERDOSE,2
HU,PAIN IN EXTREMITY,2
HU,THROMBOCYTOPENIA,2
HU,WEIGHT DECREASED,2
HU,ABDOMINAL DISTENSION,1
HU,ABDOMINAL PAIN UPPER,1
HU,ACINETOBACTER TEST POSITIVE,1
HU,ALBUMIN URINE ABSENT,1
HU,AMYLASE INCREASED,1
HU,ANAEMIA,1
HU,ANAPHYLACTIC REACTION,1
HU,ARTHRALGIA,1
HU,ATRIAL FIBRILLATION,1
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
HU,AXILLARY PAIN,1
HU,BLOOD ALBUMIN INCREASED,1
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HU,BLOOD CHOLESTEROL INCREASED,1
HU,BLOOD CREATININE INCREASED,1
HU,BLOOD GLUCOSE INCREASED,1
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
HU,BLOOD POTASSIUM INCREASED,1
HU,BLOOD PRESSURE FLUCTUATION,1
HU,BLOOD SODIUM INCREASED,1
HU,BLOOD UREA INCREASED,1
HU,BRONCHIECTASIS,1
HU,CARDIAC FAILURE,1
HU,CHEST PAIN,1
HU,CHOKING,1
HU,CIRCULATORY COLLAPSE,1
HU,CONDITION AGGRAVATED,1
HU,COUGH,1
HU,DEATH,1
HU,DEHYDRATION,1
HU,DERMATITIS ALLERGIC,1
HU,DISEASE RECURRENCE,1
HU,DIZZINESS,1
HU,DRUG ADMINISTRATION ERROR,1
HU,DRUG HYPERSENSITIVITY,1
HU,DRY THROAT,1
HU,DYSGEUSIA,1
HU,EOSINOPHILIA,1
HU,EPISTAXIS,1
HU,FACE INJURY,1
HU,FUNGAL OESOPHAGITIS,1
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HU,GENERALISED OEDEMA,1
HU,GLOMERULAR FILTRATION RATE DECREASED,1
HU,HAEMATOCRIT DECREASED,1
HU,HAEMATOTOXICITY,1
HU,HAEMOGLOBIN DECREASED,1
HU,HAEMORRHAGIC TRANSFORMATION STROKE,1
HU,HALLUCINATION,1
HU,HEADACHE,1
HU,HEART RATE INCREASED,1
HU,HEPATIC STEATOSIS,1
HU,HEPATOMEGALY,1
HU,HYPERSENSITIVITY,1
HU,HYPERTENSION,1
HU,HYPOAESTHESIA,1
HU,HYPOKALAEMIA,1
HU,HYPOTHYROIDISM,1
HU,HYPOTONY OF EYE,1
HU,HYPOXIA,1
HU,ILEUS PARALYTIC,1
HU,INCORRECT DOSE ADMINISTERED,1
HU,INJECTION SITE ERYTHEMA,1
HU,INJECTION SITE PRURITUS,1
HU,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
HU,INTESTINAL HAEMORRHAGE,1
HU,INTRACRANIAL PRESSURE INCREASED,1
HU,LARYNGEAL CANCER,1
HU,LEUKOPENIA,1
HU,LIPASE INCREASED,1
HU,LOW DENSITY LIPOPROTEIN INCREASED,1
HU,LUNG DISORDER,1
HU,LUNG INFILTRATION,1
HU,LYMPHOCYTE COUNT DECREASED,1
HU,LYMPHOPENIA,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,MEAN CELL VOLUME DECREASED,1
HU,MENINGITIS,1
HU,MIDDLE INSOMNIA,1
HU,MOOD ALTERED,1
HU,MUSCLE SPASMS,1
HU,NASAL INJURY,1
HU,NEUTROPENIA,1
HU,ORAL MUCOSAL BLISTERING,1
HU,OROPHARYNGEAL BLISTERING,1
HU,PERIORBITAL HAEMORRHAGE,1
HU,PLATELET COUNT DECREASED,1
HU,PLEURAL FIBROSIS,1
HU,PNEUMONITIS,1
HU,PRODUCT USE IN UNAPPROVED INDICATION,1
HU,PROTEIN URINE PRESENT,1
HU,PROTHROMBIN TIME PROLONGED,1
HU,PRURITUS GENERALISED,1
HU,PULMONARY OEDEMA,1
HU,PYREXIA,1
HU,RASH,1
HU,RASH PUSTULAR,1
HU,RED CELL DISTRIBUTION WIDTH INCREASED,1
HU,RENAL FAILURE,1
HU,RETINAL HAEMORRHAGE,1
HU,RHINITIS ALLERGIC,1
HU,SECRETION DISCHARGE,1
HU,SENSITIVITY TO WEATHER CHANGE,1
HU,SINUS RHYTHM,1
HU,SMALL CELL LUNG CANCER,1
HU,SPINAL CORD HERNIATION,1
HU,SUICIDAL IDEATION,1
HU,TONGUE BLISTERING,1
HU,TOXIC SKIN ERUPTION,1
HU,TRI-IODOTHYRONINE INCREASED,1
HU,UROSEPSIS,1
HU,URTICARIA,1
HU,UVEITIS,1
HU,VASCULAR STENOSIS,1
HU,VIRAL INFECTION,1
HU,WHEEZING,1
HU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
IS,DYSPNOEA,1
IS,ERYTHEMA,1
IS,HEADACHE,1
IS,HYPOXIA,1
IS,NAUSEA,1
IS,OEDEMA PERIPHERAL,1
IS,PULMONARY OEDEMA,1
IS,URTICARIA,1
IN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
IN,ABDOMINAL PAIN,1
IN,ANXIETY,1
IN,ASTHENIA,1
IN,ASTHMA,1
IN,BLOOD IRON DECREASED,1
IN,DIARRHOEA,1
IN,DRUG INEFFECTIVE,1
IN,DYSPHONIA,1
IN,FUNGAL INFECTION,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,HEART RATE DECREASED,1
IN,HYPONATRAEMIA,1
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IN,LOWER RESPIRATORY TRACT CONGESTION,1
IN,MALAISE,1
IN,NAUSEA,1
IN,PHARYNGITIS,1
IN,PNEUMONIA,1
IN,STRONGYLOIDIASIS,1
IN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IN,VITAMIN B12 DECREASED,1
ID,ASTHMA,1
ID,DEATH,1
ID,DYSPNOEA,1
ID,LETHARGY,1
ID,RESTLESSNESS,1
ID,VOMITING,1
IR,DELIVERY,1
IR,DRUG INEFFECTIVE,1
IR,INTRAOCULAR PRESSURE INCREASED,1
IR,MATERNAL EXPOSURE DURING PREGNANCY,1
IR,NORMAL NEWBORN,1
IR,STRESS CARDIOMYOPATHY,1
IE,COUGH,20
IE,DYSPNOEA,19
IE,LOWER RESPIRATORY TRACT INFECTION,12
IE,WHEEZING,11
IE,MALAISE,10
IE,PRODUCT USE ISSUE,9
IE,DIZZINESS,8
IE,PYREXIA,8
IE,ABDOMINAL PAIN,7
IE,ASTHENIA,7
IE,ASTHMA,7
IE,DRUG INEFFECTIVE,7
IE,FATIGUE,7
IE,NAUSEA,7
IE,VOMITING,7
IE,CHEST PAIN,6
IE,CONFUSIONAL STATE,6
IE,DEATH,6
IE,FALL,6
IE,ANXIETY,5
IE,BACK PAIN,5
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
IE,MUSCULAR WEAKNESS,5
IE,PRURITUS,5
IE,URINARY TRACT INFECTION,5
IE,ACUTE KIDNEY INJURY,4
IE,ARTHRALGIA,4
IE,HAEMOGLOBIN DECREASED,4
IE,HYPERTENSION,4
IE,INFECTION,4
IE,INSOMNIA,4
IE,MUSCULOSKELETAL PAIN,4
IE,MYALGIA,4
IE,PAIN,4
IE,PALPITATIONS,4
IE,PARAESTHESIA,4
IE,PRODUCTIVE COUGH,4
IE,RESPIRATORY TRACT INFECTION,4
IE,VISION BLURRED,4
IE,WEIGHT DECREASED,4
IE,CELLULITIS,3
IE,CHEST DISCOMFORT,3
IE,DECREASED APPETITE,3
IE,DEPRESSION,3
IE,DIARRHOEA,3
IE,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,3
IE,GAIT DISTURBANCE,3
IE,HEPATIC FAILURE,3
IE,HYPOTENSION,3
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
IE,NASOPHARYNGITIS,3
IE,NEUTROPHIL COUNT DECREASED,3
IE,OROPHARYNGEAL PAIN,3
IE,PAIN IN EXTREMITY,3
IE,RASH GENERALISED,3
IE,RHINORRHOEA,3
IE,TINNITUS,3
IE,WHITE BLOOD CELL COUNT DECREASED,3
IE,ASCITES,2
IE,BASAL CELL CARCINOMA,2
IE,BLOOD GLUCOSE INCREASED,2
IE,BLOOD PRESSURE INCREASED,2
IE,BREAST ABSCESS,2
IE,BRONCHOSPASM,2
IE,CARDIAC ARREST,2
IE,CONDITION AGGRAVATED,2
IE,CONSTIPATION,2
IE,CROHN^S DISEASE,2
IE,DRY SKIN,2
IE,EYE PAIN,2
IE,EYE PRURITUS,2
IE,HAEMATOCHEZIA,2
IE,HAEMATURIA,2
IE,HAEMORRHAGE,2
IE,HEADACHE,2
IE,HEART RATE INCREASED,2
IE,HEPATIC CIRRHOSIS,2
IE,HYPERSENSITIVITY,2
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
IE,INJECTION SITE ERYTHEMA,2
IE,IRRITABILITY,2
IE,JAUNDICE,2
IE,JOINT STIFFNESS,2
IE,LIP SWELLING,2
IE,LUNG DISORDER,2
IE,NASAL CONGESTION,2
IE,NEUROPATHY PERIPHERAL,2
IE,NEUTROPHIL COUNT INCREASED,2
IE,NIGHT SWEATS,2
IE,OEDEMA,2
IE,OVARIAN CYST,2
IE,OVARIAN HYPERSTIMULATION SYNDROME,2
IE,PAIN IN JAW,2
IE,PANCREATITIS,2
IE,PNEUMONIA,2
IE,PULMONARY EMBOLISM,2
IE,RASH,2
IE,SEIZURE,2
IE,SEPSIS,2
IE,SINUSITIS,2
IE,SMALL CELL LUNG CANCER METASTATIC,2
IE,TACHYCARDIA,2
IE,VIRAL INFECTION,2
IE,VISUAL IMPAIRMENT,2
IE,WHITE BLOOD CELL COUNT INCREASED,2
IE,ABDOMINAL ADHESIONS,1
IE,ABDOMINAL DISCOMFORT,1
IE,ABDOMINAL PAIN UPPER,1
IE,ABNORMAL CLOTTING FACTOR,1
IE,ACROCHORDON,1
IE,ACUTE PSYCHOSIS,1
IE,AGITATION,1
IE,ALOPECIA,1
IE,AMNESIA,1
IE,ANAL PRURITUS,1
IE,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
IE,AORTIC DILATATION,1
IE,ARRHYTHMIA,1
IE,ATYPICAL FEMUR FRACTURE,1
IE,BALANOPOSTHITIS,1
IE,BASILAR ARTERY ANEURYSM,1
IE,BLADDER DISORDER,1
IE,BLISTER,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD CHOLESTEROL INCREASED,1
IE,BLOOD PRESSURE SYSTOLIC INCREASED,1
IE,BLOOD SODIUM DECREASED,1
IE,BLOOD URINE PRESENT,1
IE,BODY TEMPERATURE FLUCTUATION,1
IE,BONE PAIN,1
IE,BRADYCARDIA FOETAL,1
IE,BRONCHIECTASIS,1
IE,BRONCHIOLITIS,1
IE,BRONCHITIS,1
IE,BURNING SENSATION,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CARDIAC FAILURE CONGESTIVE,1
IE,CARDIAC VALVE RUPTURE,1
IE,CARDIOMYOPATHY,1
IE,CATARRH,1
IE,CENTRAL NERVOUS SYSTEM INFECTION,1
IE,CEREBRAL INFARCTION,1
IE,CHEST X-RAY ABNORMAL,1
IE,CHILLS,1
IE,CHRONIC FATIGUE SYNDROME,1
IE,CHRONIC GASTRITIS,1
IE,CLAUSTROPHOBIA,1
IE,CORONARY ARTERY DISEASE,1
IE,CYSTITIS,1
IE,DEEP VEIN THROMBOSIS,1
IE,DEPRESSED MOOD,1
IE,DERMAL CYST,1
IE,DEVICE ISSUE,1
IE,DEVICE MALFUNCTION,1
IE,DEVICE OCCLUSION,1
IE,DEVICE RELATED INFECTION,1
IE,DIABETIC KETOACIDOSIS,1
IE,DISCOMFORT,1
IE,DISORIENTATION,1
IE,DISTURBANCE IN ATTENTION,1
IE,DIVERTICULITIS,1
IE,DIVERTICULUM,1
IE,DRUG DOSE OMISSION,1
IE,DRUG HYPERSENSITIVITY,1
IE,DYSGEUSIA,1
IE,DYSPEPSIA,1
IE,DYSTONIA,1
IE,EAR CONGESTION,1
IE,EAR PAIN,1
IE,EAR PRURITUS,1
IE,ECCHYMOSIS,1
IE,ECZEMA INFECTED,1
IE,EMOTIONAL DISTRESS,1
IE,ENCEPHALOPATHY,1
IE,ENDOCARDITIS,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,EPISTAXIS,1
IE,ERYTHEMA,1
IE,EXPIRED PRODUCT ADMINISTERED,1
IE,EXTRA DOSE ADMINISTERED,1
IE,EYE DISORDER,1
IE,EYELID PTOSIS,1
IE,FACE OEDEMA,1
IE,FEAR,1
IE,FEELING ABNORMAL,1
IE,FEELING HOT,1
IE,FLUSHING,1
IE,FOETAL EXPOSURE DURING PREGNANCY,1
IE,FUNGAL OESOPHAGITIS,1
IE,GASTRITIS EROSIVE,1
IE,GASTROINTESTINAL DISORDER,1
IE,GINGIVAL PAIN,1
IE,GROIN PAIN,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMOGLOBIN INCREASED,1
IE,HAEMORRHOIDS,1
IE,HEART RATE DECREASED,1
IE,HELICOBACTER INFECTION,1
IE,HOSPITALISATION,1
IE,HYPERBILIRUBINAEMIA,1
IE,HYPERHIDROSIS,1
IE,HYPOAESTHESIA,1
IE,HYPOGLYCAEMIA,1
IE,HYPONATRAEMIA,1
IE,HYPOXIA,1
IE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IE,INCORRECT DOSE ADMINISTERED,1
IE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IE,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
IE,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,1
IE,INFLAMMATION,1
IE,INFLUENZA LIKE ILLNESS,1
IE,INFUSION RELATED REACTION,1
IE,INJECTION SITE PRURITUS,1
IE,INJECTION SITE REACTION,1
IE,INJECTION SITE WARMTH,1
IE,INTENTIONAL PRODUCT MISUSE,1
IE,INVESTIGATION,1
IE,JOINT CREPITATION,1
IE,JOINT INJURY,1
IE,LACERATION,1
IE,LETHARGY,1
IE,LEUKOPENIA,1
IE,LIP OEDEMA,1
IE,LOCAL SWELLING,1
IE,LUNG ABSCESS,1
IE,LUNG NEOPLASM MALIGNANT,1
IE,LYMPHOMA,1
IE,MASTITIS,1
IE,MEMORY IMPAIRMENT,1
IE,MENISCUS INJURY,1
IE,MENTAL DISORDER,1
IE,MOBILITY DECREASED,1
IE,MONARTHRITIS,1
IE,MONOCYTE COUNT DECREASED,1
IE,MUSCLE ATROPHY,1
IE,MUSCLE STRAIN,1
IE,MUSCLE TWITCHING,1
IE,MUSCULOSKELETAL CHEST PAIN,1
IE,MUSCULOSKELETAL STIFFNESS,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,MYOCLONUS,1
IE,MYOSITIS,1
IE,NAIL DISCOLOURATION,1
IE,NASAL PRURITUS,1
IE,NECK PAIN,1
IE,NEOPLASM MALIGNANT,1
IE,NERVE COMPRESSION,1
IE,NERVOUS SYSTEM DISORDER,1
IE,NERVOUSNESS,1
IE,NEURALGIA,1
IE,NEUROTOXICITY,1
IE,NIGHTMARE,1
IE,NOCTURIA,1
IE,OSTEOARTHRITIS,1
IE,OSTEONECROSIS,1
IE,OSTEONECROSIS OF JAW,1
IE,OTITIS MEDIA,1
IE,OXYGEN SATURATION DECREASED,1
IE,PAINFUL RESPIRATION,1
IE,PANCREATITIS ACUTE,1
IE,PANIC DISORDER,1
IE,PARAESTHESIA ORAL,1
IE,PEAK EXPIRATORY FLOW RATE DECREASED,1
IE,PELVIC PAIN,1
IE,PERIPHERAL SWELLING,1
IE,PERNICIOUS ANAEMIA,1
IE,PHARYNGEAL CYST,1
IE,PHARYNGITIS,1
IE,PHLEBITIS SUPERFICIAL,1
IE,PLATELET COUNT DECREASED,1
IE,PLATELET COUNT INCREASED,1
IE,PLEURAL EFFUSION,1
IE,PLEURISY,1
IE,PLEURITIC PAIN,1
IE,PNEUMOTHORAX,1
IE,POST-TUSSIVE VOMITING,1
IE,POSTOPERATIVE WOUND INFECTION,1
IE,PRESYNCOPE,1
IE,PRIMARY CILIARY DYSKINESIA,1
IE,PRODUCT QUALITY ISSUE,1
IE,PRODUCT USE IN UNAPPROVED INDICATION,1
IE,PROLAPSE,1
IE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IE,PROSTATOMEGALY,1
IE,PSORIASIS,1
IE,PSYCHOTIC DISORDER,1
IE,PULMONARY PAIN,1
IE,RESPIRATORY DISORDER,1
IE,RESPIRATORY DISTRESS,1
IE,RESPIRATORY RATE INCREASED,1
IE,RESPIRATORY SYMPTOM,1
IE,SCHIZOPHRENIA_ PARANOID TYPE,1
IE,SCIATICA,1
IE,SEIZURE LIKE PHENOMENA,1
IE,SENSATION OF FOREIGN BODY,1
IE,SINUS DISORDER,1
IE,SINUS PAIN,1
IE,SKIN DISORDER,1
IE,SKIN INJURY,1
IE,SKIN LESION,1
IE,SMALL CELL LUNG CANCER RECURRENT,1
IE,SNEEZING,1
IE,SOFT TISSUE INJURY,1
IE,SOMNOLENCE,1
IE,STAPHYLOCOCCAL INFECTION,1
IE,STRESS,1
IE,SUICIDAL BEHAVIOUR,1
IE,SYNOVIAL SARCOMA METASTATIC,1
IE,TACHYPNOEA,1
IE,TENDON DISORDER,1
IE,THROAT IRRITATION,1
IE,THROAT TIGHTNESS,1
IE,THROMBOSIS IN DEVICE,1
IE,TOOTH ABSCESS,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,UPPER LIMB FRACTURE,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,URINARY HESITATION,1
IE,URTICARIA,1
IE,VENTRICULAR TACHYCARDIA,1
IE,VIRAL RASH,1
IE,VITAMIN B12 DEFICIENCY,1
IE,WHITE BLOOD CELLS URINE,1
IE,WRONG DEVICE USED,1
IE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IL,DYSPNOEA,5
IL,PNEUMONIA,5
IL,PYREXIA,4
IL,ABDOMINAL PAIN,3
IL,ASTHMA,3
IL,DRUG INEFFECTIVE,3
IL,INTERNATIONAL NORMALISED RATIO INCREASED,3
IL,ACCIDENTAL EXPOSURE TO PRODUCT,2
IL,ACUTE KIDNEY INJURY,2
IL,ASTHENIA,2
IL,BRONCHIECTASIS,2
IL,ESCHERICHIA BACTERAEMIA,2
IL,HOSPITALISATION,2
IL,PRODUCT QUALITY ISSUE,2
IL,SYNCOPE,2
IL,ACUTE RESPIRATORY FAILURE,1
IL,ANAEMIA,1
IL,ANAPHYLACTIC REACTION,1
IL,ANGINA PECTORIS,1
IL,BLINDNESS TRANSIENT,1
IL,BLINDNESS UNILATERAL,1
IL,BLOOD CREATININE INCREASED,1
IL,BLOOD PRESSURE INCREASED,1
IL,CARDIAC ARREST,1
IL,CARDIOVASCULAR DISORDER,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,CONDITION AGGRAVATED,1
IL,CONSTIPATION,1
IL,COUGH,1
IL,DECREASED APPETITE,1
IL,DEEP VEIN THROMBOSIS,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DISEASE PROGRESSION,1
IL,DIZZINESS,1
IL,ERYTHEMA,1
IL,FEELING ABNORMAL,1
IL,GENERAL PHYSICAL HEALTH DETERIORATION,1
IL,HAEMATEMESIS,1
IL,HAEMOGLOBIN DECREASED,1
IL,HAEMOPTYSIS,1
IL,HEAD DISCOMFORT,1
IL,HEADACHE,1
IL,HEART RATE INCREASED,1
IL,HYDROCEPHALUS,1
IL,HYPERTENSION,1
IL,HYPERTRICHOSIS,1
IL,INFLUENZA,1
IL,INFUSION RELATED REACTION,1
IL,INTRAVENTRICULAR HAEMORRHAGE,1
IL,LEUKOCYTOSIS,1
IL,LOSS OF CONSCIOUSNESS,1
IL,MATERNAL EXPOSURE DURING PREGNANCY,1
IL,MULTI-ORGAN FAILURE,1
IL,NAUSEA,1
IL,NEUTROPENIA,1
IL,NONINFECTIVE GINGIVITIS,1
IL,NORMAL NEWBORN,1
IL,OEDEMA PERIPHERAL,1
IL,ORAL PAIN,1
IL,OROPHARYNGITIS FUNGAL,1
IL,OSTEONECROSIS OF JAW,1
IL,OXYGEN SATURATION DECREASED,1
IL,POSTOPERATIVE WOUND INFECTION,1
IL,PRODUCT USE ISSUE,1
IL,PULMONARY HYPERTENSION,1
IL,PULMONARY VENO-OCCLUSIVE DISEASE,1
IL,RENAL CELL CARCINOMA,1
IL,RESPIRATORY DISORDER,1
IL,SEPTIC SHOCK,1
IL,SWELLING FACE,1
IL,TACHYCARDIA,1
IL,TONGUE FUNGAL INFECTION,1
IL,VISION BLURRED,1
IL,VOMITING,1
IT,DYSPNOEA,12
IT,TREMOR,8
IT,ERYTHEMA,7
IT,HYPERSENSITIVITY,7
IT,MALAISE,7
IT,PALPITATIONS,6
IT,ACUTE HAEMORRHAGIC OEDEMA OF INFANCY,5
IT,BRONCHOSPASM,5
IT,DRUG ABUSE,5
IT,EYELID OEDEMA,5
IT,DRUG INEFFECTIVE,4
IT,LOSS OF CONSCIOUSNESS,4
IT,OVERDOSE,4
IT,PERIORBITAL OEDEMA,4
IT,PURPURA,4
IT,URTICARIA,4
IT,ABDOMINAL PAIN,3
IT,ACUTE MYOCARDIAL INFARCTION,3
IT,ACUTE RESPIRATORY FAILURE,3
IT,ASTHMA,3
IT,DIARRHOEA,3
IT,EYE PRURITUS,3
IT,FALL,3
IT,HEADACHE,3
IT,INTENTIONAL SELF-INJURY,3
IT,NAUSEA,3
IT,PARAESTHESIA,3
IT,PRESYNCOPE,3
IT,PRURITUS GENERALISED,3
IT,PYREXIA,3
IT,SINUS TACHYCARDIA,3
IT,SOPOR,3
IT,STEVENS-JOHNSON SYNDROME,3
IT,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
IT,TACHYCARDIA,3
IT,AGITATION,2
IT,ANAPHYLACTIC SHOCK,2
IT,ASTHENIA,2
IT,ASTHMATIC CRISIS,2
IT,ATRIAL FIBRILLATION,2
IT,COUGH,2
IT,DISCOMFORT,2
IT,DRUG USE DISORDER,2
IT,DYSPEPSIA,2
IT,DYSPHONIA,2
IT,EXTRASYSTOLES,2
IT,FACE INJURY,2
IT,HEAD INJURY,2
IT,HYPOKALAEMIA,2
IT,JAUNDICE,2
IT,NEPHROPATHY,2
IT,OEDEMA PERIPHERAL,2
IT,PANCYTOPENIA,2
IT,PRURITUS,2
IT,SUBCUTANEOUS ABSCESS,2
IT,SUBDURAL HAEMATOMA,2
IT,TONGUE OEDEMA,2
IT,TOXICITY TO VARIOUS AGENTS,2
IT,WOUND,2
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IT,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
IT,ANAEMIA,1
IT,ANGIOEDEMA,1
IT,ANOXIA,1
IT,APHASIA,1
IT,APNOEA,1
IT,ARRHYTHMIA,1
IT,ARTERIAL INTRAMURAL HAEMATOMA,1
IT,ARTERIAL SPASM,1
IT,ARTERIOSPASM CORONARY,1
IT,BALANCE DISORDER,1
IT,BLOOD GLUCOSE INCREASED,1
IT,BRADYKINESIA,1
IT,BREATH SOUNDS ABNORMAL,1
IT,BRONCHITIS,1
IT,CARDIAC FAILURE,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIO-RESPIRATORY ARREST,1
IT,CHEILITIS,1
IT,CHEST DISCOMFORT,1
IT,CHEST PAIN,1
IT,CHOLESTASIS,1
IT,CIRCULATORY COLLAPSE,1
IT,CONDITION AGGRAVATED,1
IT,CONJUNCTIVITIS,1
IT,DECREASED APPETITE,1
IT,DEEP VEIN THROMBOSIS,1
IT,DEHYDRATION,1
IT,DEPRESSION,1
IT,DIZZINESS,1
IT,ELECTROCARDIOGRAM ABNORMAL,1
IT,ELECTROCARDIOGRAM QT PROLONGED,1
IT,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,1
IT,EPIDIDYMITIS,1
IT,EXPOSURE DURING PREGNANCY,1
IT,EYE INJURY,1
IT,FAECALOMA,1
IT,FEBRILE NEUTROPENIA,1
IT,FEELING HOT,1
IT,FOREIGN BODY ASPIRATION,1
IT,GAIT DISTURBANCE,1
IT,GASTRIC ULCER HAEMORRHAGE,1
IT,GASTROINTESTINAL HAEMORRHAGE,1
IT,GENERAL PHYSICAL HEALTH DETERIORATION,1
IT,GRAVITATIONAL OEDEMA,1
IT,HAEMARTHROSIS,1
IT,HAEMOPTYSIS,1
IT,HENOCH-SCHONLEIN PURPURA,1
IT,HEPATIC FAILURE,1
IT,HEPATIC FUNCTION ABNORMAL,1
IT,HYPERAEMIA,1
IT,HYPERGLYCAEMIA,1
IT,HYPERPYREXIA,1
IT,HYPERTENSION,1
IT,HYPERTRANSAMINASAEMIA,1
IT,HYPOTENSION,1
IT,INCORRECT DOSE ADMINISTERED,1
IT,INJECTION SITE EXTRAVASATION,1
IT,INJURY,1
IT,INSOMNIA,1
IT,INTERNATIONAL NORMALISED RATIO INCREASED,1
IT,JOINT INJURY,1
IT,JOINT SWELLING,1
IT,LIP SWELLING,1
IT,LIVER DISORDER,1
IT,MELAENA,1
IT,MENTAL IMPAIRMENT,1
IT,MOBILITY DECREASED,1
IT,MOVEMENT DISORDER,1
IT,NERVOUSNESS,1
IT,OXYGEN SATURATION,1
IT,PANCREATITIS,1
IT,PERICARDIAL EFFUSION,1
IT,PHARYNGEAL ERYTHEMA,1
IT,PNEUMONITIS,1
IT,PRIAPISM,1
IT,PRODUCT SUBSTITUTION ISSUE,1
IT,PROTEINURIA,1
IT,PSORIASIS,1
IT,PSYCHOMOTOR HYPERACTIVITY,1
IT,RESPIRATORY FAILURE,1
IT,SEDATION,1
IT,SENSATION OF FOREIGN BODY,1
IT,SKIN LESION,1
IT,SPUTUM RETENTION,1
IT,STOMATITIS,1
IT,SUDDEN DEATH,1
IT,SUICIDE ATTEMPT,1
IT,SWELLING FACE,1
IT,SYNCOPE,1
IT,TACHYPNOEA,1
IT,TONGUE FUNGAL INFECTION,1
IT,TRANSAMINASES INCREASED,1
IT,VASCULITIS,1
IT,VERTIGO,1
IT,VOMITING,1
IT,WEIGHT DECREASED,1
IT,WHEEZING,1
IT,WRONG DRUG ADMINISTERED,1
IT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
JM,DEATH,2
JM,NOCTURNAL DYSPNOEA,1
JM,RESPIRATORY FAILURE,1
JP,BRONCHITIS,1
KE,CARDIAC DISORDER,1
KE,DEPENDENCE,1
KE,DYSGEUSIA,1
KE,DYSPNOEA,1
KE,MALAISE,1
KE,OROPHARYNGEAL PAIN,1
KE,PRODUCT QUALITY ISSUE,1
KE,RENAL FAILURE CHRONIC,1
KE,RESPIRATORY TRACT CONGESTION,1
KE,TACHYCARDIA,1
KE,TONSILLAR DISORDER,1
KE,TONSILLAR INFLAMMATION,1
KE,TONSILLITIS BACTERIAL,1
KE,WHEEZING,1
KR,DYSPNOEA,11
KR,PNEUMONIA,11
KR,PYREXIA,6
KR,ASPARTATE AMINOTRANSFERASE INCREASED,5
KR,ABDOMINAL PAIN,4
KR,ALANINE AMINOTRANSFERASE INCREASED,4
KR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
KR,DIARRHOEA,4
KR,PLEURAL EFFUSION,4
KR,BACK PAIN,3
KR,CONSTIPATION,3
KR,HAEMOPTYSIS,3
KR,C-REACTIVE PROTEIN INCREASED,2
KR,CARDIAC ARREST,2
KR,COUGH,2
KR,DELIRIUM,2
KR,DYSPEPSIA,2
KR,FALL,2
KR,HYPERTENSIVE CRISIS,2
KR,INSOMNIA,2
KR,LIVER FUNCTION TEST INCREASED,2
KR,NAUSEA,2
KR,NEUTROPHIL COUNT DECREASED,2
KR,PLATELET COUNT DECREASED,2
KR,RIB FRACTURE,2
KR,VOMITING,2
KR,ABDOMINAL DISCOMFORT,1
KR,ABORTION,1
KR,ABORTION SPONTANEOUS,1
KR,ACUTE KIDNEY INJURY,1
KR,ACUTE MYOCARDIAL INFARCTION,1
KR,ADRENAL INSUFFICIENCY,1
KR,ANAEMIA,1
KR,ANAPHYLACTIC SHOCK,1
KR,ANGINA PECTORIS,1
KR,APPENDICITIS,1
KR,ASCITES,1
KR,ATRIAL FIBRILLATION,1
KR,BK VIRUS INFECTION,1
KR,BLOOD BILIRUBIN INCREASED,1
KR,BLOOD GLUCOSE INCREASED,1
KR,BLOOD POTASSIUM DECREASED,1
KR,BRAIN DEATH,1
KR,BRAIN INJURY,1
KR,CARDIAC ABLATION,1
KR,CARDIAC FAILURE,1
KR,CEREBRAL INFARCTION,1
KR,COLD SWEAT,1
KR,CYANOSIS,1
KR,DEATH,1
KR,DECREASED APPETITE,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DIABETIC NEUROPATHY,1
KR,DIZZINESS,1
KR,DRUG ADMINISTRATION ERROR,1
KR,ERYTHEMA NODOSUM,1
KR,EXPIRED PRODUCT ADMINISTERED,1
KR,EXPOSURE DURING PREGNANCY,1
KR,FATIGUE,1
KR,FEBRILE NEUTROPENIA,1
KR,FEELING ABNORMAL,1
KR,FLUID RETENTION,1
KR,FORCED EXPIRATORY VOLUME INCREASED,1
KR,GASTRIC CANCER,1
KR,HEART RATE INCREASED,1
KR,HEPATITIS,1
KR,HEPATITIS ALCOHOLIC,1
KR,HYPERCALCAEMIA,1
KR,HYPERTENSION,1
KR,HYPERTONIC BLADDER,1
KR,HYPOALBUMINAEMIA,1
KR,HYPOKALAEMIA,1
KR,ILL-DEFINED DISORDER,1
KR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
KR,INFARCTION,1
KR,INFLUENZA LIKE ILLNESS,1
KR,INTERSTITIAL LUNG DISEASE,1
KR,JEJUNAL PERFORATION,1
KR,KLEBSIELLA INFECTION,1
KR,LIVER INJURY,1
KR,LOSS OF CONSCIOUSNESS,1
KR,MATERNAL EXPOSURE DURING PREGNANCY,1
KR,MELAENA,1
KR,MYALGIA,1
KR,MYCOPLASMA INFECTION,1
KR,OEDEMA PERIPHERAL,1
KR,OROPHARYNGEAL PAIN,1
KR,OVERDOSE,1
KR,OXYGEN SATURATION DECREASED,1
KR,PAIN IN EXTREMITY,1
KR,PANCREATITIS,1
KR,PARAESTHESIA,1
KR,PARAINFLUENZAE VIRUS INFECTION,1
KR,PERICARDIAL EFFUSION,1
KR,PERINEAL ERYTHEMA,1
KR,PERIPHERAL SENSORY NEUROPATHY,1
KR,PLICATED TONGUE,1
KR,PNEUMONIA STREPTOCOCCAL,1
KR,PO2 DECREASED,1
KR,PRODUCT USE IN UNAPPROVED INDICATION,1
KR,PRODUCTIVE COUGH,1
KR,RASH ERYTHEMATOUS,1
KR,RASH VESICULAR,1
KR,RENAL FAILURE ACUTE,1
KR,RESPIRATORY FAILURE,1
KR,RHINORRHOEA,1
KR,SEPTIC SHOCK,1
KR,SKIN DISCOLOURATION,1
KR,SPINAL COMPRESSION FRACTURE,1
KR,SPINAL FRACTURE,1
KR,STAPHYLOCOCCAL INFECTION,1
KR,STOMATITIS,1
KR,SWELLING FACE,1
KR,THORACIC VERTEBRAL FRACTURE,1
KR,TONGUE PARALYSIS,1
KR,TREMOR,1
KR,URINARY TRACT INFECTION,1
KR,URINE OUTPUT DECREASED,1
KR,URTICARIA,1
KW,ABDOMINAL DISTENSION,1
KW,ASCITES,1
KW,DIZZINESS,1
KW,DYSPNOEA,1
KW,HAEMOGLOBIN DECREASED,1
KW,HEPATIC FAILURE,1
KW,HEPATOPULMONARY SYNDROME,1
KW,HYPOKINESIA,1
LV,AGITATION,1
LV,ASTHMA,1
LV,COUGH,1
LV,DRUG INEFFECTIVE,1
LV,DYSPNOEA,1
LV,FEELING HOT,1
LV,PSYCHOTIC DISORDER,1
LV,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
LB,COUGH,2
LB,FATIGUE,2
LB,INFLUENZA,2
LB,ABDOMINAL DISTENSION,1
LB,ANXIETY,1
LB,APHASIA,1
LB,ARTHRALGIA,1
LB,ASTHENIA,1
LB,BLOOD CREATININE INCREASED,1
LB,BRONCHOSPASM,1
LB,CEREBROVASCULAR ACCIDENT,1
LB,DEHYDRATION,1
LB,DIAPHRAGMATIC DISORDER,1
LB,DIARRHOEA,1
LB,DYSPNOEA,1
LB,EAR PRURITUS,1
LB,GAIT DISTURBANCE,1
LB,HEADACHE,1
LB,HYPERTENSION,1
LB,INSOMNIA,1
LB,LARYNGEAL OEDEMA,1
LB,LARYNGOSPASM,1
LB,MUSCLE SPASMS,1
LB,MYOCARDIAL INFARCTION,1
LB,OVARIAN CYST,1
LB,PAIN,1
LB,PARAESTHESIA,1
LB,PERIPHERAL SWELLING,1
LB,PNEUMONIA,1
LB,PULMONARY OEDEMA,1
LB,PYREXIA,1
LB,RASH,1
LB,SWELLING,1
LB,TACHYCARDIA,1
LB,URINE OUTPUT DECREASED,1
LB,VOMITING,1
LB,WEIGHT INCREASED,1
LU,DIABETES MELLITUS,1
MG,RESPIRATORY FAILURE,1
MY,DIZZINESS,2
MY,DYSPNOEA,2
MY,PRURITUS,2
MY,ABDOMINAL DISCOMFORT,1
MY,ANGIOEDEMA,1
MY,ASTHMA,1
MY,CHEST DISCOMFORT,1
MY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MY,DIARRHOEA,1
MY,DISCOMFORT,1
MY,EPILEPSY,1
MY,EXCESSIVE EYE BLINKING,1
MY,FATIGUE,1
MY,LOSS OF CONSCIOUSNESS,1
MY,NAUSEA,1
MY,ORBITAL OEDEMA,1
MY,PRODUCT ODOUR ABNORMAL,1
MY,PRODUCT QUALITY ISSUE,1
MY,PROSTATISM,1
MY,RASH MACULO-PAPULAR,1
MY,SOMNOLENCE,1
MY,SPONTANEOUS PENILE ERECTION,1
MY,SPUTUM DISCOLOURED,1
MY,THROAT IRRITATION,1
MT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
MT,DYSPNOEA,3
MT,ASTHMA,2
MT,DYSPNOEA AT REST,2
MT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
MT,NASAL CONGESTION,2
MT,PRODUCT USE IN UNAPPROVED INDICATION,2
MT,PRODUCTIVE COUGH,2
MT,PULMONARY SENSITISATION,2
MT,BLOOD CHLORIDE DECREASED,1
MT,BLOOD CHOLESTEROL INCREASED,1
MT,BLOOD GLUCOSE INCREASED,1
MT,BLOOD POTASSIUM INCREASED,1
MT,BLOOD URIC ACID INCREASED,1
MT,C-REACTIVE PROTEIN INCREASED,1
MT,CARDIAC ARREST,1
MT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MT,HIGH DENSITY LIPOPROTEIN DECREASED,1
MT,LOW DENSITY LIPOPROTEIN INCREASED,1
MT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MT,RESPIRATORY FAILURE,1
MT,TOTAL CHOLESTEROL/HDL RATIO INCREASED,1
MT,UNEVALUABLE EVENT,1
MT,WHITE BLOOD CELL COUNT INCREASED,1
MU,DEATH,1
MU,FOETAL EXPOSURE DURING PREGNANCY,1
MU,PREMATURE BABY,1
MX,ASTHENIA,5
MX,DYSPNOEA,5
MX,FATIGUE,5
MX,BACK PAIN,4
MX,FEELING ABNORMAL,4
MX,MALAISE,4
MX,PRODUCT USE ISSUE,4
MX,ASPHYXIA,3
MX,COUGH,3
MX,ANXIETY,2
MX,ASTHMA,2
MX,BACK INJURY,2
MX,BRONCHIAL DISORDER,2
MX,CHEST PAIN,2
MX,CONDITION AGGRAVATED,2
MX,CONTUSION,2
MX,DEPRESSED MOOD,2
MX,DIZZINESS,2
MX,DRUG DEPENDENCE,2
MX,EXPIRED DRUG ADMINISTERED,2
MX,FALL,2
MX,GAIT DISTURBANCE,2
MX,HYPERTONIA,2
MX,HYPOXIA,2
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
MX,INFARCTION,2
MX,INFLAMMATION,2
MX,INJURY,2
MX,INSOMNIA,2
MX,IRRITABILITY,2
MX,MEMORY IMPAIRMENT,2
MX,MOOD ALTERED,2
MX,PAIN IN EXTREMITY,2
MX,PARAESTHESIA,2
MX,PYREXIA,2
MX,RESPIRATORY FAILURE,2
MX,SENSITIVITY TO WEATHER CHANGE,2
MX,TACHYCARDIA,2
MX,TENSION,2
MX,THROMBOSIS,2
MX,VISUAL IMPAIRMENT,2
MX,WEIGHT DECREASED,2
MX,ALANINE AMINOTRANSFERASE INCREASED,1
MX,ANAEMIA,1
MX,ASPARTATE AMINOTRANSFERASE INCREASED,1
MX,ASTHMATIC CRISIS,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD PRESSURE INCREASED,1
MX,BURNING SENSATION,1
MX,CARDIOMEGALY,1
MX,CATARACT,1
MX,CHEST DISCOMFORT,1
MX,DIPLOPIA,1
MX,DISEASE PROGRESSION,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG PRESCRIBING ERROR,1
MX,EYE PAIN,1
MX,GLOSSODYNIA,1
MX,HAEMATOCRIT DECREASED,1
MX,HAEMOGLOBIN DECREASED,1
MX,HEADACHE,1
MX,HYPERSOMNIA,1
MX,INFECTION,1
MX,LUNG DISORDER,1
MX,MICTURITION URGENCY,1
MX,MOUTH BREATHING,1
MX,MYOCARDIAL INFARCTION,1
MX,NASOPHARYNGITIS,1
MX,OBLITERATIVE BRONCHIOLITIS,1
MX,PAINFUL RESPIRATION,1
MX,PENILE HAEMORRHAGE,1
MX,PENILE PAIN,1
MX,PNEUMONIA,1
MX,RASH PRURITIC,1
MX,RHINORRHOEA,1
MX,RIGHT VENTRICULAR FAILURE,1
MX,SEDATION,1
MX,SEIZURE,1
MX,STOMATITIS,1
MX,TRANSFUSION,1
MX,VISION BLURRED,1
MX,VOMITING,1
MA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
NL,DYSPNOEA,15
NL,PNEUMONIA,11
NL,DIZZINESS,8
NL,FATIGUE,8
NL,PRURITUS,8
NL,CHEST PAIN,6
NL,MUSCLE SPASMS,6
NL,PAIN,6
NL,RENAL IMPAIRMENT,6
NL,ANXIETY,5
NL,MALAISE,5
NL,PERIPHERAL SWELLING,5
NL,ABDOMINAL PAIN,4
NL,CHEST DISCOMFORT,4
NL,DRUG INEFFECTIVE,4
NL,ECZEMA,4
NL,HEADACHE,4
NL,NAUSEA,4
NL,PAIN IN EXTREMITY,4
NL,RESPIRATORY FAILURE,4
NL,VASCULAR OCCLUSION,4
NL,BONE PAIN,3
NL,BRONCHOSPASM,3
NL,DECREASED APPETITE,3
NL,DEHYDRATION,3
NL,DEPRESSED MOOD,3
NL,DERMATITIS CONTACT,3
NL,DIARRHOEA,3
NL,DRUG HYPERSENSITIVITY,3
NL,EPILEPSY,3
NL,ERYTHEMA,3
NL,OROPHARYNGEAL PAIN,3
NL,PULMONARY EMBOLISM,3
NL,PYREXIA,3
NL,SKIN EXFOLIATION,3
NL,THROAT IRRITATION,3
NL,TINNITUS,3
NL,URTICARIA,3
NL,WEIGHT DECREASED,3
NL,ABDOMINAL DISCOMFORT,2
NL,ARRHYTHMIA,2
NL,ARTHRALGIA,2
NL,ASTHENIA,2
NL,ASTHMA,2
NL,BLOOD CREATININE INCREASED,2
NL,BLOOD PRESSURE DECREASED,2
NL,BLOOD PRESSURE INCREASED,2
NL,CARDIAC ARREST,2
NL,CHOLECYSTITIS,2
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NL,CONFUSIONAL STATE,2
NL,DEATH,2
NL,EAR PRURITUS,2
NL,EXPOSURE DURING PREGNANCY,2
NL,FLUID INTAKE REDUCED,2
NL,GAIT DISTURBANCE,2
NL,HAEMOGLOBIN DECREASED,2
NL,HYPERHIDROSIS,2
NL,HYPERSENSITIVITY,2
NL,HYPERTENSION,2
NL,HYPERTONIA,2
NL,INFLUENZA LIKE ILLNESS,2
NL,LEG AMPUTATION,2
NL,LIVER DISORDER,2
NL,LIVER FUNCTION TEST ABNORMAL,2
NL,LOSS OF CONSCIOUSNESS,2
NL,MOUTH SWELLING,2
NL,MULTI-ORGAN FAILURE,2
NL,MUSCULAR WEAKNESS,2
NL,MYALGIA,2
NL,MYOCARDIAL INFARCTION,2
NL,NASOPHARYNGITIS,2
NL,OEDEMA,2
NL,ORAL PRURITUS,2
NL,PARAESTHESIA,2
NL,PULMONARY HYPERTENSION,2
NL,RASH ERYTHEMATOUS,2
NL,RESPIRATORY TRACT INFECTION,2
NL,RETINAL INFARCTION,2
NL,RHINORRHOEA,2
NL,SEASONAL ALLERGY,2
NL,SEPSIS,2
NL,SOMNOLENCE,2
NL,SUICIDAL IDEATION,2
NL,TACHYCARDIA,2
NL,THROMBOSIS,2
NL,TOXICITY TO VARIOUS AGENTS,2
NL,TREMOR,2
NL,VISION BLURRED,2
NL,VISUAL IMPAIRMENT,2
NL,VOMITING,2
NL,ABDOMINAL PAIN UPPER,1
NL,ABDOMINAL WALL ABSCESS,1
NL,ABORTION OF ECTOPIC PREGNANCY,1
NL,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
NL,ACUTE MYELOID LEUKAEMIA,1
NL,AGGRESSION,1
NL,AGITATION,1
NL,ALBUMINURIA,1
NL,ALOPECIA,1
NL,ALVEOLITIS ALLERGIC,1
NL,ANAEMIA,1
NL,ANAPHYLACTIC REACTION,1
NL,ANGIOEDEMA,1
NL,APHASIA,1
NL,APHONIA,1
NL,ARTERIOSCLEROSIS,1
NL,ATRIAL FIBRILLATION,1
NL,AUTOIMMUNE HEPATITIS,1
NL,BACK PAIN,1
NL,BACTERIAL INFECTION,1
NL,BENIGN PROSTATIC HYPERPLASIA,1
NL,BILIARY TRACT DISORDER,1
NL,BLOOD ALBUMIN INCREASED,1
NL,BLOOD GLUCOSE DECREASED,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BLOOD IMMUNOGLOBULIN G INCREASED,1
NL,BLOOD MAGNESIUM DECREASED,1
NL,BLOOD UREA INCREASED,1
NL,BRONCHIAL SECRETION RETENTION,1
NL,BRONCHIOLITIS,1
NL,BRONCHOSPASM PARADOXICAL,1
NL,C-REACTIVE PROTEIN INCREASED,1
NL,CAESAREAN SECTION,1
NL,CANDIDA INFECTION,1
NL,CARDIAC FAILURE,1
NL,CEREBRAL HAEMORRHAGE,1
NL,CEREBRAL VENOUS THROMBOSIS,1
NL,CHOLELITHIASIS,1
NL,CLONUS,1
NL,CONCOMITANT DISEASE PROGRESSION,1
NL,CONJUNCTIVITIS,1
NL,CONSTIPATION,1
NL,COUGH,1
NL,DEPRESSION,1
NL,DEPRESSION SUICIDAL,1
NL,DERMATITIS,1
NL,DISEASE PROGRESSION,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG LEVEL INCREASED,1
NL,DRY MOUTH,1
NL,DYSGEUSIA,1
NL,DYSPHAGIA,1
NL,DYSPHONIA,1
NL,ECTOPIC PREGNANCY,1
NL,EMOTIONAL DISTRESS,1
NL,ERYSIPELAS,1
NL,ERYTHEMA INFECTIOSUM,1
NL,EXANTHEMA SUBITUM,1
NL,EXTRASYSTOLES,1
NL,EYE PAIN,1
NL,FAECES HARD,1
NL,FEBRILE NEUTROPENIA,1
NL,FEELING ABNORMAL,1
NL,FEMUR FRACTURE,1
NL,FLUID RETENTION,1
NL,FOETAL EXPOSURE DURING PREGNANCY,1
NL,FOOT DEFORMITY,1
NL,FRACTURE,1
NL,FRACTURE DELAYED UNION,1
NL,GASTROINTESTINAL NECROSIS,1
NL,GENERAL PHYSICAL HEALTH DETERIORATION,1
NL,GESTATIONAL TROPHOBLASTIC DETACHMENT,1
NL,HAEMATOCHEZIA,1
NL,HAEMORRHAGE,1
NL,HEPATIC ENZYME INCREASED,1
NL,HIP FRACTURE,1
NL,HYPERGLYCAEMIA,1
NL,HYPERSEXUALITY,1
NL,HYPOKALAEMIA,1
NL,HYPOMAGNESAEMIA,1
NL,HYPOPROTEINAEMIA,1
NL,HYPOTENSION,1
NL,HYPOVOLAEMIC SHOCK,1
NL,HYPOXIA,1
NL,ILEUS,1
NL,IMMUNE THROMBOCYTOPENIC PURPURA,1
NL,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,1
NL,INFUSION RELATED REACTION,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE SWELLING,1
NL,INSOMNIA,1
NL,INTERNAL HAEMORRHAGE,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTESTINAL ISCHAEMIA,1
NL,INTESTINAL PERFORATION,1
NL,ISCHAEMIA,1
NL,ISCHAEMIC STROKE,1
NL,JC VIRUS INFECTION,1
NL,LARGE INTESTINE PERFORATION,1
NL,LEFT VENTRICULAR DILATATION,1
NL,LEFT VENTRICULAR DYSFUNCTION,1
NL,LEUKOPENIA,1
NL,LIVE BIRTH,1
NL,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,1
NL,LUNG DISORDER,1
NL,LUPUS NEPHRITIS,1
NL,LUPUS-LIKE SYNDROME,1
NL,MEMORY IMPAIRMENT,1
NL,MENORRHAGIA,1
NL,MENTAL IMPAIRMENT,1
NL,METABOLIC ACIDOSIS,1
NL,MOOD SWINGS,1
NL,MULTIPLE SCLEROSIS RELAPSE,1
NL,MUSCULAR DYSTROPHY,1
NL,MUSCULOSKELETAL DISORDER,1
NL,MYASTHENIA GRAVIS,1
NL,MYDRIASIS,1
NL,MYOCARDIAL FIBROSIS,1
NL,NASAL SEPTUM PERFORATION,1
NL,NERVOUSNESS,1
NL,NON-SMALL CELL LUNG CANCER,1
NL,OEDEMA PERIPHERAL,1
NL,OESOPHAGEAL DISORDER,1
NL,ORGANISING PNEUMONIA,1
NL,OSTEOARTHRITIS,1
NL,OXYGEN SATURATION DECREASED,1
NL,PAINFUL RESPIRATION,1
NL,PALPITATIONS,1
NL,PANCREATITIS,1
NL,PANIC ATTACK,1
NL,PANNICULITIS,1
NL,PAPULE,1
NL,PERITONITIS,1
NL,PERSONALITY CHANGE,1
NL,PLATELET COUNT DECREASED,1
NL,PNEUMONIA ASPIRATION,1
NL,PNEUMONIA ESCHERICHIA,1
NL,PNEUMOTHORAX,1
NL,POLYDACTYLY,1
NL,POLYMYALGIA RHEUMATICA,1
NL,PRE-ECLAMPSIA,1
NL,PRESCRIBED UNDERDOSE,1
NL,PROTEINURIA,1
NL,PULMONARY HAEMORRHAGE,1
NL,PULMONARY SEPSIS,1
NL,RECTAL HAEMORRHAGE,1
NL,RESPIRATORY DISTRESS,1
NL,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
NL,RESTLESSNESS,1
NL,RHINOVIRUS INFECTION,1
NL,SARCOIDOSIS,1
NL,SKIN MASS,1
NL,SKIN ODOUR ABNORMAL,1
NL,SPEECH DISORDER,1
NL,STEROID WITHDRAWAL SYNDROME,1
NL,STRABISMUS,1
NL,STRESS,1
NL,STRESS URINARY INCONTINENCE,1
NL,SUBILEUS,1
NL,SUDDEN DEATH,1
NL,SYNCOPE,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROAT TIGHTNESS,1
NL,THROMBOCYTOPENIA,1
NL,TOOTH DISCOLOURATION,1
NL,TRANSFUSION,1
NL,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,URETEROLITHIASIS,1
NL,URINARY RETENTION,1
NL,UTERINE HYPOTONUS,1
NL,VERTIGO,1
NL,WEIGHT INCREASED,1
NL,WHEEZING,1
NL,WRIST DEFORMITY,1
NZ,COUGH,3
NZ,MALAISE,3
NZ,NAUSEA,3
NZ,PNEUMONIA,3
NZ,PYREXIA,3
NZ,CHEST DISCOMFORT,2
NZ,CHOKING,2
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NZ,DRUG INEFFECTIVE,2
NZ,DYSPNOEA,2
NZ,FALL,2
NZ,HYPOXIA,2
NZ,LOWER RESPIRATORY TRACT INFECTION,2
NZ,PRODUCT QUALITY ISSUE,2
NZ,WHEEZING,2
NZ,ABDOMINAL PAIN UPPER,1
NZ,ANAEMIA,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANXIETY,1
NZ,AORTIC ANEURYSM,1
NZ,ARTHRALGIA,1
NZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
NZ,ASTHENIA,1
NZ,ASTHMA,1
NZ,ATRIAL FIBRILLATION,1
NZ,B-CELL LYMPHOMA,1
NZ,BACK PAIN,1
NZ,BASAL CELL CARCINOMA,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BRONCHOSPASM,1
NZ,CARDIAC DISORDER,1
NZ,CHEST PAIN,1
NZ,CHILLS,1
NZ,CHOLECYSTITIS,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,CHONDROPATHY,1
NZ,CONSTIPATION,1
NZ,CORONARY ARTERY STENOSIS,1
NZ,CORONARY ARTERY THROMBOSIS,1
NZ,CRYSTAL ARTHROPATHY,1
NZ,DIVERTICULUM,1
NZ,DIZZINESS,1
NZ,DYSGEUSIA,1
NZ,DYSPEPSIA,1
NZ,DYSPHAGIA,1
NZ,EMBOLISM VENOUS,1
NZ,FOAMING AT MOUTH,1
NZ,GASTRIC ULCER,1
NZ,GASTROINTESTINAL HAEMORRHAGE,1
NZ,GLOMERULAR FILTRATION RATE DECREASED,1
NZ,GOUT,1
NZ,HAEMOGLOBIN DECREASED,1
NZ,HEADACHE,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERTENSION,1
NZ,HYPOKALAEMIA,1
NZ,HYPONATRAEMIA,1
NZ,HYPOTENSION,1
NZ,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
NZ,INFLUENZA,1
NZ,INVASIVE DUCTAL BREAST CARCINOMA,1
NZ,JOINT SWELLING,1
NZ,LOBAR PNEUMONIA,1
NZ,LUNG DISORDER,1
NZ,MELAENA,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,MYELODYSPLASTIC SYNDROME,1
NZ,MYOCARDIAL INFARCTION,1
NZ,OEDEMA PERIPHERAL,1
NZ,ORAL HERPES,1
NZ,PANCREATIC CARCINOMA,1
NZ,PARAESTHESIA ORAL,1
NZ,PRODUCTIVE COUGH,1
NZ,PULMONARY OEDEMA,1
NZ,SEPSIS,1
NZ,TACHYCARDIA,1
NZ,VOMITING,1
NZ,WEIGHT BEARING DIFFICULTY,1
NZ,WOUND INFECTION BACTERIAL,1
NG,CHEST DISCOMFORT,1
NG,CHEST PAIN,1
NG,DYSPNOEA,1
NG,PALPITATIONS,1
NG,SLEEP DISORDER,1
NG,SPUTUM INCREASED,1
NG,WHEEZING,1
NO,FATIGUE,3
NO,ASTHMA,2
NO,BRAIN INJURY,2
NO,COMA,2
NO,DRUG EFFECT PROLONGED,2
NO,PAIN IN EXTREMITY,2
NO,PARAESTHESIA,2
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NO,ANGER,1
NO,ANXIETY,1
NO,AORTIC DISORDER,1
NO,AORTIC VALVE INCOMPETENCE,1
NO,ARTHRALGIA,1
NO,ASTHENIA,1
NO,BACK PAIN,1
NO,CHEST DISCOMFORT,1
NO,CHILLS,1
NO,CONDITION AGGRAVATED,1
NO,COUGH,1
NO,DEMYELINATION,1
NO,DERMATITIS ALLERGIC,1
NO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NO,DRUG-INDUCED LIVER INJURY,1
NO,ERUCTATION,1
NO,ERYTHEMA,1
NO,HALLUCINATION_ AUDITORY,1
NO,HEADACHE,1
NO,HYPERSENSITIVITY,1
NO,HYPERTENSIVE HEART DISEASE,1
NO,HYPOAESTHESIA,1
NO,INFECTION,1
NO,JOINT STIFFNESS,1
NO,LEUKOCYTOCLASTIC VASCULITIS,1
NO,MULTIPLE SCLEROSIS,1
NO,MUSCULOSKELETAL PAIN,1
NO,MUSCULOSKELETAL STIFFNESS,1
NO,NASAL SEPTUM PERFORATION,1
NO,NECK PAIN,1
NO,NEPHROLITHIASIS,1
NO,NEUROLOGICAL SYMPTOM,1
NO,NEUROPATHY PERIPHERAL,1
NO,OPTIC NEURITIS,1
NO,ORAL PRURITUS,1
NO,OSTEITIS,1
NO,OSTEONECROSIS OF JAW,1
NO,PAIN,1
NO,PAROSMIA,1
NO,PERIORBITAL OEDEMA,1
NO,PORPHYRIA NON-ACUTE,1
NO,PRURITUS,1
NO,PSORIASIS,1
NO,PULMONARY EMBOLISM,1
NO,RASH,1
NO,RASH MACULAR,1
NO,RASH PRURITIC,1
NO,SINUS CONGESTION,1
NO,SLEEP DISORDER,1
NO,SOMNOLENCE,1
NO,SPLENIC HAEMORRHAGE,1
NO,SUICIDAL IDEATION,1
NO,THINKING ABNORMAL,1
NO,THROAT IRRITATION,1
NO,URTICARIA,1
NO,UVEITIS,1
NO,VOMITING,1
NO,WEIGHT DECREASED,1
NO,WITHDRAWAL SYNDROME,1
PK,ASTHMA,1
PK,CONSTIPATION,1
PK,COUGH,1
PK,DYSPNOEA,1
PK,HAEMOPTYSIS,1
PK,HEPATIC FAILURE,1
PK,PRODUCT USE ISSUE,1
PK,PRODUCTIVE COUGH,1
PK,RESPIRATORY FAILURE,1
PK,SWELLING FACE,1
PK,WHEEZING,1
PE,ASTHMATIC CRISIS,5
PE,PRODUCT USE ISSUE,3
PE,DRUG INEFFECTIVE,2
PE,HEADACHE,2
PE,ABDOMINAL PAIN,1
PE,AGITATION,1
PE,ANXIETY,1
PE,ASTHMA,1
PE,BLOOD PRESSURE INCREASED,1
PE,CHOKING,1
PE,CHOKING SENSATION,1
PE,CHOLELITHIASIS,1
PE,CROUP INFECTIOUS,1
PE,DEPRESSION,1
PE,DISCOMFORT,1
PE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
PE,DYSPHONIA,1
PE,DYSPNOEA,1
PE,GASTRIC INFECTION,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,INFLUENZA,1
PE,INTESTINAL PERFORATION,1
PE,MALAISE,1
PE,NASOPHARYNGITIS,1
PE,OROPHARYNGEAL DISCOMFORT,1
PE,PAIN,1
PE,PNEUMONIA,1
PE,PNEUMONITIS,1
PE,PRODUCT USE IN UNAPPROVED INDICATION,1
PE,PRODUCTIVE COUGH,1
PE,PYREXIA,1
PE,RESPIRATORY TRACT INFECTION,1
PE,SEPSIS,1
PE,VISUAL IMPAIRMENT,1
PH,ANAEMIA,2
PH,ANGIODYSPLASIA,2
PH,ARRHYTHMIA SUPRAVENTRICULAR,2
PH,CARDIO-RESPIRATORY ARREST,2
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PH,HYPOVOLAEMIC SHOCK,2
PH,PEPTIC ULCER,2
PH,PNEUMONIA,2
PH,PRODUCT QUALITY ISSUE,2
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PH,ABDOMINAL PAIN UPPER,1
PH,ACUTE RESPIRATORY FAILURE,1
PH,ANXIETY,1
PH,ASTHMA,1
PH,BLOOD GLUCOSE INCREASED,1
PH,CARDIAC ARREST,1
PH,CHOLELITHIASIS,1
PH,CYANOSIS,1
PH,DEVICE ISSUE,1
PH,DEVICE MALFUNCTION,1
PH,DYSPNOEA,1
PH,HYPERSENSITIVITY,1
PH,LIQUID PRODUCT PHYSICAL ISSUE,1
PH,NEPHRITIS,1
PH,OESOPHAGEAL OBSTRUCTION,1
PH,PLATELET COUNT DECREASED,1
PH,PYREXIA,1
PH,SEPSIS,1
PH,TUBERCULOSIS,1
PH,URINARY TRACT INFECTION BACTERIAL,1
PH,VOMITING,1
PL,ASTHMA,3
PL,DYSPNOEA,3
PL,ABDOMINAL PAIN,2
PL,ABDOMINAL PAIN UPPER,2
PL,CHEST PAIN,2
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PL,DEATH,2
PL,HEADACHE,2
PL,NEUTROPHIL COUNT INCREASED,2
PL,PNEUMONIA,2
PL,PYREXIA,2
PL,WEIGHT DECREASED,2
PL,ABDOMINAL DISTENSION,1
PL,ABNORMAL BEHAVIOUR,1
PL,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
PL,ACUTE KIDNEY INJURY,1
PL,ANAEMIA,1
PL,ANGER,1
PL,ANGINA PECTORIS,1
PL,ANGINA UNSTABLE,1
PL,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
PL,ANXIETY,1
PL,ARTHRALGIA,1
PL,ATRIAL FIBRILLATION,1
PL,BLOOD CALCIUM DECREASED,1
PL,BRONCHIECTASIS,1
PL,C-REACTIVE PROTEIN INCREASED,1
PL,CARDIAC ARREST,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CHOLELITHIASIS,1
PL,COELIAC DISEASE,1
PL,COLITIS ULCERATIVE,1
PL,CONSTIPATION,1
PL,COUGH,1
PL,DEPRESSION,1
PL,DERMATITIS ATOPIC,1
PL,DIARRHOEA,1
PL,DRY MOUTH,1
PL,DYSPEPSIA,1
PL,EAR PAIN,1
PL,EMOTIONAL DISORDER,1
PL,ENCEPHALITIS,1
PL,EROSIVE DUODENITIS,1
PL,ERUCTATION,1
PL,ERYTHEMA,1
PL,EXCESSIVE CERUMEN PRODUCTION,1
PL,FEAR,1
PL,FEELING ABNORMAL,1
PL,FLATULENCE,1
PL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
PL,FUNGAL OESOPHAGITIS,1
PL,GASTRITIS HAEMORRHAGIC,1
PL,GASTROINTESTINAL HAEMORRHAGE,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,HAEMOPTYSIS,1
PL,HIATUS HERNIA,1
PL,HYPERSENSITIVITY,1
PL,ILEUS,1
PL,INFECTION,1
PL,LYME DISEASE,1
PL,METABOLIC ACIDOSIS,1
PL,MIGRAINE,1
PL,MULTIPLE SCLEROSIS RELAPSE,1
PL,MYOCARDIAL INFARCTION,1
PL,NAUSEA,1
PL,NERVOUSNESS,1
PL,OEDEMA PERIPHERAL,1
PL,OSTEOARTHRITIS,1
PL,OSTEOPOROSIS,1
PL,OVARIAN ENLARGEMENT,1
PL,PAIN,1
PL,PRURITUS,1
PL,PULSELESS ELECTRICAL ACTIVITY,1
PL,RASH,1
PL,RESPIRATORY FAILURE,1
PL,RHEUMATIC DISORDER,1
PL,RHINITIS ALLERGIC,1
PL,RHINORRHOEA,1
PL,SPUTUM DISCOLOURED,1
PL,STAPHYLOCOCCUS TEST POSITIVE,1
PL,SUICIDAL IDEATION,1
PL,TINNITUS,1
PL,TYPE 1 DIABETES MELLITUS,1
PL,UPPER RESPIRATORY TRACT INFECTION,1
PL,WEIGHT INCREASED,1
PL,WHITE BLOOD CELL COUNT INCREASED,1
PT,ANOSMIA,1
PT,DYSGEUSIA,1
PT,DYSPNOEA,1
PT,ERYTHEMA,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYELID MYOCLONUS,1
PT,LARYNGEAL OEDEMA,1
PT,NORMAL NEWBORN,1
PT,PELVIC PAIN,1
PT,PROLONGED RUPTURE OF MEMBRANES,1
PT,SWELLING FACE,1
PT,TONGUE OEDEMA,1
PT,TREMOR,1
PT,URTICARIA,1
PT,VOMITING,1
PR,PAIN,15
PR,INJECTION SITE PAIN,14
PR,ASTHMA,12
PR,DRUG INEFFECTIVE,9
PR,HEADACHE,9
PR,MALAISE,9
PR,BRONCHITIS,7
PR,FATIGUE,7
PR,NASOPHARYNGITIS,7
PR,NAUSEA,7
PR,BLOOD GLUCOSE INCREASED,6
PR,CONSTIPATION,5
PR,DIZZINESS,5
PR,PYREXIA,5
PR,DIARRHOEA,4
PR,ERYTHEMA,4
PR,INJECTION SITE PRURITUS,4
PR,PAIN IN EXTREMITY,4
PR,VOMITING,4
PR,ARTHRALGIA,3
PR,CHEST PAIN,3
PR,COUGH,3
PR,DECREASED APPETITE,3
PR,DYSPEPSIA,3
PR,HAEMOGLOBIN DECREASED,3
PR,INFECTION,3
PR,NASAL CONGESTION,3
PR,PRURITUS GENERALISED,3
PR,RASH,3
PR,ABDOMINAL DISCOMFORT,2
PR,ABDOMINAL PAIN UPPER,2
PR,ANXIETY,2
PR,ASTHENIA,2
PR,BLINDNESS,2
PR,BREAST MASS,2
PR,BRONCHITIS CHRONIC,2
PR,CARPAL TUNNEL SYNDROME,2
PR,CATARACT,2
PR,CELLULITIS,2
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PR,DEPRESSED MOOD,2
PR,DEPRESSION,2
PR,DIABETES MELLITUS,2
PR,DRY MOUTH,2
PR,DYSGEUSIA,2
PR,FACIAL PARALYSIS,2
PR,FEELING HOT,2
PR,GAIT DISTURBANCE,2
PR,HEART RATE INCREASED,2
PR,HYPERSENSITIVITY,2
PR,INFLAMMATION,2
PR,INJECTION SITE ERYTHEMA,2
PR,INJECTION SITE RASH,2
PR,INSOMNIA,2
PR,INTRADUCTAL PAPILLOMA OF BREAST,2
PR,LIMB DISCOMFORT,2
PR,LOCAL SWELLING,2
PR,MEMORY IMPAIRMENT,2
PR,OSTEOARTHRITIS,2
PR,OSTEOMYELITIS,2
PR,PERIPHERAL SWELLING,2
PR,PNEUMONIA,2
PR,PSORIASIS,2
PR,PULMONARY MASS,2
PR,RASH MACULAR,2
PR,SKIN EXFOLIATION,2
PR,SLEEP APNOEA SYNDROME,2
PR,SLOW SPEECH,2
PR,SUICIDE ATTEMPT,2
PR,THERMAL BURN,2
PR,URINARY TRACT INFECTION,2
PR,VISION BLURRED,2
PR,WEIGHT DECREASED,2
PR,ABDOMINAL PAIN,1
PR,ABSCESS BACTERIAL,1
PR,AGEUSIA,1
PR,ANAL FISSURE,1
PR,ANAL INFECTION,1
PR,ANGINA PECTORIS,1
PR,ARTHRITIS,1
PR,ASPHYXIA,1
PR,ATELECTASIS,1
PR,BACTERIAL INFECTION,1
PR,BLISTER,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD PRESSURE DIASTOLIC ABNORMAL,1
PR,BONE PAIN,1
PR,BREAST ABSCESS,1
PR,BREAST DISORDER,1
PR,BURNING SENSATION,1
PR,BURSITIS,1
PR,CARDIAC MURMUR,1
PR,CARDIOVASCULAR DISORDER,1
PR,CONFUSIONAL STATE,1
PR,COORDINATION ABNORMAL,1
PR,CORONARY ARTERY DISEASE,1
PR,CRYING,1
PR,DENGUE FEVER,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DIABETIC NEUROPATHY,1
PR,DIAPHRAGMALGIA,1
PR,DIPLOPIA,1
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PR,DRY EYE,1
PR,DRY SKIN,1
PR,DYSPHONIA,1
PR,DYSPNOEA,1
PR,EAR DISCOMFORT,1
PR,EAR PAIN,1
PR,EMPHYSEMA,1
PR,ESCHERICHIA URINARY TRACT INFECTION,1
PR,EYE SWELLING,1
PR,EYE ULCER,1
PR,FIBROMYALGIA,1
PR,FRACTURE,1
PR,FUNGAL INFECTION,1
PR,GASTROENTERITIS,1
PR,GASTROINTESTINAL HAEMORRHAGE,1
PR,GLOSSODYNIA,1
PR,GOITRE,1
PR,HAEMOPTYSIS,1
PR,HEART RATE DECREASED,1
PR,HEART VALVE STENOSIS,1
PR,HEPATIC STEATOSIS,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERTENSION,1
PR,HYPERTRIGLYCERIDAEMIA,1
PR,HYPOKINESIA,1
PR,HYPOTENSION,1
PR,HYPOTHYROIDISM,1
PR,INCOHERENT,1
PR,INFARCTION,1
PR,INFLUENZA,1
PR,INJECTION SITE ABSCESS,1
PR,INJECTION SITE COLDNESS,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE INDURATION,1
PR,INJECTION SITE OEDEMA,1
PR,INJECTION SITE WARMTH,1
PR,INJURY ASSOCIATED WITH DEVICE,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,LABORATORY TEST ABNORMAL,1
PR,MAJOR DEPRESSION,1
PR,MENISCUS OPERATION,1
PR,MENTAL DISORDER,1
PR,MOTOR DYSFUNCTION,1
PR,MUSCLE SPASMS,1
PR,MUSCULAR WEAKNESS,1
PR,MYALGIA,1
PR,NEOPLASM MALIGNANT,1
PR,OEDEMA,1
PR,OESOPHAGEAL PAIN,1
PR,OESOPHAGITIS,1
PR,ONYCHOMADESIS,1
PR,ORAL DISCOMFORT,1
PR,ORAL PAIN,1
PR,ORAL SURGERY,1
PR,OROPHARYNGEAL PAIN,1
PR,OSTEOPOROSIS,1
PR,PARAESTHESIA ORAL,1
PR,PERINEAL INJURY,1
PR,PERIORBITAL OEDEMA,1
PR,PHARYNGITIS,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POST PROCEDURAL COMPLICATION,1
PR,POSTOPERATIVE RESPIRATORY FAILURE,1
PR,POSTOPERATIVE THROMBOSIS,1
PR,PSORIATIC ARTHROPATHY,1
PR,PULMONARY EMBOLISM,1
PR,PULMONARY HYPERTENSION,1
PR,PULMONARY OEDEMA,1
PR,RASH GENERALISED,1
PR,RECTAL HAEMORRHAGE,1
PR,RENAL CANCER,1
PR,RENAL PAIN,1
PR,RESPIRATORY TRACT INFECTION,1
PR,RHEUMATOID ARTHRITIS,1
PR,RHINITIS,1
PR,RHINORRHOEA,1
PR,RHONCHI,1
PR,SCRATCH,1
PR,SKIN ABRASION,1
PR,SKIN DISORDER,1
PR,SKIN FISSURES,1
PR,SOMNOLENCE,1
PR,SUICIDAL IDEATION,1
PR,SWELLING FACE,1
PR,TENDON PAIN,1
PR,TENDON RUPTURE,1
PR,TESTICULAR HAEMORRHAGE,1
PR,THIRST,1
PR,THYROID MASS,1
PR,THYROID NEOPLASM,1
PR,TONGUE DISORDER,1
PR,TOOTH EXTRACTION,1
PR,TRACHEAL OEDEMA,1
PR,TUBERCULOSIS,1
PR,URTICARIA,1
PR,VERTIGO,1
PR,VIRAL INFECTION,1
PR,VISUAL IMPAIRMENT,1
PR,VITAMIN D DEFICIENCY,1
PR,WEIGHT FLUCTUATION,1
PR,WRONG PATIENT RECEIVED MEDICATION,1
RO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
RO,PNEUMONIA,5
RO,PYREXIA,5
RO,ANAEMIA,3
RO,NAUSEA,3
RO,ABDOMINAL PAIN,2
RO,BONE PAIN,2
RO,CHRONIC KIDNEY DISEASE,2
RO,DIZZINESS,2
RO,ENTEROCOLITIS,2
RO,HYPOTENSION,2
RO,JAUNDICE,2
RO,RESPIRATORY TRACT INFECTION,2
RO,SEPSIS,2
RO,TACHYCARDIA,2
RO,TUMOUR LYSIS SYNDROME,2
RO,VOMITING,2
RO,AGGRESSION,1
RO,AGITATION,1
RO,ANGINA PECTORIS,1
RO,APPENDICECTOMY,1
RO,ASPHYXIA,1
RO,ASTHMATIC CRISIS,1
RO,BLOOD PRESSURE INCREASED,1
RO,CHILLS,1
RO,CHOKING SENSATION,1
RO,CRYING,1
RO,DECREASED APPETITE,1
RO,DIARRHOEA,1
RO,DRUG INEFFECTIVE,1
RO,DYSPNOEA,1
RO,EYE PAIN,1
RO,FATIGUE,1
RO,FLUSHING,1
RO,HEADACHE,1
RO,HYPERTENSION,1
RO,HYPERURICAEMIA,1
RO,HYPOALBUMINAEMIA,1
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
RO,INTENTIONAL SELF-INJURY,1
RO,INTERSTITIAL LUNG DISEASE,1
RO,INTERVERTEBRAL DISC PROTRUSION,1
RO,LACERATION,1
RO,LUNG NEOPLASM MALIGNANT,1
RO,MELAENA,1
RO,MIDDLE INSOMNIA,1
RO,MYALGIA,1
RO,NEUTROPENIA,1
RO,ORAL CANDIDIASIS,1
RO,ORTHOSTATIC HYPOTENSION,1
RO,OVERDOSE,1
RO,PAIN IN EXTREMITY,1
RO,PANIC ATTACK,1
RO,PLEURAL EFFUSION,1
RO,SLEEP DISORDER,1
RO,STEVENS-JOHNSON SYNDROME,1
RO,THROMBOCYTOPENIA,1
RO,TRACHEOBRONCHITIS,1
RO,TREMOR,1
RO,VENTRICULAR FIBRILLATION,1
RO,WEIGHT DECREASED,1
RU,DRUG INEFFECTIVE,6
RU,ASTHMA,3
RU,BLOOD PRESSURE INCREASED,2
RU,DYSPNOEA,2
RU,STATUS ASTHMATICUS,2
RU,TACHYCARDIA,2
RU,ANISOMETROPIA,1
RU,ARRHYTHMIA,1
RU,ASPHYXIA,1
RU,ASTHENIA,1
RU,BLOOD CALCIUM DECREASED,1
RU,BRONCHOSPASM,1
RU,CARDIOGENIC SHOCK,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,CONGENITAL ARTERIAL MALFORMATION,1
RU,DEATH,1
RU,DEVICE MALFUNCTION,1
RU,DRUG DEPENDENCE,1
RU,EOSINOPHIL COUNT INCREASED,1
RU,FACIAL PARESIS,1
RU,GAZE PALSY,1
RU,HEART RATE INCREASED,1
RU,HYPERMETROPIA,1
RU,HYPERTENSION,1
RU,HYPOSPADIAS,1
RU,HYPOTONIA,1
RU,ISCHAEMIC STROKE,1
RU,LOSS OF CONSCIOUSNESS,1
RU,LUNG CANCER METASTATIC,1
RU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
RU,MONOCYTE COUNT INCREASED,1
RU,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
RU,MYOCARDIAL INFARCTION,1
RU,PNEUMONIA,1
RU,PNEUMOTHORAX,1
RU,POLYDACTYLY,1
RU,PRODUCT COUNTERFEIT,1
RU,PRODUCT QUALITY ISSUE,1
RU,PROSTATIC ADENOMA,1
RU,PULMONARY EMBOLISM,1
RU,RENAL NEOPLASM,1
RU,RESPIRATORY ARREST,1
RU,SCOLIOSIS,1
RU,SEIZURE,1
RU,TACHYARRHYTHMIA,1
RU,TONGUE PARALYSIS,1
RU,TRIGEMINAL NERVE PARESIS,1
RU,URINARY TRACT DISORDER,1
RU,VERTIGO,1
RU,VOMITING,1
WS,ASTHENIA,1
WS,GASTROINTESTINAL HAEMORRHAGE,1
SA,VOMITING,2
SA,ARTHROPATHY,1
SA,BLOOD ALBUMIN DECREASED,1
SA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SA,BLOOD CREATININE INCREASED,1
SA,BRADYPNOEA,1
SA,CATARACT,1
SA,CEREBRAL VENTRICLE DILATATION,1
SA,CEREBROVASCULAR ACCIDENT,1
SA,CHILLS,1
SA,CLINODACTYLY,1
SA,CRYPTORCHISM,1
SA,DECREASED ACTIVITY,1
SA,DYSKINESIA,1
SA,DYSMORPHISM,1
SA,DYSPNOEA,1
SA,EAR MALFORMATION,1
SA,FATIGUE,1
SA,FOETAL DISTRESS SYNDROME,1
SA,FOETAL EXPOSURE DURING PREGNANCY,1
SA,FOETAL GROWTH RESTRICTION,1
SA,HERPES SIMPLEX PHARYNGITIS,1
SA,HYPOKINESIA,1
SA,HYPOVENTILATION,1
SA,LISSENCEPHALY,1
SA,MUSCLE ENZYME INCREASED,1
SA,MYOSITIS,1
SA,NECK DEFORMITY,1
SA,NEPHROTIC SYNDROME,1
SA,NERVOUS SYSTEM DISORDER,1
SA,NEURODEGENERATIVE DISORDER,1
SA,OEDEMA,1
SA,OLIGOHYDRAMNIOS,1
SA,PAIN,1
SA,PATENT DUCTUS ARTERIOSUS,1
SA,PROTEINURIA,1
SA,PYREXIA,1
SA,RASH,1
SA,RED REFLEX ABNORMAL,1
SA,SEPSIS,1
SA,SUDDEN CARDIAC DEATH,1
SA,URINE ALBUMIN/CREATININE RATIO INCREASED,1
SN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SN,MOUTH ULCERATION,1
SN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
RS,ASTHMA,1
RS,CAROTID ARTERY DISEASE,1
RS,CHEST PAIN,1
RS,CHOLELITHIASIS,1
RS,COUGH,1
RS,DYSPNOEA,1
RS,EPISTAXIS,1
RS,HEPATIC CANCER,1
RS,HEPATIC CIRRHOSIS,1
RS,ISCHAEMIC STROKE,1
RS,LIPID METABOLISM DISORDER,1
RS,NASAL DRYNESS,1
RS,OBSTRUCTIVE AIRWAYS DISORDER,1
RS,PRODUCTIVE COUGH,1
RS,WHEEZING,1
SG,RASH,4
SG,ANGIOEDEMA,3
SG,APPENDICITIS,1
SG,ATRIAL FLUTTER,1
SG,CARDIAC FIBRILLATION,1
SG,FACE OEDEMA,1
SG,HYPOAESTHESIA,1
SG,HYPOTENSION,1
SG,PALPITATIONS,1
SG,SEPSIS,1
SG,TACHYCARDIA,1
SG,URTICARIA,1
SG,VENTRICULAR TACHYCARDIA,1
SK,ANGINA PECTORIS,1
SK,APHTHOUS STOMATITIS,1
SK,BREAST CANCER STAGE III,1
SK,CHOKING,1
SK,COUGH,1
SK,EXPOSURE DURING PREGNANCY,1
SK,EYE INFECTION TOXOPLASMAL,1
SK,HYPONATRAEMIA,1
SK,INTERSTITIAL LUNG DISEASE,1
SK,LIVE BIRTH,1
SK,MALAISE,1
SK,MALIGNANT NEOPLASM PROGRESSION,1
SK,MATERNAL EXPOSURE BEFORE PREGNANCY,1
SK,MULTI-ORGAN DISORDER,1
SK,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
SK,MYOCARDIAL INFARCTION,1
SK,PLACENTA PRAEVIA,1
SK,PNEUMONIA,1
SK,PRODUCT QUALITY ISSUE,1
SI,DYSPNOEA,3
SI,BODY TEMPERATURE INCREASED,2
SI,MALAISE,2
SI,BRONCHOSPASM,1
SI,CEREBROVASCULAR ACCIDENT,1
SI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SI,EXTRAVASATION BLOOD,1
SI,HAEMATOMA,1
SI,HAEMOPTYSIS,1
SI,HIP FRACTURE,1
SI,HYPERHIDROSIS,1
SI,HYPERTENSION,1
SI,LEGIONELLA INFECTION,1
SI,LUNG NEOPLASM MALIGNANT,1
SI,MIDDLE INSOMNIA,1
SI,NAUSEA,1
SI,OXYGEN SATURATION DECREASED,1
SI,PALLOR,1
SI,SLEEP TERROR,1
ZA,PNEUMONIA,2
ZA,ACUTE CORONARY SYNDROME,1
ZA,ACUTE MYOCARDIAL INFARCTION,1
ZA,ANAEMIA MEGALOBLASTIC,1
ZA,ARTERIOSPASM CORONARY,1
ZA,CEREBROVASCULAR ACCIDENT,1
ZA,CIRCUMCISION,1
ZA,CORONARY ARTERY THROMBOSIS,1
ZA,DEATH,1
ZA,HYPOGLYCAEMIC COMA,1
ZA,HYPOKALAEMIA,1
ZA,HYPOTENSION,1
ZA,HYPOTHYROIDISM,1
ZA,INGUINAL HERNIA,1
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ZA,PSEUDOMONAL SEPSIS,1
ZA,RENAL IMPAIRMENT,1
ES,PNEUMONIA,9
ES,DIARRHOEA,6
ES,CEREBROVASCULAR ACCIDENT,5
ES,DYSPNOEA,5
ES,INSOMNIA,5
ES,RESPIRATORY FAILURE,5
ES,URINARY TRACT INFECTION,5
ES,ANAEMIA,4
ES,ASTHENIA,4
ES,ATRIAL FIBRILLATION,4
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
ES,DRUG INEFFECTIVE,4
ES,FALL,4
ES,HYPERKALAEMIA,4
ES,HYPOTENSION,4
ES,NAUSEA,4
ES,NEUTROPENIA,4
ES,WEIGHT DECREASED,4
ES,ABDOMINAL DISCOMFORT,3
ES,ABDOMINAL PAIN UPPER,3
ES,ASTHMA,3
ES,BRONCHOSPASM,3
ES,DIZZINESS,3
ES,FATIGUE,3
ES,GASTROINTESTINAL HAEMORRHAGE,3
ES,HEADACHE,3
ES,HYPOKALAEMIA,3
ES,HYPONATRAEMIA,3
ES,MUSCULAR WEAKNESS,3
ES,NASOPHARYNGITIS,3
ES,NEUROPATHY PERIPHERAL,3
ES,PYREXIA,3
ES,RESPIRATORY TRACT INFECTION,3
ES,RHABDOMYOLYSIS,3
ES,SYNCOPE,3
ES,WHEEZING,3
ES,ACUTE KIDNEY INJURY,2
ES,ADRENAL INSUFFICIENCY,2
ES,AGRANULOCYTOSIS,2
ES,ANGINA PECTORIS,2
ES,BACTERAEMIA,2
ES,BRONCHIAL DISORDER,2
ES,BRONCHITIS,2
ES,CARDIAC FAILURE,2
ES,CHEST PAIN,2
ES,CONDITION AGGRAVATED,2
ES,COUGH,2
ES,DECREASED APPETITE,2
ES,DUODENAL NEOPLASM,2
ES,FEELING ABNORMAL,2
ES,HYPERGLYCAEMIA,2
ES,INCORRECT DOSE ADMINISTERED,2
ES,INJECTION SITE ERYTHEMA,2
ES,INJECTION SITE MASS,2
ES,INJECTION SITE PAIN,2
ES,INJECTION SITE PRURITUS,2
ES,INTENTIONAL PRODUCT MISUSE,2
ES,LOSS OF CONSCIOUSNESS,2
ES,MALIGNANT NEOPLASM PROGRESSION,2
ES,METABOLIC ACIDOSIS,2
ES,MYALGIA,2
ES,NERVOUSNESS,2
ES,PAIN,2
ES,PAIN IN EXTREMITY,2
ES,PRODUCT QUALITY ISSUE,2
ES,PRODUCT USE IN UNAPPROVED INDICATION,2
ES,RENAL FAILURE,2
ES,SEPTIC SHOCK,2
ES,SUICIDAL IDEATION,2
ES,TACHYCARDIA,2
ES,THROAT IRRITATION,2
ES,THROMBOCYTOPENIA,2
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,2
ES,URTICARIA,2
ES,VOMITING,2
ES,WRONG DRUG ADMINISTERED,2
ES,ABDOMINAL PAIN,1
ES,ABNORMAL LOSS OF WEIGHT,1
ES,ABORTION INDUCED,1
ES,ACUTE HEPATIC FAILURE,1
ES,ACUTE RESPIRATORY FAILURE,1
ES,ANAL HAEMORRHAGE,1
ES,ANAPHYLACTIC REACTION,1
ES,ANGIOEDEMA,1
ES,ANURIA,1
ES,ANXIETY,1
ES,AORTITIS,1
ES,APATHY,1
ES,APPARENT DEATH,1
ES,ARTHRALGIA,1
ES,ARTHRITIS,1
ES,ASPHYXIA,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,BLADDER PAIN,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD GLUCOSE INCREASED,1
ES,BLOOD PRESSURE DECREASED,1
ES,BLOOD PRESSURE INCREASED,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BONE PAIN,1
ES,CARDIO-RESPIRATORY ARREST,1
ES,CEREBRAL HAEMORRHAGE,1
ES,CHEST DISCOMFORT,1
ES,CHOLELITHIASIS,1
ES,COLITIS,1
ES,COMA SCALE ABNORMAL,1
ES,CONFUSIONAL STATE,1
ES,CONSTIPATION,1
ES,CROHN^S DISEASE,1
ES,CYSTITIS KLEBSIELLA,1
ES,DEPRESSION,1
ES,DEVICE MALFUNCTION,1
ES,DIABETES MELLITUS,1
ES,DIABETIC HYPEROSMOLAR COMA,1
ES,DIVERTICULAR PERFORATION,1
ES,DRUG ADMINISTRATION ERROR,1
ES,DRUG DOSE TITRATION NOT PERFORMED,1
ES,DRUG EFFECT INCOMPLETE,1
ES,DRUG-INDUCED LIVER INJURY,1
ES,DRY MOUTH,1
ES,DYSKINESIA,1
ES,DYSPEPSIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSURIA,1
ES,ENCEPHALOPATHY,1
ES,ENDOCARDITIS,1
ES,ERYTHEMA,1
ES,FAECALOMA,1
ES,FEAR,1
ES,FEBRILE NEUTROPENIA,1
ES,FORCED EXPIRATORY VOLUME DECREASED,1
ES,GAIT DISTURBANCE,1
ES,GASTRIC ULCER,1
ES,GASTRITIS,1
ES,GASTROENTERITIS,1
ES,GASTROINTESTINAL INJURY,1
ES,GASTROINTESTINAL STOMA COMPLICATION,1
ES,GENERAL PHYSICAL HEALTH DETERIORATION,1
ES,GRANULOMA SKIN,1
ES,HAEMATEMESIS,1
ES,HAEMORRHAGE,1
ES,HEAD INJURY,1
ES,HEPATIC ENCEPHALOPATHY,1
ES,HEPATIC FAILURE,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HIATUS HERNIA,1
ES,HUMERUS FRACTURE,1
ES,HYPERLACTACIDAEMIA,1
ES,HYPERSENSITIVITY,1
ES,HYPERTRANSAMINASAEMIA,1
ES,HYPOCALCAEMIA,1
ES,HYPOMAGNESAEMIA,1
ES,HYPOTONIA,1
ES,HYPOXIA,1
ES,INCORRECT PRODUCT STORAGE,1
ES,INFECTION,1
ES,INJECTION SITE HAEMATOMA,1
ES,INJECTION SITE INDURATION,1
ES,INJECTION SITE URTICARIA,1
ES,INJECTION SITE WARMTH,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,IRRITABILITY,1
ES,ISCHAEMIC HEPATITIS,1
ES,JOINT SWELLING,1
ES,KIDNEY INFECTION,1
ES,LEUKOCYTOSIS,1
ES,MALAISE,1
ES,MASS,1
ES,MASTITIS,1
ES,MELAENA,1
ES,MOBILITY DECREASED,1
ES,MULTI-ORGAN FAILURE,1
ES,MUSCLE STRAIN,1
ES,MUSCULOSKELETAL PAIN,1
ES,MUSCULOSKELETAL STIFFNESS,1
ES,MYELODYSPLASTIC SYNDROME,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,NECK PAIN,1
ES,NEUROLEPTIC MALIGNANT SYNDROME,1
ES,NEUTROPHIL COUNT DECREASED,1
ES,NEUTROPHILIC DERMATOSIS,1
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
ES,OBSESSIVE THOUGHTS,1
ES,OEDEMA PERIPHERAL,1
ES,ORAL HERPES,1
ES,OXYGEN CONSUMPTION DECREASED,1
ES,PALLOR,1
ES,PALPITATIONS,1
ES,PANCREATIC INJURY,1
ES,PANCREATITIS ACUTE,1
ES,PANIC REACTION,1
ES,PERIPHERAL SWELLING,1
ES,PERITONITIS,1
ES,PHARYNGITIS,1
ES,PNEUMONIA BACTERIAL,1
ES,PORTAL VEIN THROMBOSIS,1
ES,PRODUCTIVE COUGH,1
ES,PROTEIN URINE PRESENT,1
ES,PRURITUS GENERALISED,1
ES,PULMONARY OEDEMA,1
ES,PULMONARY SEPSIS,1
ES,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,1
ES,RENAL FAILURE CHRONIC,1
ES,RENAL IMPAIRMENT,1
ES,RENAL SALT-WASTING SYNDROME,1
ES,RESPIRATORY DISORDER,1
ES,ROAD TRAFFIC ACCIDENT,1
ES,SARCOIDOSIS,1
ES,SHOCK,1
ES,SINUS BRADYCARDIA,1
ES,SKIN ULCER,1
ES,SKIN WARM,1
ES,SMALL INTESTINE CARCINOMA,1
ES,SPEECH DISORDER,1
ES,SPUTUM INCREASED,1
ES,STOMATITIS,1
ES,SUFFOCATION FEELING,1
ES,SUICIDAL BEHAVIOUR,1
ES,SUPRAVENTRICULAR TACHYCARDIA,1
ES,SWELLING FACE,1
ES,UMBILICAL HERNIA,1
ES,UNINTENDED PREGNANCY,1
ES,UTERINE LEIOMYOMA,1
ES,VASCULITIS,1
ES,VULVOVAGINAL SWELLING,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
LK,DRUG INEFFECTIVE,1
SE,COUGH,2
SE,AGGRESSION,1
SE,ANGIOPATHY,1
SE,ASTHENIA,1
SE,BRONCHITIS,1
SE,CAESAREAN SECTION,1
SE,DEPRESSION,1
SE,DEVICE FAILURE,1
SE,DYSPNOEA,1
SE,EAR INFECTION,1
SE,EXPOSURE DURING PREGNANCY,1
SE,FACIAL BONES FRACTURE,1
SE,FALL,1
SE,FATIGUE,1
SE,HAEMOLYSIS,1
SE,HAEMOLYTIC ANAEMIA,1
SE,HEAD INJURY,1
SE,HIP SURGERY,1
SE,HYPERSENSITIVITY,1
SE,HYPOAESTHESIA,1
SE,ILL-DEFINED DISORDER,1
SE,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,1
SE,MOOD SWINGS,1
SE,MYASTHENIA GRAVIS,1
SE,NORMAL NEWBORN,1
SE,ORAL MUCOSAL BLISTERING,1
SE,OROPHARYNGEAL PAIN,1
SE,PARAESTHESIA ORAL,1
SE,PHARYNGEAL OEDEMA,1
SE,RENAL FAILURE,1
SE,RESPIRATORY DISTRESS,1
SE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
SE,RESPIRATORY TRACT HAEMORRHAGE,1
SE,RESPIRATORY TRACT INFLAMMATION,1
SE,SENSORY LOSS,1
SE,SINUSITIS,1
SE,SLEEP DISORDER,1
SE,SOMNAMBULISM,1
SE,STRESS CARDIOMYOPATHY,1
SE,TOXIC SKIN ERUPTION,1
SE,TOXICITY TO VARIOUS AGENTS,1
SE,WEIGHT INCREASED,1
CH,DYSPNOEA,15
CH,ACUTE KIDNEY INJURY,13
CH,EXPOSURE DURING PREGNANCY,13
CH,HYPOTENSION,13
CH,FOETAL GROWTH RESTRICTION,11
CH,ANAEMIA,10
CH,ANURIA,9
CH,HYPOKALAEMIA,9
CH,HYPOGLYCAEMIA NEONATAL,8
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,8
CH,PREMATURE BABY,8
CH,BRADYCARDIA,7
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,7
CH,FOETAL EXPOSURE DURING PREGNANCY,7
CH,TACHYCARDIA,7
CH,THROMBOCYTOPENIA,7
CH,ACCIDENTAL OVERDOSE,6
CH,ALTERED STATE OF CONSCIOUSNESS,6
CH,ATRIAL SEPTAL DEFECT,6
CH,RENAL FAILURE,6
CH,ABORTION SPONTANEOUS,5
CH,ANGIOEDEMA,5
CH,ASTHMA,5
CH,BRONCHOPULMONARY DYSPLASIA,5
CH,CONGENITAL INGUINAL HERNIA,5
CH,DELIRIUM,5
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
CH,LACTIC ACIDOSIS,5
CH,MATERNAL EXPOSURE DURING PREGNANCY,5
CH,METABOLIC ALKALOSIS,5
CH,PALPITATIONS,5
CH,PATENT DUCTUS ARTERIOSUS,5
CH,PNEUMONIA,5
CH,PREMATURE DELIVERY,5
CH,TACHYPNOEA,5
CH,VOMITING,5
CH,ASTHENIA,4
CH,ATRIOVENTRICULAR BLOCK COMPLETE,4
CH,CARDIAC DISORDER,4
CH,CARDIO-RESPIRATORY ARREST,4
CH,CARDIOGENIC SHOCK,4
CH,DIARRHOEA,4
CH,DIZZINESS,4
CH,FALL,4
CH,HYPERBILIRUBINAEMIA NEONATAL,4
CH,LOSS OF CONSCIOUSNESS,4
CH,MELAENA,4
CH,NEONATAL INFECTION,4
CH,SEIZURE,4
CH,SYNCOPE,4
CH,URTICARIA,4
CH,ANAEMIA NEONATAL,3
CH,ATRIAL FIBRILLATION,3
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,BLOOD PRESSURE DECREASED,3
CH,CARDIAC MURMUR,3
CH,COUGH,3
CH,ENDOTRACHEAL INTUBATION,3
CH,EOSINOPHILIA,3
CH,EPISTAXIS,3
CH,GENERAL PHYSICAL HEALTH DETERIORATION,3
CH,HALLUCINATION,3
CH,HYPERGLYCAEMIA,3
CH,HYPOTHERMIA NEONATAL,3
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CH,JAUNDICE NEONATAL,3
CH,LEUKOPENIA,3
CH,MEDICATION ERROR,3
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
CH,OXYGEN SATURATION DECREASED,3
CH,PAPULE,3
CH,PLACENTAL INSUFFICIENCY,3
CH,PLEURAL EFFUSION,3
CH,POOR WEIGHT GAIN NEONATAL,3
CH,PREGNANCY,3
CH,RESPIRATORY ACIDOSIS,3
CH,RESPIRATORY ARREST,3
CH,RESPIRATORY DISTRESS,3
CH,RESPIRATORY FAILURE,3
CH,TOOTH LOSS,3
CH,TOXICITY TO VARIOUS AGENTS,3
CH,TREMOR,3
CH,ACUTE MYOCARDIAL INFARCTION,2
CH,ALOPECIA,2
CH,ANXIETY,2
CH,APPLICATION SITE HAEMORRHAGE,2
CH,ARTHRALGIA,2
CH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
CH,BACK PAIN,2
CH,BLOOD SODIUM DECREASED,2
CH,BRONCHOSPASM,2
CH,CARDIAC ARREST,2
CH,CARDIAC FAILURE,2
CH,CEREBRAL HAEMORRHAGE,2
CH,CEREBROVASCULAR ACCIDENT,2
CH,CHILLS,2
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CH,COMA,2
CH,CONDITION AGGRAVATED,2
CH,CONFUSIONAL STATE,2
CH,DEATH,2
CH,DECREASED APPETITE,2
CH,DEHYDRATION,2
CH,DEPRESSION,2
CH,DIABETES MELLITUS,2
CH,DIABETIC KETOACIDOSIS,2
CH,DISTURBANCE IN ATTENTION,2
CH,DRUG ABUSE,2
CH,DRUG ADMINISTRATION ERROR,2
CH,DUODENAL ULCER,2
CH,DUODENAL ULCER HAEMORRHAGE,2
CH,DYSARTHRIA,2
CH,ELECTROCARDIOGRAM QT PROLONGED,2
CH,EPSTEIN-BARR VIRUS INFECTION,2
CH,ERYTHEMA,2
CH,FATIGUE,2
CH,FOREIGN BODY ASPIRATION,2
CH,GLYCOSURIA,2
CH,HAEMOGLOBIN DECREASED,2
CH,HEPATITIS E,2
CH,HYPERVENTILATION,2
CH,HYPONATRAEMIA,2
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
CH,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
CH,INTENTIONAL OVERDOSE,2
CH,INTERSTITIAL LUNG DISEASE,2
CH,JAUNDICE,2
CH,LOCALISED OEDEMA,2
CH,LUNG INFECTION,2
CH,MALAISE,2
CH,MATERNAL DRUGS AFFECTING FOETUS,2
CH,NAUSEA,2
CH,NEPHROPATHY TOXIC,2
CH,NEUTROPENIA,2
CH,NOSOCOMIAL INFECTION,2
CH,ORGANISING PNEUMONIA,2
CH,PALLOR,2
CH,PANIC ATTACK,2
CH,PNEUMONIA ASPIRATION,2
CH,PRESYNCOPE,2
CH,PRODUCT USE ISSUE,2
CH,PRURITUS,2
CH,RASH MACULO-PAPULAR,2
CH,RENAL IMPAIRMENT,2
CH,RENAL TUBULAR DISORDER,2
CH,SEPSIS,2
CH,SINUS TACHYCARDIA,2
CH,STREPTOCOCCAL INFECTION,2
CH,SUBDURAL HAEMATOMA,2
CH,TACHYARRHYTHMIA,2
CH,TRACHEOSTOMY,2
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CH,VISUAL IMPAIRMENT,2
CH,WHEEZING,2
CH,ABDOMINAL PAIN,1
CH,ABDOMINAL WALL HAEMATOMA,1
CH,ABORTION MISSED,1
CH,ACUTE PRERENAL FAILURE,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,AGE-RELATED MACULAR DEGENERATION,1
CH,AGEUSIA,1
CH,AGITATION,1
CH,AMNESIA,1
CH,ANAL FISTULA,1
CH,ANAPHYLACTIC SHOCK,1
CH,ANGINA PECTORIS,1
CH,ANOSMIA,1
CH,AORTIC ARTERIOSCLEROSIS,1
CH,APHASIA,1
CH,APNOEA,1
CH,ARTHROPATHY,1
CH,ASTHMATIC CRISIS,1
CH,ATELECTASIS,1
CH,BENIGN PROSTATIC HYPERPLASIA,1
CH,BLIGHTED OVUM,1
CH,BLINDNESS UNILATERAL,1
CH,BLOOD BLISTER,1
CH,BLOOD CREATININE INCREASED,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD LACTIC ACID INCREASED,1
CH,BLOOD PRESSURE FLUCTUATION,1
CH,BLOOD PRESSURE SYSTOLIC INCREASED,1
CH,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CH,BRAIN STEM SYNDROME,1
CH,BRONCHITIS BACTERIAL,1
CH,C-REACTIVE PROTEIN INCREASED,1
CH,CANDIDA INFECTION,1
CH,CARDIAC FLUTTER,1
CH,CARPAL TUNNEL SYNDROME,1
CH,CEREBRAL DISORDER,1
CH,CHEILITIS,1
CH,CHRONIC KIDNEY DISEASE,1
CH,CONJUNCTIVITIS,1
CH,DEEP VEIN THROMBOSIS,1
CH,DEPRESSED MOOD,1
CH,DIPLOPIA,1
CH,DISEASE PROGRESSION,1
CH,DISEASE RECURRENCE,1
CH,DRUG DEPENDENCE,1
CH,DRUG EFFECT DECREASED,1
CH,DRUG WITHDRAWAL SYNDROME,1
CH,DRUG WITHDRAWAL SYNDROME NEONATAL,1
CH,DRUG-INDUCED LIVER INJURY,1
CH,DRY MOUTH,1
CH,DRY THROAT,1
CH,DYSLIPIDAEMIA,1
CH,DYSPHAGIA,1
CH,DYSPNOEA AT REST,1
CH,ECZEMA,1
CH,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
CH,ENANTHEMA,1
CH,ENTEROBACTER INFECTION,1
CH,EOSINOPHILIC PNEUMONIA,1
CH,EXPOSURE DURING BREAST FEEDING,1
CH,EXTRAVASATION,1
CH,FAECES DISCOLOURED,1
CH,FEBRILE NEUTROPENIA,1
CH,FLUSHING,1
CH,FOETAL EXPOSURE TIMING UNSPECIFIED,1
CH,GASTROINTESTINAL HAEMORRHAGE,1
CH,GASTROINTESTINAL MALFORMATION,1
CH,GESTATIONAL HYPERTENSION,1
CH,GLAUCOMA,1
CH,GLOSSITIS,1
CH,HAEMATEMESIS,1
CH,HAEMATOCHEZIA,1
CH,HAEMATURIA,1
CH,HALLUCINATION_ AUDITORY,1
CH,HEAD INJURY,1
CH,HEADACHE,1
CH,HEART RATE INCREASED,1
CH,HEMIPARESIS,1
CH,HEPATITIS,1
CH,HICCUPS,1
CH,HYPERBILIRUBINAEMIA,1
CH,HYPERCALCAEMIA,1
CH,HYPERCAPNIA,1
CH,HYPERHIDROSIS,1
CH,HYPERKALAEMIA,1
CH,HYPERLACTACIDAEMIA,1
CH,HYPERPHOSPHATAEMIA,1
CH,HYPERSENSITIVITY,1
CH,HYPOACUSIS,1
CH,HYPOCALCAEMIA,1
CH,HYPOGLYCAEMIA,1
CH,HYPOTONIA,1
CH,HYPOVOLAEMIC SHOCK,1
CH,IDIOPATHIC PULMONARY FIBROSIS,1
CH,IMMOBILE,1
CH,INFLUENZA,1
CH,INGUINAL HERNIA,1
CH,INSOMNIA,1
CH,ISCHAEMIC STROKE,1
CH,KETOACIDOSIS,1
CH,LACERATION,1
CH,LACRIMATION INCREASED,1
CH,LIMB DISCOMFORT,1
CH,LIP SWELLING,1
CH,LIVER INJURY,1
CH,LYMPHOCYTE COUNT INCREASED,1
CH,MACULAR OEDEMA,1
CH,MALIGNANT NEOPLASM OF AMPULLA OF VATER,1
CH,MEMORY IMPAIRMENT,1
CH,MENINGIOMA,1
CH,METABOLIC ACIDOSIS,1
CH,METASTASES TO BONE,1
CH,METASTASES TO LIVER,1
CH,MIXED LIVER INJURY,1
CH,MULTI-ORGAN FAILURE,1
CH,MUSCULAR WEAKNESS,1
CH,MUSCULOSKELETAL PAIN,1
CH,MYOCARDIAL NECROSIS MARKER INCREASED,1
CH,MYOPATHY,1
CH,NEPHROGENIC DIABETES INSIPIDUS,1
CH,NEUTROPENIC SEPSIS,1
CH,NEUTROPHIL COUNT DECREASED,1
CH,NIGHTMARE,1
CH,NORMAL NEWBORN,1
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CH,OEDEMA PERIPHERAL,1
CH,OPTIC NEURITIS,1
CH,OROPHARYNGEAL SWELLING,1
CH,OSTEOPOROTIC FRACTURE,1
CH,OVERDOSE,1
CH,PAIN IN EXTREMITY,1
CH,PANCREATITIS,1
CH,PANCYTOPENIA,1
CH,PERIPHERAL SWELLING,1
CH,PETECHIAE,1
CH,PLACENTAL DISORDER,1
CH,PNEUMONIA STAPHYLOCOCCAL,1
CH,POOR SUCKING REFLEX,1
CH,PREGNANCY ON ORAL CONTRACEPTIVE,1
CH,PRESCRIBED OVERDOSE,1
CH,PRODUCT USE IN UNAPPROVED INDICATION,1
CH,PROLONGED EXPIRATION,1
CH,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CH,PROTEINURIA,1
CH,PROTHROMBIN TIME PROLONGED,1
CH,PRURITUS GENERALISED,1
CH,PULMONARY EMBOLISM,1
CH,PULMONARY HYPERTENSION,1
CH,PYELOCALIECTASIS,1
CH,PYREXIA,1
CH,QUALITY OF LIFE DECREASED,1
CH,RASH,1
CH,RENAL FAILURE ACUTE,1
CH,RENAL TUBULAR NECROSIS,1
CH,RESPIRATORY DISORDER,1
CH,RETINAL HAEMORRHAGE,1
CH,RETINAL VEIN OCCLUSION,1
CH,RHINOVIRUS INFECTION,1
CH,RIB FRACTURE,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,ROAD TRAFFIC ACCIDENT,1
CH,SCIATICA,1
CH,SEPTIC SHOCK,1
CH,SERRATIA INFECTION,1
CH,SHOCK HAEMORRHAGIC,1
CH,SINUS BRADYCARDIA,1
CH,SKIN DISCOLOURATION,1
CH,SKIN TEST POSITIVE,1
CH,SKIN ULCER,1
CH,SKIN WOUND,1
CH,SLEEP DISORDER,1
CH,SOPOR,1
CH,STAPHYLOCOCCAL INFECTION,1
CH,SUICIDE ATTEMPT,1
CH,SUPRAVENTRICULAR TACHYCARDIA,1
CH,SWELLING FACE,1
CH,SWOLLEN TONGUE,1
CH,TALIPES,1
CH,THINKING ABNORMAL,1
CH,THORACIC VERTEBRAL FRACTURE,1
CH,TOOTH DISCOLOURATION,1
CH,TOOTH INJURY,1
CH,TOOTHACHE,1
CH,TORSADE DE POINTES,1
CH,TRANSAMINASES INCREASED,1
CH,TRANSIENT ISCHAEMIC ATTACK,1
CH,TUBULOINTERSTITIAL NEPHRITIS,1
CH,TYPE I HYPERSENSITIVITY,1
CH,TYPE III IMMUNE COMPLEX MEDIATED REACTION,1
CH,TYPE IV HYPERSENSITIVITY REACTION,1
CH,URINARY TRACT INFECTION,1
CH,UVEITIS,1
CH,VASODILATATION,1
CH,VENOUS STENOSIS,1
CH,VENTRICULAR FIBRILLATION,1
CH,VERTIGO,1
CH,VISUAL ACUITY REDUCED,1
CH,VITAMIN D DEFICIENCY,1
CH,VITH NERVE PARESIS,1
CH,VITREOUS DETACHMENT,1
CH,VITREOUS FLOATERS,1
TW,ARRHYTHMIA,2
TW,ARTERIAL OCCLUSIVE DISEASE,2
TW,DYSPNOEA,2
TW,HAEMORRHAGE,2
TW,HEART RATE INCREASED,2
TW,STENT PLACEMENT,2
TW,TREMOR,2
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TW,DUODENAL ULCER,1
TW,FUNGAEMIA,1
TW,HEPATITIS,1
TW,HYPOVOLAEMIC SHOCK,1
TW,PERITONITIS,1
TW,PNEUMONIA,1
TW,PYREXIA,1
TW,SEPSIS,1
TW,SEPTIC SHOCK,1
TW,SJOGREN^S SYNDROME,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,ANAPHYLACTIC REACTION,1
TH,ANGINA PECTORIS,1
TH,BASEDOW^S DISEASE,1
TH,BLOOD PRESSURE DECREASED,1
TH,CARDIAC FAILURE CONGESTIVE,1
TH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TH,DIZZINESS,1
TH,DYSPNOEA,1
TH,EPIGASTRIC DISCOMFORT,1
TH,HAEMATURIA,1
TH,HYPOKALAEMIA,1
TH,HYPONATRAEMIA,1
TH,HYPOVOLAEMIC SHOCK,1
TH,ISCHAEMIC STROKE,1
TH,PRURITUS,1
TH,RASH MACULO-PAPULAR,1
TH,RESPIRATORY FAILURE,1
TH,SKIN LESION,1
TH,SOMNOLENCE,1
TT,COMA,1
TT,DYSPNOEA,1
TN,ACUTE RESPIRATORY FAILURE,1
TN,BRONCHOSPASM PARADOXICAL,1
TN,MYOCARDITIS,1
TN,PULMONARY OEDEMA,1
TN,RESPIRATORY FAILURE,1
TR,DYSPNOEA,6
TR,PNEUMONIA,6
TR,LOSS OF CONSCIOUSNESS,5
TR,SUPRAVENTRICULAR TACHYCARDIA,5
TR,TACHYCARDIA,5
TR,ANXIETY,4
TR,ASTHENIA,4
TR,DRUG ABUSE,4
TR,HYPOKALAEMIA,4
TR,SUICIDE ATTEMPT,4
TR,VENTRICULAR FIBRILLATION,4
TR,BACK PAIN,3
TR,DIZZINESS,3
TR,ERYTHEMA,3
TR,HYPERGLYCAEMIA,3
TR,NAUSEA,3
TR,RESPIRATORY FAILURE,3
TR,CARDIO-RESPIRATORY ARREST,2
TR,COUGH,2
TR,DEPENDENCE,2
TR,GAIT DISTURBANCE,2
TR,HAEMOPTYSIS,2
TR,HYPERTENSION,2
TR,HYPOTENSION,2
TR,INTENTIONAL OVERDOSE,2
TR,OVERDOSE,2
TR,PULMONARY ALVEOLAR HAEMORRHAGE,2
TR,PULMONARY OEDEMA,2
TR,TACHYPNOEA,2
TR,TONGUE OEDEMA,2
TR,TOXICITY TO VARIOUS AGENTS,2
TR,TREMOR,2
TR,VISION BLURRED,2
TR,VOMITING,2
TR,ABDOMINAL WALL HAEMATOMA,1
TR,ACINETOBACTER INFECTION,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME,1
TR,ACUTE HEPATIC FAILURE,1
TR,ACUTE KIDNEY INJURY,1
TR,AGITATION,1
TR,ALKALOSIS HYPOKALAEMIC,1
TR,ANAEMIA,1
TR,ANURIA,1
TR,ARTHRALGIA,1
TR,ASCITES,1
TR,ASTHMA,1
TR,ATRIAL FLUTTER,1
TR,AXILLARY PAIN,1
TR,BLOOD IMMUNOGLOBULIN E INCREASED,1
TR,BLOOD PRESSURE DECREASED,1
TR,BLOOD SODIUM DECREASED,1
TR,BLOOD TEST ABNORMAL,1
TR,BONE PAIN,1
TR,BRONCHOSTENOSIS,1
TR,CARDIAC PROCEDURE COMPLICATION,1
TR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TR,CONDITION AGGRAVATED,1
TR,DEATH,1
TR,DIARRHOEA,1
TR,DISEASE PROGRESSION,1
TR,DRUG DOSE OMISSION,1
TR,DRUG INEFFECTIVE,1
TR,ELECTROCARDIOGRAM QT PROLONGED,1
TR,FATIGUE,1
TR,FEBRILE NEUTROPENIA,1
TR,GASTRIC HAEMORRHAGE,1
TR,HEART VALVE OPERATION,1
TR,HERNIA REPAIR,1
TR,HYPERHIDROSIS,1
TR,HYPERSENSITIVITY,1
TR,HYPOGLYCAEMIA,1
TR,ILEUS,1
TR,INCARCERATED HERNIA,1
TR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
TR,INFLUENZA,1
TR,INFUSION RELATED REACTION,1
TR,INTENTIONAL PRODUCT MISUSE,1
TR,INTERNATIONAL NORMALISED RATIO INCREASED,1
TR,LUNG NEOPLASM MALIGNANT,1
TR,MALAISE,1
TR,MEMORY IMPAIRMENT,1
TR,MUSCULOSKELETAL STIFFNESS,1
TR,MYALGIA,1
TR,OSTEOPOROSIS,1
TR,PALPITATIONS,1
TR,PARAESTHESIA,1
TR,PERIPHERAL SWELLING,1
TR,PNEUMONIA CYTOMEGALOVIRAL,1
TR,PNEUMONITIS,1
TR,POLYNEUROPATHY,1
TR,PROCEDURAL HAEMORRHAGE,1
TR,PROTHROMBIN TIME PROLONGED,1
TR,PULMONARY ARTERIAL HYPERTENSION,1
TR,PYREXIA,1
TR,RALES,1
TR,RESPIRATORY DEPRESSION,1
TR,RESPIRATORY DISTRESS,1
TR,SINUS TACHYCARDIA,1
TR,SOMNOLENCE,1
TR,SWELLING FACE,1
TR,SYRINGE ISSUE,1
TR,TENSION,1
TR,UNDERDOSE,1
TR,URTICARIA,1
TR,VENTRICULAR TACHYCARDIA,1
TR,VERTIGO,1
TR,WHITE BLOOD CELL COUNT INCREASED,1
TR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
UA,BRONCHITIS CHRONIC,1
UA,CARDIOPULMONARY FAILURE,1
UA,CONVULSION,1
UA,CRYING,1
UA,FEBRILE NEUTROPENIA,1
UA,LOSS OF CONSCIOUSNESS,1
UA,PNEUMONIA,1
UA,PULMONARY ARTERY THROMBOSIS,1
UA,URINARY INCONTINENCE,1
AE,ABORTION SPONTANEOUS,1
AE,HYPOCALCAEMIA,1
AE,MATERNAL EXPOSURE DURING PREGNANCY,1
AE,TACHYCARDIA,1
GB,DYSPNOEA,236
GB,MALAISE,227
GB,DIZZINESS,172
GB,HEADACHE,161
GB,NAUSEA,158
GB,FATIGUE,123
GB,DIARRHOEA,121
GB,VOMITING,109
GB,ASTHMA,107
GB,LOWER RESPIRATORY TRACT INFECTION,98
GB,CONFUSIONAL STATE,96
GB,MYALGIA,95
GB,CHEST DISCOMFORT,94
GB,TREMOR,93
GB,WHEEZING,93
GB,COUGH,91
GB,DEPRESSION,89
GB,FEELING ABNORMAL,84
GB,ANXIETY,83
GB,MUSCLE SPASMS,83
GB,PRURITUS,83
GB,AGGRESSION,81
GB,SWOLLEN TONGUE,80
GB,RASH,78
GB,HALLUCINATION,77
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,74
GB,NIGHTMARE,69
GB,CHEST PAIN,67
GB,DYSPHAGIA,63
GB,SUICIDAL IDEATION,61
GB,ABDOMINAL PAIN,60
GB,ARTHRALGIA,57
GB,ASTHENIA,57
GB,PAIN IN EXTREMITY,57
GB,URTICARIA,57
GB,SWELLING FACE,55
GB,SOMNOLENCE,54
GB,CONDITION AGGRAVATED,53
GB,INSOMNIA,53
GB,LOSS OF CONSCIOUSNESS,53
GB,LETHARGY,52
GB,PAIN,52
GB,LIP SWELLING,51
GB,HYPOTENSION,50
GB,VISION BLURRED,49
GB,SLEEP DISORDER,48
GB,PNEUMONIA,47
GB,DISTURBANCE IN ATTENTION,46
GB,ABDOMINAL DISCOMFORT,44
GB,PERIPHERAL SWELLING,44
GB,CONTUSION,43
GB,PARAESTHESIA,43
GB,DECREASED APPETITE,42
GB,ACUTE KIDNEY INJURY,41
GB,PYREXIA,41
GB,PALPITATIONS,40
GB,HYPERSENSITIVITY,39
GB,BALANCE DISORDER,38
GB,JOINT SWELLING,38
GB,PRODUCT QUALITY ISSUE,38
GB,DEPRESSED MOOD,37
GB,MUSCULAR WEAKNESS,37
GB,SYNCOPE,37
GB,ABNORMAL BEHAVIOUR,36
GB,OROPHARYNGEAL PAIN,36
GB,AGITATION,35
GB,DYSPEPSIA,35
GB,DIPLOPIA,34
GB,DRY MOUTH,33
GB,ANGER,32
GB,DYSGEUSIA,32
GB,HYPERHIDROSIS,31
GB,DRUG INEFFECTIVE,30
GB,SOMNAMBULISM,30
GB,BLISTER,29
GB,ERYTHEMA,29
GB,ABDOMINAL PAIN UPPER,28
GB,HYPOAESTHESIA,28
GB,ANGIOEDEMA,27
GB,DYSURIA,27
GB,FALL,27
GB,HYPONATRAEMIA,27
GB,ORAL PAIN,27
GB,VISUAL IMPAIRMENT,27
GB,BRONCHOSPASM,26
GB,EPISTAXIS,26
GB,CONSTIPATION,25
GB,DISORIENTATION,24
GB,HYPOGLYCAEMIA,24
GB,LIVER FUNCTION TEST ABNORMAL,24
GB,MEMORY IMPAIRMENT,24
GB,MUSCLE TWITCHING,24
GB,SINUSITIS,24
GB,CHILLS,23
GB,DEATH,23
GB,EYE INFECTION,23
GB,EYE SWELLING,23
GB,HEART RATE INCREASED,23
GB,INHIBITORY DRUG INTERACTION,23
GB,DEHYDRATION,22
GB,SKIN EXFOLIATION,22
GB,BACK PAIN,21
GB,CHOKING,21
GB,DELIRIUM,21
GB,DYSARTHRIA,21
GB,FLATULENCE,21
GB,HAEMATOMA,21
GB,MOOD ALTERED,21
GB,MOUTH ULCERATION,21
GB,RESPIRATORY FAILURE,21
GB,ACCIDENTAL OVERDOSE,20
GB,ANAPHYLACTIC REACTION,20
GB,ARRHYTHMIA,20
GB,FEELING HOT,20
GB,ORAL CANDIDIASIS,20
GB,PERSONALITY CHANGE,20
GB,BRADYCARDIA,19
GB,EYE PAIN,19
GB,HAEMOGLOBIN DECREASED,19
GB,INFLUENZA LIKE ILLNESS,19
GB,OEDEMA PERIPHERAL,19
GB,AMNESIA,18
GB,CARDIAC ARREST,18
GB,DRUG WITHDRAWAL SYNDROME,18
GB,ECZEMA,18
GB,FAECES DISCOLOURED,17
GB,FOETAL EXPOSURE DURING PREGNANCY,17
GB,GLOSSODYNIA,17
GB,HYPERSOMNIA,17
GB,HYPERTENSION,17
GB,PANIC ATTACK,17
GB,SLEEP TERROR,17
GB,TENDONITIS,17
GB,ABDOMINAL DISTENSION,16
GB,ALOPECIA,16
GB,BLOOD MAGNESIUM DECREASED,16
GB,GAIT DISTURBANCE,16
GB,HICCUPS,16
GB,INTERNATIONAL NORMALISED RATIO INCREASED,16
GB,IRRITABILITY,16
GB,PHARYNGEAL OEDEMA,16
GB,RASH PRURITIC,16
GB,SALIVARY HYPERSECRETION,16
GB,THROAT TIGHTNESS,16
GB,CELLULITIS,15
GB,HAEMATEMESIS,15
GB,OVERDOSE,15
GB,PRODUCTIVE COUGH,15
GB,PRURITUS GENERALISED,15
GB,WOUND SECRETION,15
GB,CEREBROVASCULAR ACCIDENT,14
GB,HEART RATE DECREASED,14
GB,PHOTOPHOBIA,14
GB,PSORIASIS,14
GB,TACHYCARDIA,14
GB,TOXICITY TO VARIOUS AGENTS,14
GB,WEIGHT INCREASED,14
GB,ANAEMIA,13
GB,CHROMATURIA,13
GB,CIRCULATORY COLLAPSE,13
GB,EYE IRRITATION,13
GB,GYNAECOMASTIA,13
GB,HEAD DISCOMFORT,13
GB,MENTAL DISORDER,13
GB,MOBILITY DECREASED,13
GB,MOOD SWINGS,13
GB,NEUTROPENIC SEPSIS,13
GB,PRODUCT SUBSTITUTION ISSUE,13
GB,TINNITUS,13
GB,TRANSIENT ISCHAEMIC ATTACK,13
GB,ABNORMAL WEIGHT GAIN,12
GB,BLOOD CALCIUM DECREASED,12
GB,BLOOD POTASSIUM DECREASED,12
GB,BLOOD SODIUM DECREASED,12
GB,MOUTH SWELLING,12
GB,NERVOUSNESS,12
GB,NEUTROPENIA,12
GB,NIGHT SWEATS,12
GB,PARANOIA,12
GB,SKIN HYPERTROPHY,12
GB,ABNORMAL FAECES,11
GB,ABORTION SPONTANEOUS,11
GB,BLOOD URINE PRESENT,11
GB,CHRONIC KIDNEY DISEASE,11
GB,DRUG INTOLERANCE,11
GB,GASTRIC DISORDER,11
GB,GASTROOESOPHAGEAL REFLUX DISEASE,11
GB,GOUT,11
GB,HALLUCINATION_ VISUAL,11
GB,LIVER INJURY,11
GB,MUSCLE ATROPHY,11
GB,MUSCULOSKELETAL STIFFNESS,11
GB,MYOCARDIAL INFARCTION,11
GB,OBSTRUCTIVE AIRWAYS DISORDER,11
GB,POLLAKIURIA,11
GB,PRESYNCOPE,11
GB,SPEECH DISORDER,11
GB,VIITH NERVE PARALYSIS,11
GB,AGITATION NEONATAL,10
GB,APHASIA,10
GB,ATRIAL FIBRILLATION,10
GB,BLISTER RUPTURE,10
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
GB,BODY TEMPERATURE DECREASED,10
GB,BURNING SENSATION,10
GB,COLD SWEAT,10
GB,DEVELOPMENTAL HIP DYSPLASIA,10
GB,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,10
GB,ERYTHEMA MULTIFORME,10
GB,FLUSHING,10
GB,GASTROINTESTINAL HAEMORRHAGE,10
GB,INCREASED APPETITE,10
GB,LOCAL SWELLING,10
GB,MUSCULOSKELETAL CHEST PAIN,10
GB,NEPHROPATHY TOXIC,10
GB,PNEUMONITIS,10
GB,RADIAL NERVE PALSY,10
GB,RASH GENERALISED,10
GB,RHINORRHOEA,10
GB,SCREAMING,10
GB,TARDIVE DYSKINESIA,10
GB,TEARFULNESS,10
GB,UNRESPONSIVE TO STIMULI,10
GB,URINARY RETENTION,10
GB,URINARY TRACT INFECTION,10
GB,VULVOVAGINAL CANDIDIASIS,10
GB,AUTOPHOBIA,9
GB,BLOOD PRESSURE INCREASED,9
GB,BONE PAIN,9
GB,CHOLELITHIASIS,9
GB,DYSTONIA,9
GB,EPILEPSY,9
GB,FACTITIOUS DISORDER,9
GB,FLUID INTAKE REDUCED,9
GB,GENERAL PHYSICAL HEALTH DETERIORATION,9
GB,HAEMOPTYSIS,9
GB,HIATUS HERNIA,9
GB,HYPERACUSIS,9
GB,HYPERKINESIA,9
GB,IRRITABLE BOWEL SYNDROME,9
GB,LIMB DISCOMFORT,9
GB,LIVER DISORDER,9
GB,MATERNAL EXPOSURE DURING PREGNANCY,9
GB,NEUTROPHIL COUNT DECREASED,9
GB,PLEURAL EFFUSION,9
GB,PULMONARY EMBOLISM,9
GB,RASH ERYTHEMATOUS,9
GB,RECTAL HAEMORRHAGE,9
GB,RENAL IMPAIRMENT,9
GB,RENAL PAIN,9
GB,RESTLESS LEGS SYNDROME,9
GB,RETCHING,9
GB,SEDATION,9
GB,SELECTIVE EATING DISORDER,9
GB,STRESS,9
GB,SWELLING,9
GB,TENDON PAIN,9
GB,THROAT IRRITATION,9
GB,THROMBOSIS,9
GB,TONGUE DISCOLOURATION,9
GB,WEIGHT DECREASED,9
GB,ABDOMINAL PAIN LOWER,8
GB,ABNORMAL DREAMS,8
GB,ABNORMAL LOSS OF WEIGHT,8
GB,ABNORMAL SENSATION IN EYE,8
GB,ACIDOSIS,8
GB,ANTISOCIAL BEHAVIOUR,8
GB,BLOOD PHOSPHORUS DECREASED,8
GB,C-REACTIVE PROTEIN INCREASED,8
GB,CARDIAC FAILURE,8
GB,CROHN^S DISEASE,8
GB,CRYING,8
GB,DIFFUSE ALVEOLAR DAMAGE,8
GB,DYSPNOEA EXERTIONAL,8
GB,EFFUSION,8
GB,ERUCTATION,8
GB,FEAR,8
GB,FIBULA FRACTURE,8
GB,FLUID RETENTION,8
GB,FOOT FRACTURE,8
GB,GLOMERULAR FILTRATION RATE DECREASED,8
GB,HOSTILITY,8
GB,HYPERKALAEMIA,8
GB,LUNG CONSOLIDATION,8
GB,LYMPHADENOPATHY,8
GB,OSTEOPENIA,8
GB,PERIODONTITIS,8
GB,PIGMENTATION DISORDER,8
GB,PRODUCT USE ISSUE,8
GB,RESTLESSNESS,8
GB,SEPSIS,8
GB,SLOW SPEECH,8
GB,SLUGGISHNESS,8
GB,SNEEZING,8
GB,STATUS ASTHMATICUS,8
GB,TEMPORAL ARTERITIS,8
GB,TRICHOTILLOMANIA,8
GB,ALCOHOL ABUSE,7
GB,ANGINA PECTORIS,7
GB,APPETITE DISORDER,7
GB,BASAL CELL CARCINOMA,7
GB,BLEBITIS,7
GB,BLOOD ELECTROLYTES ABNORMAL,7
GB,BRONCHITIS,7
GB,DELUSION,7
GB,DISCOMFORT,7
GB,DIVERTICULAR PERFORATION,7
GB,DYSAESTHESIA,7
GB,DYSPHONIA,7
GB,ERECTILE DYSFUNCTION,7
GB,FEELING COLD,7
GB,GINGIVAL BLEEDING,7
GB,HOT FLUSH,7
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,7
GB,INFLUENZA,7
GB,JOINT DISLOCATION,7
GB,LEUKOPENIA,7
GB,MANIA,7
GB,MUCOSAL INFLAMMATION,7
GB,NASOPHARYNGITIS,7
GB,NIPPLE PAIN,7
GB,ONYCHOCLASIS,7
GB,PHOTOSENSITIVITY REACTION,7
GB,PIGMENT DISPERSION SYNDROME,7
GB,PULMONARY OEDEMA,7
GB,RADIUS FRACTURE,7
GB,RASH MACULO-PAPULAR,7
GB,SECRETION DISCHARGE,7
GB,SEIZURE,7
GB,SKIN BURNING SENSATION,7
GB,SKIN INFECTION,7
GB,SUICIDAL BEHAVIOUR,7
GB,TENON^S CYST,7
GB,ABASIA,6
GB,AFFECTIVE DISORDER,6
GB,ALANINE AMINOTRANSFERASE INCREASED,6
GB,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,6
GB,ARTHRITIS,6
GB,BLINDNESS,6
GB,BLOOD BILIRUBIN INCREASED,6
GB,BLOOD PRESSURE DECREASED,6
GB,CEREBRAL HAEMORRHAGE,6
GB,CLOSTRIDIUM DIFFICILE COLITIS,6
GB,DEREALISATION,6
GB,DERMATITIS ALLERGIC,6
GB,DREAMY STATE,6
GB,DRUG ABUSE,6
GB,DRUG WITHDRAWAL SYNDROME NEONATAL,6
GB,DRUG-INDUCED LIVER INJURY,6
GB,DYSPHEMIA,6
GB,EAR DISCOMFORT,6
GB,ENURESIS,6
GB,EYE DISORDER,6
GB,FLUID OVERLOAD,6
GB,GINGIVAL PAIN,6
GB,HAEMATURIA,6
GB,HYPERMETROPIA,6
GB,HYPOACUSIS,6
GB,HYPOCALCAEMIA,6
GB,HYPOKALAEMIA,6
GB,ILEUS PARALYTIC,6
GB,INCOHERENT,6
GB,INCORRECT DOSE ADMINISTERED,6
GB,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,6
GB,JAUNDICE,6
GB,JAUNDICE CHOLESTATIC,6
GB,JOINT CREPITATION,6
GB,LIBIDO DECREASED,6
GB,MIGRAINE,6
GB,MYOCARDIAL ISCHAEMIA,6
GB,NERVOUS SYSTEM DISORDER,6
GB,PALLOR,6
GB,PARAESTHESIA ORAL,6
GB,PARTIAL SEIZURES,6
GB,PERITONITIS,6
GB,REACTION TO EXCIPIENT,6
GB,SEROTONIN SYNDROME,6
GB,SOCIAL AVOIDANT BEHAVIOUR,6
GB,SWEAT GLAND DISORDER,6
GB,TENDERNESS,6
GB,TONGUE BLISTERING,6
GB,TONGUE ULCERATION,6
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,6
GB,URINARY INCONTINENCE,6
GB,WHITE BLOOD CELL COUNT INCREASED,6
GB,WITHDRAWAL SYNDROME,6
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,5
GB,ANTINUCLEAR ANTIBODY POSITIVE,5
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,5
GB,BLOOD GLUCOSE INCREASED,5
GB,BLOOD URINE,5
GB,C-REACTIVE PROTEIN DECREASED,5
GB,CANDIDA INFECTION,5
GB,COLITIS,5
GB,COLITIS ISCHAEMIC,5
GB,DEEP VEIN THROMBOSIS,5
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,5
GB,DIABETIC KETOACIDOSIS,5
GB,DRUG DISPENSING ERROR,5
GB,DRUG ERUPTION,5
GB,DYSSTASIA,5
GB,EAR PAIN,5
GB,EATING DISORDER,5
GB,EXPIRED PRODUCT ADMINISTERED,5
GB,EXPOSURE DURING PREGNANCY,5
GB,EYE PRURITUS,5
GB,FACIAL PAIN,5
GB,FEEDING DISORDER,5
GB,GASTRIC HAEMORRHAGE,5
GB,GASTROINTESTINAL DISORDER,5
GB,GASTROINTESTINAL STOMA OUTPUT INCREASED,5
GB,GLOSSITIS,5
GB,HYPERAESTHESIA,5
GB,HYPOPHAGIA,5
GB,IMMUNOSUPPRESSION,5
GB,INFECTION,5
GB,INFLAMMATORY MARKER INCREASED,5
GB,LOBAR PNEUMONIA,5
GB,LYMPHOPROLIFERATIVE DISORDER,5
GB,NASAL DRYNESS,5
GB,NECK PAIN,5
GB,NEUROPATHY PERIPHERAL,5
GB,NON-CARDIAC CHEST PAIN,5
GB,OBESITY,5
GB,OCULAR DISCOMFORT,5
GB,OCULAR HYPERAEMIA,5
GB,OESOPHAGEAL CARCINOMA,5
GB,OESOPHAGITIS,5
GB,POLYURIA,5
GB,RASH MACULAR,5
GB,RAYNAUD^S PHENOMENON,5
GB,RENAL DISORDER,5
GB,RENAL FAILURE,5
GB,SENSATION OF FOREIGN BODY,5
GB,SKIN ULCER,5
GB,TYPE 2 DIABETES MELLITUS,5
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
GB,ACUTE MYOCARDIAL INFARCTION,4
GB,AGEUSIA,4
GB,ANORGASMIA,4
GB,ASCITES,4
GB,ATYPICAL FRACTURE,4
GB,BLOOD COUNT ABNORMAL,4
GB,BRADYPHRENIA,4
GB,BRUXISM,4
GB,COGNITIVE DISORDER,4
GB,CONTRAINDICATED PRODUCT ADMINISTERED,4
GB,CUSHINGOID,4
GB,CUSHING^S SYNDROME,4
GB,DEAFNESS,4
GB,DRY SKIN,4
GB,ELECTROCARDIOGRAM QT PROLONGED,4
GB,EYELID MARGIN CRUSTING,4
GB,FAECES SOFT,4
GB,FEELING DRUNK,4
GB,FOREIGN BODY,4
GB,FREQUENT BOWEL MOVEMENTS,4
GB,GASTROENTERITIS,4
GB,GASTROINTESTINAL ULCER,4
GB,GENERALISED TONIC-CLONIC SEIZURE,4
GB,GENITAL HYPOAESTHESIA,4
GB,GROIN PAIN,4
GB,HAEMATOCHEZIA,4
GB,HEPATIC ENCEPHALOPATHY,4
GB,HYPERGLYCAEMIA,4
GB,HYPOGEUSIA,4
GB,HYPOMAGNESAEMIA,4
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
GB,LUNG INFECTION,4
GB,LYMPHOEDEMA,4
GB,MENTAL IMPAIRMENT,4
GB,MOVEMENT DISORDER,4
GB,MUSCLE TIGHTNESS,4
GB,MUSCULOSKELETAL PAIN,4
GB,ONYCHOLYSIS,4
GB,OSTEOARTHRITIS,4
GB,OSTEONECROSIS,4
GB,OSTEOPOROSIS,4
GB,PANCREATITIS,4
GB,PERIPHERAL COLDNESS,4
GB,POOR QUALITY SLEEP,4
GB,POTENTIATING DRUG INTERACTION,4
GB,PREMATURE EJACULATION,4
GB,PRODUCT FORMULATION ISSUE,4
GB,PSYCHOMOTOR HYPERACTIVITY,4
GB,PULMONARY FIBROSIS,4
GB,PULMONARY MASS,4
GB,RENAL INJURY,4
GB,RESPIRATORY TRACT INFECTION,4
GB,RETROPERITONEAL HAEMATOMA,4
GB,RETROPERITONEAL HAEMORRHAGE,4
GB,SELF-INJURIOUS IDEATION,4
GB,SEXUAL DYSFUNCTION,4
GB,SINUS CONGESTION,4
GB,SKIN HYPERPIGMENTATION,4
GB,SLOW RESPONSE TO STIMULI,4
GB,STOMATITIS,4
GB,SUNBURN,4
GB,SUSPECTED COUNTERFEIT PRODUCT,4
GB,TENDON DISCOMFORT,4
GB,TRANSAMINASES INCREASED,4
GB,UPPER RESPIRATORY TRACT INFECTION,4
GB,UROSEPSIS,4
GB,VOMITING PROJECTILE,4
GB,VULVOVAGINAL DISCOMFORT,4
GB,ABDOMINAL SEPSIS,3
GB,ACQUIRED EPIDERMOLYSIS BULLOSA,3
GB,ACUTE HEPATIC FAILURE,3
GB,ADVERSE DRUG REACTION,3
GB,AMENORRHOEA,3
GB,ANAPHYLACTIC SHOCK,3
GB,BRONCHOSPASM PARADOXICAL,3
GB,CARDIAC DISORDER,3
GB,CARPAL TUNNEL SYNDROME,3
GB,CEREBROVASCULAR DISORDER,3
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
GB,COAGULOPATHY,3
GB,COLOUR BLINDNESS ACQUIRED,3
GB,COMMUNICATION DISORDER,3
GB,CYSTITIS,3
GB,DEFAECATION URGENCY,3
GB,DEVICE ISSUE,3
GB,DIABETES MELLITUS,3
GB,DISEASE PROGRESSION,3
GB,DRUG ADMINISTRATION ERROR,3
GB,DRUG DOSE OMISSION,3
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
GB,DRY THROAT,3
GB,EMOTIONAL DISORDER,3
GB,FACIAL PARESIS,3
GB,FEMUR FRACTURE,3
GB,FOREIGN BODY ASPIRATION,3
GB,FOREIGN BODY IN RESPIRATORY TRACT,3
GB,FRUSTRATION TOLERANCE DECREASED,3
GB,GASTRITIS,3
GB,GASTROINTESTINAL MOTILITY DISORDER,3
GB,HALLUCINATIONS_ MIXED,3
GB,HYPERVENTILATION,3
GB,HYPOAESTHESIA ORAL,3
GB,HYPOXIA,3
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
GB,INCORRECT DRUG ADMINISTRATION DURATION,3
GB,INJECTION SITE SWELLING,3
GB,INTERSTITIAL LUNG DISEASE,3
GB,LACRIMATION INCREASED,3
GB,LIGAMENT SPRAIN,3
GB,LIP BLISTER,3
GB,LIP PAIN,3
GB,MEDICATION ERROR,3
GB,MELAENA,3
GB,MIGRAINE WITH AURA,3
GB,NASAL CONGESTION,3
GB,NECK INJURY,3
GB,NON-SMALL CELL LUNG CANCER,3
GB,OBSESSIVE-COMPULSIVE DISORDER,3
GB,OESOPHAGEAL PAIN,3
GB,PANIC REACTION,3
GB,PEPTIC ULCER,3
GB,PETECHIAE,3
GB,PHARYNGEAL ERYTHEMA,3
GB,PHLEBITIS,3
GB,PHOTOPSIA,3
GB,PRIAPISM,3
GB,PROTEINURIA,3
GB,PSORIATIC ARTHROPATHY,3
GB,RASH PAPULAR,3
GB,RESPIRATORY ARREST,3
GB,RESPIRATORY DISORDER,3
GB,RESPIRATORY DISTRESS,3
GB,RETINOPATHY,3
GB,RHEUMATOID ARTHRITIS,3
GB,RIB FRACTURE,3
GB,SCHOOL REFUSAL,3
GB,SENSATION OF PRESSURE,3
GB,SINUS HEADACHE,3
GB,SKIN DISORDER,3
GB,SUBCUTANEOUS ABSCESS,3
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
GB,TENDON RUPTURE,3
GB,THROMBOCYTOPENIA,3
GB,TONGUE DISCOMFORT,3
GB,TRABECULECTOMY,3
GB,ULCER,3
GB,VAGINAL HAEMORRHAGE,3
GB,VENTRICULAR FIBRILLATION,3
GB,VENTRICULAR HYPERTROPHY,3
GB,VERTIGO,3
GB,VITAMIN D DEFICIENCY,3
GB,WHITE BLOOD CELL COUNT DECREASED,3
GB,ACNE,2
GB,ACUTE CORONARY SYNDROME,2
GB,ADVERSE EVENT,2
GB,ALCOHOLISM,2
GB,ANGLE CLOSURE GLAUCOMA,2
GB,AORTIC STENOSIS,2
GB,APHAGIA,2
GB,ARTERIOSCLEROSIS,2
GB,ARTHROPATHY,2
GB,ASPERGILLUS INFECTION,2
GB,ATRIAL FLUTTER,2
GB,ATYPICAL FEMUR FRACTURE,2
GB,ATYPICAL MYCOBACTERIAL INFECTION,2
GB,BLADDER CANCER,2
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,2
GB,BLOOD CHOLESTEROL INCREASED,2
GB,BLOOD DISORDER,2
GB,BLOOD POTASSIUM INCREASED,2
GB,BODY TEMPERATURE INCREASED,2
GB,BREAST ABSCESS,2
GB,BREAST PAIN,2
GB,BREATH ODOUR,2
GB,BRONCHIECTASIS,2
GB,CARDIAC FAILURE CONGESTIVE,2
GB,CHEILITIS,2
GB,CHOKING SENSATION,2
GB,CHOLECYSTITIS,2
GB,CHOLECYSTITIS ACUTE,2
GB,CLUMSINESS,2
GB,COORDINATION ABNORMAL,2
GB,CYANOSIS,2
GB,CYTOMEGALOVIRUS INFECTION,2
GB,DEPRESSION SUICIDAL,2
GB,DIABETES MELLITUS INADEQUATE CONTROL,2
GB,DISORGANISED SPEECH,2
GB,DISSOCIATION,2
GB,DIVERTICULITIS,2
GB,DRUG EFFECT INCOMPLETE,2
GB,DRUG HYPERSENSITIVITY,2
GB,DRY EYE,2
GB,DUODENITIS,2
GB,DYSKINESIA,2
GB,DYSMORPHISM,2
GB,EJACULATION FAILURE,2
GB,EMPHYSEMA,2
GB,ENERGY INCREASED,2
GB,EXPIRED DRUG ADMINISTERED,2
GB,EXTRASYSTOLES,2
GB,EYE HAEMORRHAGE,2
GB,FACE OEDEMA,2
GB,FEBRILE NEUTROPENIA,2
GB,FOETAL DEATH,2
GB,FOOD CRAVING,2
GB,GALLBLADDER PAIN,2
GB,GASTRITIS EROSIVE,2
GB,GASTROINTESTINAL HYPOMOTILITY,2
GB,GASTROINTESTINAL STOMA COMPLICATION,2
GB,GENITAL ULCERATION,2
GB,GLAUCOMA,2
GB,HAEMODYNAMIC INSTABILITY,2
GB,HALLUCINATION_ AUDITORY,2
GB,HEAD INJURY,2
GB,HEMIPARESIS,2
GB,HEPATIC ENZYME INCREASED,2
GB,HEPATITIS,2
GB,HEPATOMEGALY,2
GB,HEPATOTOXICITY,2
GB,HOSPITALISATION,2
GB,HUNGER,2
GB,HYPOTHYROIDISM,2
GB,INFECTED SKIN ULCER,2
GB,INJECTION SITE ERYTHEMA,2
GB,INJECTION SITE PAIN,2
GB,INTENTIONAL SELF-INJURY,2
GB,INTERNATIONAL NORMALISED RATIO DECREASED,2
GB,IRON DEFICIENCY ANAEMIA,2
GB,JARISCH-HERXHEIMER REACTION,2
GB,LEARNING DISORDER,2
GB,LESION EXCISION,2
GB,LOSS OF LIBIDO,2
GB,MALIGNANT NEOPLASM PROGRESSION,2
GB,MANTLE CELL LYMPHOMA,2
GB,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,2
GB,MENTAL FATIGUE,2
GB,MICTURITION URGENCY,2
GB,MUCOSAL ULCERATION,2
GB,MUSCULOSKELETAL DISCOMFORT,2
GB,NERVE INJURY,2
GB,NEURALGIA,2
GB,OBLITERATIVE BRONCHIOLITIS,2
GB,OEDEMA MOUTH,2
GB,OESOPHAGEAL OBSTRUCTION,2
GB,ORAL PRURITUS,2
GB,ORTHOSTATIC HYPOTENSION,2
GB,OSTEONECROSIS OF JAW,2
GB,OXYGEN SATURATION DECREASED,2
GB,PAIN OF SKIN,2
GB,PANCREATITIS ACUTE,2
GB,PANCYTOPENIA,2
GB,PARKINSONISM,2
GB,PEMPHIGOID,2
GB,PERICARDITIS,2
GB,PLEURITIC PAIN,2
GB,PNEUMOTHORAX,2
GB,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
GB,PSYCHIATRIC SYMPTOM,2
GB,PULMONARY CONGESTION,2
GB,PULMONARY HYPERTENSION,2
GB,PULMONARY MYCOSIS,2
GB,PULSE ABNORMAL,2
GB,RALES,2
GB,RASH VESICULAR,2
GB,REPETITIVE SPEECH,2
GB,SCIATICA,2
GB,SENSORY DISTURBANCE,2
GB,SHOCK,2
GB,SKIN INDURATION,2
GB,SMALL INTESTINAL OBSTRUCTION,2
GB,SPLENOMEGALY,2
GB,STEREOTYPY,2
GB,STEVENS-JOHNSON SYNDROME,2
GB,SUBDURAL HAEMATOMA,2
GB,TENOSYNOVITIS,2
GB,TERMINAL INSOMNIA,2
GB,TIBIA FRACTURE,2
GB,TRANSFUSION,2
GB,TUMOUR PAIN,2
GB,TYPE 1 DIABETES MELLITUS,2
GB,ULCER HAEMORRHAGE,2
GB,UNINTENDED PREGNANCY,2
GB,VASCULAR INJURY,2
GB,VENTRICULAR FAILURE,2
GB,VIRAL INFECTION,2
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
GB,VISUAL ACUITY REDUCED,2
GB,WOUND HAEMORRHAGE,2
GB,WRIST FRACTURE,2
GB,ABDOMINAL ADHESIONS,1
GB,ABDOMINAL SYMPTOM,1
GB,ACQUIRED HAEMOPHILIA,1
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
GB,ACUTE LEFT VENTRICULAR FAILURE,1
GB,ACUTE PSYCHOSIS,1
GB,ADRENAL INSUFFICIENCY,1
GB,AGORAPHOBIA,1
GB,ALLERGIC GRANULOMATOUS ANGIITIS,1
GB,ALLERGIC OEDEMA,1
GB,ALLERGIC REACTION TO EXCIPIENT,1
GB,ALOPECIA TOTALIS,1
GB,ALTERED STATE OF CONSCIOUSNESS,1
GB,ALVEOLAR BONE RESORPTION,1
GB,ALVEOLITIS ALLERGIC,1
GB,AMAUROSIS FUGAX,1
GB,AMYLASE INCREASED,1
GB,ANAEMIA VITAMIN B12 DEFICIENCY,1
GB,ANAL INCONTINENCE,1
GB,ANAPHYLACTOID REACTION,1
GB,ANKLE FRACTURE,1
GB,ANOSMIA,1
GB,ANTASTHMATIC DRUG LEVEL ABOVE THERAPEUTIC,1
GB,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
GB,ANURIA,1
GB,AORTIC ANEURYSM,1
GB,APATHY,1
GB,APPENDICECTOMY,1
GB,APPENDICITIS,1
GB,APPLICATION SITE EROSION,1
GB,APPLICATION SITE SWELLING,1
GB,APRAXIA,1
GB,ARCUS LIPOIDES,1
GB,ARTERIOSCLEROSIS CORONARY ARTERY,1
GB,ARTERIOSPASM CORONARY,1
GB,ARTHRITIS ENTEROPATHIC,1
GB,ARTHRITIS INFECTIVE,1
GB,ASPHYXIA,1
GB,ATAXIA,1
GB,ATRIAL TACHYCARDIA,1
GB,ATROPHIC VULVOVAGINITIS,1
GB,AUTOANTIBODY TEST,1
GB,AUTOIMMUNE NEPHRITIS,1
GB,AZOTAEMIA,1
GB,BACTERIAL TRACHEITIS,1
GB,BALANITIS CANDIDA,1
GB,BASILAR ARTERY THROMBOSIS,1
GB,BINGE EATING,1
GB,BLADDER CATHETERISATION,1
GB,BLADDER DISORDER,1
GB,BLADDER NEOPLASM,1
GB,BLADDER SPASM,1
GB,BLEEDING TIME PROLONGED,1
GB,BLEPHAROSPASM,1
GB,BLINDNESS TRANSIENT,1
GB,BLINDNESS UNILATERAL,1
GB,BLOOD BLISTER,1
GB,BLOOD CHOLESTEROL ABNORMAL,1
GB,BLOOD CREATININE INCREASED,1
GB,BLOOD FIBRINOGEN INCREASED,1
GB,BLOOD HIV RNA INCREASED,1
GB,BLOOD IMMUNOGLOBULIN M INCREASED,1
GB,BLOOD LACTIC ACID INCREASED,1
GB,BLOOD PRESSURE DIASTOLIC DECREASED,1
GB,BLOOD PRESSURE FLUCTUATION,1
GB,BLOOD PRESSURE SYSTOLIC DECREASED,1
GB,BLOOD TESTOSTERONE DECREASED,1
GB,BLOOD UREA INCREASED,1
GB,BONE DISORDER,1
GB,BRAIN STEM STROKE,1
GB,BREAST SWELLING,1
GB,BRONCHIAL DISORDER,1
GB,BRONCHIAL HYPERREACTIVITY,1
GB,BRONCHIAL OBSTRUCTION,1
GB,BRONCHITIS CHEMICAL,1
GB,BRONCHOPNEUMONIA,1
GB,BRONCHOPULMONARY DYSPLASIA,1
GB,CAESAREAN SECTION,1
GB,CARDIAC FAILURE ACUTE,1
GB,CARDIAC FLUTTER,1
GB,CARDIAC HYPERTROPHY,1
GB,CARDIAC PACEMAKER INSERTION,1
GB,CARDIAC VALVE DISEASE,1
GB,CARDIOACTIVE DRUG LEVEL INCREASED,1
GB,CARDIOMEGALY,1
GB,CARDIOTHORACIC RATIO INCREASED,1
GB,CAROTID ARTERY STENOSIS,1
GB,CATARACT,1
GB,CATARACT OPERATION,1
GB,CEREBRAL ATROPHY,1
GB,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
GB,CEREBRAL THROMBOSIS,1
GB,CERVICOGENIC HEADACHE,1
GB,CHANGE OF BOWEL HABIT,1
GB,CHEST X-RAY ABNORMAL,1
GB,CHRONIC SPONTANEOUS URTICARIA,1
GB,CIRCUMORAL OEDEMA,1
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR,1
GB,CLOSTRIDIUM DIFFICILE INFECTION,1
GB,CLUSTER HEADACHE,1
GB,COELIAC DISEASE,1
GB,COLITIS ULCERATIVE,1
GB,COLON CANCER,1
GB,CONGENITAL HEART VALVE DISORDER,1
GB,CONJUNCTIVITIS,1
GB,CONJUNCTIVITIS ALLERGIC,1
GB,CONSCIOUSNESS FLUCTUATING,1
GB,CONTRAINDICATED DRUG ADMINISTERED,1
GB,CONVULSION,1
GB,COR PULMONALE,1
GB,CORONARY ARTERY THROMBOSIS,1
GB,CREATININE URINE INCREASED,1
GB,CROUP INFECTIOUS,1
GB,DEFIANT BEHAVIOUR,1
GB,DEMYELINATION,1
GB,DEPRESSIVE SYMPTOM,1
GB,DERMATITIS,1
GB,DERMATITIS EXFOLIATIVE,1
GB,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
GB,DEVICE EXPULSION,1
GB,DEVICE FAILURE,1
GB,DEVICE MALFUNCTION,1
GB,DEVICE RELATED INFECTION,1
GB,DIABETIC NEUROPATHY,1
GB,DIFFUSE VASCULITIS,1
GB,DISSEMINATED TUBERCULOSIS,1
GB,DISSOCIATIVE DISORDER,1
GB,DISTURBANCE IN SEXUAL AROUSAL,1
GB,DIZZINESS EXERTIONAL,1
GB,DIZZINESS POSTURAL,1
GB,DRUG ADMINISTERED IN WRONG DEVICE,1
GB,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
GB,DRUG EFFECT DECREASED,1
GB,DRUG EFFECT DELAYED,1
GB,DRUG LEVEL ABOVE THERAPEUTIC,1
GB,DRUG LEVEL INCREASED,1
GB,DRUG PRESCRIBING ERROR,1
GB,DRUG RESISTANCE,1
GB,DRUG SCREEN NEGATIVE,1
GB,DUODENAL ULCER,1
GB,DYSGRAPHIA,1
GB,DYSMENORRHOEA,1
GB,EAR INFECTION,1
GB,EAR SWELLING,1
GB,ECTOPIC PREGNANCY,1
GB,EJACULATION DISORDER,1
GB,EMBOLISM VENOUS,1
GB,ENCEPHALITIS,1
GB,ENDOMETRIAL CANCER STAGE III,1
GB,ENTEROVESICAL FISTULA,1
GB,EOSINOPHILIA,1
GB,EPIDERMAL NECROSIS,1
GB,EPIGASTRIC DISCOMFORT,1
GB,ERYTHROPENIA,1
GB,ERYTHROPOIESIS ABNORMAL,1
GB,ESSENTIAL TREMOR,1
GB,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
GB,EUPHORIC MOOD,1
GB,EXERCISE TOLERANCE DECREASED,1
GB,EXPOSED BONE IN JAW,1
GB,EXTERNAL EAR CELLULITIS,1
GB,EXTRA DOSE ADMINISTERED,1
GB,EYE INFLAMMATION,1
GB,EYELID OEDEMA,1
GB,EYELID PTOSIS,1
GB,FACTOR V LEIDEN MUTATION,1
GB,FAECAL INCONTINENCE,1
GB,FAECES PALE,1
GB,FEEDING DISORDER NEONATAL,1
GB,FEELING OF DESPAIR,1
GB,FEMORAL ARTERY EMBOLISM,1
GB,FOETAL CYSTIC HYGROMA,1
GB,FOOD INTOLERANCE,1
GB,FOREIGN BODY REACTION,1
GB,GALLBLADDER DISORDER,1
GB,GALLBLADDER EMPYEMA,1
GB,GALLBLADDER PERFORATION,1
GB,GASTRIC ULCER HAEMORRHAGE,1
GB,GASTRIC ULCER PERFORATION,1
GB,GASTROENTERITIS VIRAL,1
GB,GASTROINTESTINAL INFLAMMATION,1
GB,GASTROINTESTINAL PAIN,1
GB,GENERALISED ANXIETY DISORDER,1
GB,GENITAL DISCOMFORT,1
GB,GESTATIONAL DIABETES,1
GB,GINGIVAL DISORDER,1
GB,GOUTY ARTHRITIS,1
GB,GRIEF REACTION,1
GB,HAEMATOCRIT DECREASED,1
GB,HAEMOLYSIS,1
GB,HAEMORRHAGE IN PREGNANCY,1
GB,HAIR GROWTH ABNORMAL,1
GB,HEARING IMPAIRED,1
GB,HEART BLOCK CONGENITAL,1
GB,HEART DISEASE CONGENITAL,1
GB,HEART RATE IRREGULAR,1
GB,HEMIANOPIA,1
GB,HEMIPLEGIA,1
GB,HEPATIC CIRRHOSIS,1
GB,HEPATIC FAILURE,1
GB,HEPATIC FUNCTION ABNORMAL,1
GB,HEPATIC STEATOSIS,1
GB,HEPATITIS ACUTE,1
GB,HERPES SIMPLEX,1
GB,HERPES ZOSTER,1
GB,HIGH DENSITY LIPOPROTEIN DECREASED,1
GB,HYDRONEPHROSIS,1
GB,HYPERCAPNIA,1
GB,HYPEREOSINOPHILIC SYNDROME,1
GB,HYPERINSULINAEMIA,1
GB,HYPERLIPIDAEMIA,1
GB,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
GB,HYPEROSMOLAR STATE,1
GB,HYPOKINESIA,1
GB,HYPOPHOSPHATAEMIA,1
GB,HYPOPITUITARISM,1
GB,HYPOTHERMIA,1
GB,HYPOTONIA,1
GB,HYPOVENTILATION,1
GB,ILL-DEFINED DISORDER,1
GB,IMMOBILE,1
GB,IMPAIRED DRIVING ABILITY,1
GB,IMPAIRED HEALING,1
GB,IMPAIRED WORK ABILITY,1
GB,IMPETIGO,1
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GB,INCREASED TENDENCY TO BRUISE,1
GB,INFECTED BITE,1
GB,INFECTIOUS COLITIS,1
GB,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
GB,INFECTIVE GLOSSITIS,1
GB,INFLAMMATION,1
GB,INFUSION RELATED REACTION,1
GB,INJECTION SITE CELLULITIS,1
GB,INJECTION SITE IRRITATION,1
GB,INJECTION SITE PRURITUS,1
GB,INJECTION SITE WARMTH,1
GB,INTELLIGENCE INCREASED,1
GB,INTENTIONAL DRUG MISUSE,1
GB,INTENTIONAL OVERDOSE,1
GB,INTENTIONAL PRODUCT MISUSE,1
GB,INTENTIONAL PRODUCT USE ISSUE,1
GB,INTESTINAL HAEMORRHAGE,1
GB,INTESTINAL OBSTRUCTION,1
GB,INTRACRANIAL PRESSURE INCREASED,1
GB,INVASIVE DUCTAL BREAST CARCINOMA,1
GB,ISCHAEMIA,1
GB,ISCHAEMIC STROKE,1
GB,JOINT INJURY,1
GB,JOINT LOCK,1
GB,JOINT STIFFNESS,1
GB,JUDGEMENT IMPAIRED,1
GB,KIDNEY FIBROSIS,1
GB,KIDNEY INFECTION,1
GB,KNEE ARTHROPLASTY,1
GB,KNEE DEFORMITY,1
GB,LACERATION,1
GB,LACTIC ACIDOSIS,1
GB,LARGE INTESTINE PERFORATION,1
GB,LARYNGEAL CANCER,1
GB,LEFT VENTRICULAR DYSFUNCTION,1
GB,LEFT VENTRICULAR FAILURE,1
GB,LEFT VENTRICULAR HYPERTROPHY,1
GB,LIBIDO INCREASED,1
GB,LICHEN SCLEROSUS,1
GB,LID SULCUS DEEPENED,1
GB,LIMB INJURY,1
GB,LIP DRY,1
GB,LOCALISED INFECTION,1
GB,LOOSE TOOTH,1
GB,LOSS OF CONTROL OF LEGS,1
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,1
US,DYSPNOEA,9316
US,DRUG INEFFECTIVE,7245
US,DEVICE USE ERROR,4934
US,PRODUCT QUALITY ISSUE,4029
US,COUGH,3754
US,PNEUMONIA,3605
US,DRUG DOSE OMISSION,3471
US,FATIGUE,3384
US,ASTHMA,3064
US,NAUSEA,3039
US,MALAISE,3031
US,HEADACHE,2961
US,PAIN,2735
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2425
US,DIARRHOEA,2363
US,DIZZINESS,2269
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2144
US,FALL,1909
US,PRODUCT CLEANING INADEQUATE,1802
US,VOMITING,1773
US,BRONCHITIS,1759
US,ANXIETY,1740
US,ASTHENIA,1729
US,DEATH,1606
US,WHEEZING,1605
US,PRODUCT USE ISSUE,1540
US,ARTHRALGIA,1538
US,NASOPHARYNGITIS,1492
US,WEIGHT DECREASED,1481
US,CHEST PAIN,1443
US,PAIN IN EXTREMITY,1413
US,INSOMNIA,1377
US,BACK PAIN,1348
US,RASH,1347
US,DEPRESSION,1296
US,FEELING ABNORMAL,1282
US,CHEST DISCOMFORT,1277
US,CONDITION AGGRAVATED,1257
US,SINUSITIS,1256
US,PYREXIA,1245
US,INTENTIONAL PRODUCT MISUSE,1172
US,HYPERTENSION,1092
US,DYSPHONIA,1089
US,PRURITUS,1078
US,MUSCLE SPASMS,1074
US,WEIGHT INCREASED,1038
US,CONSTIPATION,957
US,TREMOR,953
US,DECREASED APPETITE,939
US,HYPERSENSITIVITY,933
US,DRUG HYPERSENSITIVITY,923
US,ABDOMINAL PAIN,905
US,ANAEMIA,903
US,PERIPHERAL SWELLING,895
US,GAIT DISTURBANCE,884
US,INFLUENZA,875
US,OROPHARYNGEAL PAIN,841
US,GASTROINTESTINAL HAEMORRHAGE,830
US,ABDOMINAL PAIN UPPER,824
US,MEDICATION ERROR,817
US,URINARY TRACT INFECTION,815
US,PULMONARY EMBOLISM,804
US,UNDERDOSE,802
US,MEMORY IMPAIRMENT,801
US,SOMNOLENCE,782
US,OVERDOSE,769
US,PRODUCTIVE COUGH,752
US,HOSPITALISATION,747
US,DRUG ADMINISTRATION ERROR,745
US,MYOCARDIAL INFARCTION,739
US,CARDIAC FAILURE CONGESTIVE,728
US,ABDOMINAL DISCOMFORT,714
US,DEVICE MALFUNCTION,714
US,GASTROOESOPHAGEAL REFLUX DISEASE,703
US,HYPOTENSION,702
US,HYPOAESTHESIA,694
US,INJECTION SITE PAIN,691
US,DEHYDRATION,684
US,BLOOD PRESSURE INCREASED,675
US,INJURY,664
US,HEART RATE INCREASED,653
US,MYALGIA,651
US,URTICARIA,650
US,CEREBROVASCULAR ACCIDENT,644
US,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,644
US,UPPER RESPIRATORY TRACT INFECTION,634
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,624
US,PARAESTHESIA,622
US,PALPITATIONS,618
US,DEEP VEIN THROMBOSIS,616
US,ATRIAL FIBRILLATION,614
US,OEDEMA PERIPHERAL,586
US,ALOPECIA,582
US,VISION BLURRED,582
US,INCORRECT DOSE ADMINISTERED,580
US,DRY MOUTH,576
US,INTENTIONAL PRODUCT USE ISSUE,573
US,CONTUSION,572
US,OXYGEN SATURATION DECREASED,570
US,LUNG DISORDER,569
US,MIGRAINE,569
US,DYSPEPSIA,552
US,RESPIRATORY FAILURE,549
US,RHINORRHOEA,548
US,EXPIRED PRODUCT ADMINISTERED,540
US,THROAT IRRITATION,539
US,CONFUSIONAL STATE,537
US,PRODUCT USE IN UNAPPROVED INDICATION,528
US,DRUG EFFECT DECREASED,520
US,INFECTION,518
US,LOSS OF CONSCIOUSNESS,518
US,CHILLS,512
US,NASAL CONGESTION,512
US,VISUAL IMPAIRMENT,509
US,ARTHRITIS,505
US,MUSCULAR WEAKNESS,503
US,ERYTHEMA,498
US,EPISTAXIS,494
US,CATARACT,490
US,BLOOD GLUCOSE INCREASED,487
US,ABDOMINAL DISTENSION,470
US,SEPSIS,465
US,UNEVALUABLE EVENT,464
US,HYPERHIDROSIS,460
US,DYSPHAGIA,454
US,DYSPNOEA EXERTIONAL,454
US,EMOTIONAL DISTRESS,444
US,THERAPEUTIC RESPONSE UNEXPECTED,437
US,JOINT SWELLING,431
US,NEUROPATHY PERIPHERAL,431
US,DYSGEUSIA,426
US,CARDIAC DISORDER,425
US,NERVOUSNESS,421
US,SWELLING,417
US,DIABETES MELLITUS,411
US,DEVICE ISSUE,409
US,LUNG INFECTION,408
US,ADVERSE EVENT,401
US,THROMBOSIS,398
US,STRESS,396
US,FLUID RETENTION,389
US,SEIZURE,389
US,ACUTE KIDNEY INJURY,385
US,SYNCOPE,382
US,BALANCE DISORDER,379
US,RENAL FAILURE,370
US,ILL-DEFINED DISORDER,357
US,BURNING SENSATION,354
US,HAEMOPTYSIS,353
US,HAEMOGLOBIN DECREASED,350
US,AMNESIA,344
US,TREATMENT NONCOMPLIANCE,342
US,INFLUENZA LIKE ILLNESS,337
US,GENERAL PHYSICAL HEALTH DETERIORATION,336
US,LUNG NEOPLASM MALIGNANT,335
US,MUSCULOSKELETAL PAIN,333
US,PLEURAL EFFUSION,333
US,PRODUCT PHYSICAL ISSUE,329
US,SLEEP APNOEA SYNDROME,328
US,DRUG EFFECT INCOMPLETE,327
US,FLUSHING,327
US,HYPOXIA,325
US,CELLULITIS,321
US,WHITE BLOOD CELL COUNT DECREASED,320
US,RHEUMATOID ARTHRITIS,318
US,SUICIDAL IDEATION,313
US,OEDEMA,309
US,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,308
US,OSTEOARTHRITIS,307
US,OSTEOPOROSIS,303
US,DISEASE PROGRESSION,301
US,HAEMORRHAGE,298
US,DRY SKIN,297
US,PSORIASIS,297
US,HERPES ZOSTER,288
US,STOMATITIS,288
US,PRE-EXISTING CONDITION IMPROVED,286
US,PANIC ATTACK,284
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,283
US,TACHYCARDIA,283
US,INHALATION THERAPY,282
US,SWELLING FACE,282
US,NECK PAIN,281
US,INJECTION SITE ERYTHEMA,270
US,CANDIDA INFECTION,265
US,RESPIRATORY DISTRESS,265
US,RESPIRATORY TRACT CONGESTION,265
US,SURGERY,265
US,VERTIGO,265
US,ANAPHYLACTIC REACTION,264
US,RESPIRATORY DISORDER,264
US,INJECTION SITE BRUISING,261
US,EMPHYSEMA,259
US,HOT FLUSH,259
US,ADVERSE DRUG REACTION,258
US,BLOOD CHOLESTEROL INCREASED,257
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,257
US,PULMONARY OEDEMA,255
US,RECTAL HAEMORRHAGE,254
US,ROAD TRAFFIC ACCIDENT,252
US,PLATELET COUNT DECREASED,251
US,SLEEP DISORDER,251
US,MUSCULOSKELETAL STIFFNESS,249
US,AGITATION,247
US,SPEECH DISORDER,243
US,ACUTE RESPIRATORY FAILURE,242
US,STAPHYLOCOCCAL INFECTION,242
US,RESPIRATORY TRACT INFECTION,241
US,FLATULENCE,240
US,BLOOD POTASSIUM DECREASED,239
US,THERAPEUTIC RESPONSE DECREASED,239
US,MULTIPLE SCLEROSIS RELAPSE,238
US,CARDIAC ARREST,236
US,PULMONARY CONGESTION,231
US,IRRITABILITY,230
US,THROMBOCYTOPENIA,230
US,FIBROMYALGIA,229
US,DRUG INTOLERANCE,227
US,GASTROINTESTINAL DISORDER,227
US,NEPHROLITHIASIS,227
US,VIRAL INFECTION,227
US,CROHN^S DISEASE,225
US,FEELING JITTERY,225
US,MOBILITY DECREASED,224
US,EAR INFECTION,222
US,FEELING HOT,221
US,TRANSIENT ISCHAEMIC ATTACK,221
US,LETHARGY,220
US,PULMONARY MASS,220
US,SINUS DISORDER,219
US,BONE PAIN,217
US,EXPOSURE DURING PREGNANCY,216
US,PULMONARY HYPERTENSION,213
US,ARTHROPATHY,212
US,CHOKING,212
US,INCORRECT PRODUCT STORAGE,210
US,POLLAKIURIA,210
US,THERAPY CESSATION,208
US,HALLUCINATION,207
US,DRUG DISPENSING ERROR,203
US,CHOLELITHIASIS,202
US,VISUAL ACUITY REDUCED,202
US,ACTIVITIES OF DAILY LIVING IMPAIRED,200
US,INTERVERTEBRAL DISC PROTRUSION,200
US,SKIN DISCOLOURATION,200
US,BLOOD PRESSURE DECREASED,197
US,CARDIAC FAILURE,196
US,THROAT TIGHTNESS,196
US,TINNITUS,195
US,APHONIA,194
US,DYSURIA,194
US,HEAD INJURY,194
US,SKIN EXFOLIATION,194
US,ORAL PAIN,193
US,RIB FRACTURE,190
US,NEUTROPENIA,189
US,BLISTER,188
US,CRYING,188
US,GASTRIC DISORDER,188
US,NEOPLASM MALIGNANT,187
US,RETCHING,186
US,WHITE BLOOD CELL COUNT INCREASED,186
US,ORAL CANDIDIASIS,185
US,PRODUCT TASTE ABNORMAL,185
US,LOCAL SWELLING,184
US,ABASIA,183
US,DISTURBANCE IN ATTENTION,183
US,PLASMA CELL MYELOMA,183
US,SWOLLEN TONGUE,183
US,BODY HEIGHT DECREASED,182
US,CYSTIC FIBROSIS,182
US,INJECTION SITE PRURITUS,182
US,PHARYNGEAL OEDEMA,182
US,DIVERTICULITIS,181
US,PULMONARY FUNCTION TEST DECREASED,181
US,DRY EYE,180
US,JOINT INJURY,179
US,DEVICE FAILURE,178
US,BRONCHOSPASM,177
US,EXTRA DOSE ADMINISTERED,177
US,HAEMATURIA,177
US,LYMPHADENOPATHY,177
US,MENTAL STATUS CHANGES,177
US,PANCREATITIS,177
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,177
US,EYE PAIN,176
US,PNEUMOTHORAX,176
US,HAEMATOCHEZIA,175
US,CYSTITIS,174
US,HEPATIC ENZYME INCREASED,174
US,RASH PRURITIC,174
US,NIGHT SWEATS,173
US,DEPRESSED MOOD,171
US,HYPOACUSIS,171
US,HIP FRACTURE,170
US,HYPOKALAEMIA,169
US,SNEEZING,169
US,BLOOD CREATININE INCREASED,168
US,INTERVERTEBRAL DISC DEGENERATION,167
US,TYPE 2 DIABETES MELLITUS,166
US,INJECTION SITE SWELLING,165
US,SINUS CONGESTION,165
US,DISCOMFORT,164
US,URINARY INCONTINENCE,164
US,DRUG PRESCRIBING ERROR,163
US,HAEMORRHAGIC ANAEMIA,163
US,SEASONAL ALLERGY,163
US,FUNGAL INFECTION,161
US,LARYNGITIS,161
US,FOOT FRACTURE,160
US,GLAUCOMA,159
US,LIMB INJURY,159
US,BONE DISORDER,158
US,HYPOTHYROIDISM,158
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,157
US,DRUG WITHDRAWAL SYNDROME,156
US,RESTLESS LEGS SYNDROME,156
US,INVESTIGATION,155
US,MENTAL DISORDER,155
US,UPPER LIMB FRACTURE,155
US,EYE DISORDER,152
US,HIATUS HERNIA,152
US,MULTIPLE ALLERGIES,152
US,RENAL FAILURE ACUTE,152
US,BREAST CANCER,151
US,INJECTION SITE HAEMORRHAGE,151
US,BACK DISORDER,150
US,INTENTIONAL DRUG MISUSE,150
US,MALIGNANT NEOPLASM PROGRESSION,150
US,MOOD SWINGS,150
US,NEURALGIA,150
US,PAIN IN JAW,149
US,RENAL DISORDER,149
US,DEVICE MISUSE,148
US,GLOSSODYNIA,148
US,INTENTIONAL DEVICE MISUSE,148
US,LIP SWELLING,148
US,DEVICE DISLOCATION,147
US,PRODUCT SUBSTITUTION ISSUE,147
US,MUSCULOSKELETAL CHEST PAIN,146
US,INTESTINAL OBSTRUCTION,145
US,NO ADVERSE EVENT,145
US,CLOSTRIDIUM DIFFICILE INFECTION,144
US,HEART RATE IRREGULAR,143
US,GASTRITIS,142
US,INTENTIONAL OVERDOSE,142
US,SPINAL FRACTURE,142
US,SPUTUM DISCOLOURED,142
US,PRODUCT STORAGE ERROR,141
US,UPPER GASTROINTESTINAL HAEMORRHAGE,141
US,CORONARY ARTERY DISEASE,140
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,140
US,FEAR,140
US,RASH GENERALISED,140
US,ABNORMAL BEHAVIOUR,139
US,PRESCRIBED OVERDOSE,139
US,COAGULOPATHY,138
US,SECRETION DISCHARGE,138
US,BLINDNESS,137
US,DISABILITY,137
US,UPPER-AIRWAY COUGH SYNDROME,137
US,VAGINAL HAEMORRHAGE,137
US,CONVULSION,136
US,EAR PAIN,136
US,GALLBLADDER DISORDER,136
US,LACERATION,135
US,IRRITABLE BOWEL SYNDROME,134
US,EYE SWELLING,133
US,PRURITUS GENERALISED,133
US,GOUT,132
US,INJECTION SITE REACTION,131
US,HYPERLIPIDAEMIA,130
US,DRY THROAT,129
US,OBESITY,129
US,RED BLOOD CELL COUNT DECREASED,129
US,ATELECTASIS,128
US,EYE PRURITUS,128
US,URINARY RETENTION,128
US,UTERINE PERFORATION,128
US,HYPERSOMNIA,127
US,LOWER RESPIRATORY TRACT INFECTION,127
US,OSTEOPENIA,127
US,PANCYTOPENIA,127
US,RENAL IMPAIRMENT,127
US,ARRHYTHMIA,126
US,GASTROENTERITIS VIRAL,126
US,PERICARDIAL EFFUSION,126
US,SEPTIC SHOCK,126
US,AGGRESSION,125
US,ANKLE FRACTURE,125
US,FLUID OVERLOAD,125
US,IMPAIRED HEALING,125
US,DISORIENTATION,124
US,HAEMORRHOIDS,124
US,HEART RATE DECREASED,124
US,INTENTIONAL UNDERDOSE,124
US,ACNE,123
US,ANHEDONIA,123
US,HAEMATOMA,123
US,LACRIMATION INCREASED,123
US,LIMB DISCOMFORT,123
US,HYPONATRAEMIA,122
US,OSTEOMYELITIS,122
US,VITAMIN D DEFICIENCY,122
US,SKIN ULCER,121
US,DYSARTHRIA,120
US,MEDICATION RESIDUE PRESENT,120
US,TOOTH DISORDER,120
US,BLOOD GLUCOSE DECREASED,119
US,CHRONIC KIDNEY DISEASE,119
US,INCREASED UPPER AIRWAY SECRETION,119
US,INFLAMMATION,119
US,OCULAR HYPERAEMIA,119
US,APHASIA,118
US,PULMONARY FIBROSIS,118
US,ANGER,117
US,INTERNAL HAEMORRHAGE,117
US,LOWER GASTROINTESTINAL HAEMORRHAGE,117
US,MOVEMENT DISORDER,117
US,BLOOD SODIUM DECREASED,116
US,RESTLESSNESS,116
US,WITHDRAWAL SYNDROME,116
US,JOINT STIFFNESS,115
US,ROTATOR CUFF SYNDROME,115
US,PELVIC PAIN,114
US,RESPIRATORY ARREST,114
US,ANGINA PECTORIS,113
US,FULL BLOOD COUNT DECREASED,113
US,NIGHTMARE,113
US,BACK INJURY,112
US,CHOLECYSTITIS CHRONIC,112
US,POOR QUALITY SLEEP,112
US,RASH ERYTHEMATOUS,112
US,CARPAL TUNNEL SYNDROME,111
US,COLITIS,111
US,LOWER LIMB FRACTURE,111
US,ORAL DISCOMFORT,111
US,SKIN LESION,111
US,MUSCULOSKELETAL DISCOMFORT,110
US,SPINAL OSTEOARTHRITIS,109
US,ABNORMAL DREAMS,108
US,ABNORMAL LOSS OF WEIGHT,108
US,IMPAIRED WORK ABILITY,108
US,LOCALISED INFECTION,108
US,PNEUMONIA ASPIRATION,107
US,ACCIDENTAL EXPOSURE TO PRODUCT,106
US,AGEUSIA,106
US,BLOOD PRESSURE ABNORMAL,106
US,LIVER DISORDER,106
US,MACULAR DEGENERATION,106
US,ASPARTATE AMINOTRANSFERASE INCREASED,105
US,DEMENTIA,105
US,HYPOPHAGIA,105
US,MIDDLE INSOMNIA,105
US,TOOTHACHE,105
US,CHOLECYSTECTOMY,104
US,COGNITIVE DISORDER,104
US,DYSSTASIA,104
US,MENTAL IMPAIRMENT,104
US,OSTEONECROSIS OF JAW,104
US,SCIATICA,104
US,HAEMATEMESIS,103
US,LIGAMENT SPRAIN,102
US,PULMONARY ARTERIAL HYPERTENSION,102
US,ABDOMINAL PAIN LOWER,101
US,DEAFNESS,101
US,HERNIA,101
US,ACUTE MYOCARDIAL INFARCTION,100
US,ALANINE AMINOTRANSFERASE INCREASED,99
US,COMA,99
US,EMOTIONAL DISORDER,99
US,FEELING COLD,99
US,HYPERGLYCAEMIA,99
US,HYPOGLYCAEMIA,99
US,INFUSION RELATED REACTION,99
US,PNEUMONITIS,99
US,PRESYNCOPE,99
US,SCAR,98
US,FEMUR FRACTURE,97
US,CORONARY ARTERY OCCLUSION,96
US,DIPLOPIA,96
US,EYE IRRITATION,96
US,KIDNEY INFECTION,96
US,LEUKOCYTOSIS,96
US,MOOD ALTERED,96
US,MUSCLE TWITCHING,96
US,WRIST FRACTURE,96
US,BREATH SOUNDS ABNORMAL,95
US,CARDIOMEGALY,94
US,INCORRECT DRUG ADMINISTRATION DURATION,94
US,RHINITIS ALLERGIC,94
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,94
US,RASH MACULAR,93
US,SKIN DISORDER,93
US,TOXICITY TO VARIOUS AGENTS,93
US,HEPATIC STEATOSIS,92
US,DYSKINESIA,91
US,HYPERKALAEMIA,91
US,CATARACT OPERATION,90
US,ECZEMA,90
US,HAEMATOCRIT DECREASED,90
US,INABILITY TO AFFORD MEDICATION,90
US,COLITIS ULCERATIVE,89
US,EATING DISORDER,89
US,EMERGENCY CARE EXAMINATION,89
US,KNEE ARTHROPLASTY,89
US,LIVER FUNCTION TEST ABNORMAL,89
US,RESPIRATION ABNORMAL,89
US,HUNGER,88
US,PSEUDOMONAS INFECTION,88
US,SYSTEMIC LUPUS ERYTHEMATOSUS,88
US,THINKING ABNORMAL,88
US,BRADYCARDIA,87
US,EXOSTOSIS,87
US,FAECES DISCOLOURED,87
US,MENORRHAGIA,87
US,MULTIPLE SCLEROSIS,87
US,PROCEDURAL PAIN,87
US,INTERNATIONAL NORMALISED RATIO INCREASED,86
US,SPINAL COMPRESSION FRACTURE,86
US,THYROID DISORDER,86
US,BIPOLAR DISORDER,85
US,CHROMATURIA,85
US,HEAD DISCOMFORT,85
US,PSYCHOMOTOR HYPERACTIVITY,85
US,FEBRILE NEUTROPENIA,84
US,SCOLIOSIS,84
US,WOUND,84
US,IMMUNE SYSTEM DISORDER,83
US,DENTAL CARIES,82
US,PSORIATIC ARTHROPATHY,82
US,INJECTION SITE MASS,81
US,BRONCHIECTASIS,80
US,BURSITIS,80
US,CEREBRAL HAEMORRHAGE,80
US,EMERGENCY CARE,80
US,ESSENTIAL HYPERTENSION,80
US,LABORATORY TEST ABNORMAL,80
US,STENT PLACEMENT,80
US,MUSCLE TIGHTNESS,79
US,PHARYNGITIS STREPTOCOCCAL,79
US,ENCEPHALOPATHY,78
US,FEEDING DISORDER,78
US,HEMIPARESIS,78
US,OBSTRUCTIVE AIRWAYS DISORDER,78
US,ASCITES,77
US,INCREASED TENDENCY TO BRUISE,77
US,MASS,77
US,PRODUCT ADHESION ISSUE,77
US,PULMONARY THROMBOSIS,77
US,ANGIOEDEMA,76
US,HYPOAESTHESIA ORAL,76
US,MITRAL VALVE INCOMPETENCE,76
US,TOOTH ABSCESS,76
US,BLOOD POTASSIUM INCREASED,75
US,IRON DEFICIENCY ANAEMIA,75
US,NERVOUS SYSTEM DISORDER,75
US,THROMBOPHLEBITIS SUPERFICIAL,75
US,TOOTH LOSS,75
US,CYST,74
US,DECREASED ACTIVITY,74
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,74
US,LEUKOPENIA,74
US,RASH PAPULAR,74
US,SPINAL OPERATION,74
US,SUICIDE ATTEMPT,74
US,ACCIDENTAL OVERDOSE,73
US,CARDIO-RESPIRATORY ARREST,73
US,CATAPLEXY,73
US,CHOKING SENSATION,73
US,NERVE COMPRESSION,73
US,OXYGEN SUPPLEMENTATION,73
US,THIRST,73
US,DEVICE DIFFICULT TO USE,72
US,FOETAL EXPOSURE DURING PREGNANCY,72
US,INTERSTITIAL LUNG DISEASE,72
US,METASTASES TO BONE,72
US,NERVE INJURY,72
US,SPUTUM INCREASED,72
US,BACTERIAL INFECTION,71
US,BLOOD MAGNESIUM DECREASED,71
US,CHRONIC SINUSITIS,71
US,DIVERTICULUM,71
US,PHARYNGITIS,71
US,POST-TRAUMATIC STRESS DISORDER,71
US,UNRESPONSIVE TO STIMULI,71
US,ASPIRATION,70
US,CARDIAC OPERATION,70
US,CONCUSSION,70
US,SPINAL COLUMN STENOSIS,70
US,VITAMIN D DECREASED,70
US,WEIGHT FLUCTUATION,70
US,BLOOD URINE PRESENT,69
US,CARDIOVASCULAR DISORDER,69
US,ERUCTATION,69
US,FREQUENT BOWEL MOVEMENTS,69
US,NEOPLASM PROGRESSION,69
US,PANIC REACTION,69
US,RENAL CYST,69
US,BLOOD BILIRUBIN INCREASED,68
US,EAR DISCOMFORT,68
US,HEPATIC FAILURE,68
US,IMPAIRED GASTRIC EMPTYING,68
US,INJECTION SITE RASH,68
US,MICTURITION URGENCY,68
US,NODULE,68
US,TOOTH INFECTION,68
US,AORTIC ANEURYSM,67
US,BRONCHITIS CHRONIC,67
US,HEPATIC CIRRHOSIS,67
US,INCREASED APPETITE,67
US,JOINT DISLOCATION,67
US,MATERNAL EXPOSURE DURING PREGNANCY,67
US,MENISCUS INJURY,67
US,PARAESTHESIA ORAL,67
US,SMALL INTESTINAL OBSTRUCTION,67
US,TENDONITIS,67
US,CYANOSIS,66
US,GINGIVAL PAIN,66
US,NASAL DISCOMFORT,66
US,SINUS TACHYCARDIA,66
US,COLD SWEAT,65
US,DEVICE EXPULSION,65
US,HEREDITARY ANGIOEDEMA,65
US,INCORRECT DOSAGE ADMINISTERED,65
US,JOINT RANGE OF MOTION DECREASED,65
US,LYMPHOCYTE COUNT DECREASED,65
US,TRANSFUSION,65
US,MUSCLE STRAIN,64
US,PHOTOPHOBIA,64
US,PLEURISY,64
US,SENSORY DISTURBANCE,64
US,CLOSTRIDIUM DIFFICILE COLITIS,63
US,HEARING IMPAIRED,63
US,INFUSION SITE SWELLING,63
US,KNEE OPERATION,63
US,LUNG INFILTRATION,63
US,ORAL DISORDER,63
US,TENDERNESS,63
US,WRONG PATIENT RECEIVED MEDICATION,63
US,ARTERIOSCLEROSIS,62
US,CARDIOMYOPATHY,62
US,HIP ARTHROPLASTY,62
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,62
US,MOUTH ULCERATION,62
US,SPINAL DISORDER,62
US,BLOOD COUNT ABNORMAL,61
US,BLOOD IRON DECREASED,61
US,BLOOD UREA INCREASED,61
US,INFUSION SITE PAIN,61
US,LARGE INTESTINE POLYP,61
US,MALABSORPTION,61
US,SKIN CANCER,61
US,TOOTH EXTRACTION,61
US,ACCIDENT,60
US,APPARENT DEATH,60
US,BASAL CELL CARCINOMA,60
US,BODY TEMPERATURE INCREASED,60
US,EYE INFECTION,60
US,PALLOR,60
US,PSYCHOTIC DISORDER,60
US,SINUS HEADACHE,60
US,SNORING,60
US,BLOOD PRESSURE FLUCTUATION,59
US,MENSTRUATION IRREGULAR,59
US,PNEUMONIA BACTERIAL,59
US,POST PROCEDURAL COMPLICATION,59
US,PREGNANCY,59
US,PROSTATE CANCER,59
US,BEDRIDDEN,58
US,DEVICE BREAKAGE,58
US,DRUG EFFECT DELAYED,58
US,FLANK PAIN,58
US,MUSCULOSKELETAL DISORDER,58
US,SEDATION,58
US,TRICUSPID VALVE INCOMPETENCE,58
US,ULCER,58
US,ABORTION SPONTANEOUS,57
US,BLOOD TRIGLYCERIDES INCREASED,57
US,COLON CANCER,57
US,DIALYSIS,57
US,ELECTROCARDIOGRAM QT PROLONGED,57
US,HYPERVENTILATION,57
US,INFUSION SITE ERYTHEMA,57
US,LACTIC ACIDOSIS,57
US,MUSCLE SPASTICITY,57
US,NEUTROPHIL COUNT DECREASED,57
US,RESPIRATORY TRACT IRRITATION,57
US,SKIN BURNING SENSATION,57
US,DEVICE RELATED INFECTION,56
US,DIABETIC NEUROPATHY,56
US,ECCHYMOSIS,56
US,HYSTERECTOMY,56
US,INITIAL INSOMNIA,56
US,PAIN OF SKIN,56
US,SUPRAVENTRICULAR TACHYCARDIA,56
US,DELIRIUM,55
US,GASTRIC ULCER,55
US,GASTROENTERITIS,55
US,HAND FRACTURE,55
US,IMPAIRED DRIVING ABILITY,55
US,RHINITIS,55
US,SOMNAMBULISM,55
US,SUBDURAL HAEMATOMA,55
US,BLADDER DISORDER,54
US,CENTRAL NERVOUS SYSTEM LESION,54
US,DEPRESSED LEVEL OF CONSCIOUSNESS,54
US,HAEMORRHAGE INTRACRANIAL,54
US,HYPOKINESIA,54
US,LYMPHOMA,54
US,PRESCRIBED UNDERDOSE,54
US,RIGHT VENTRICULAR FAILURE,54
US,CONJUNCTIVITIS,53
US,PARANASAL SINUS DISCOMFORT,53
US,PARANOIA,53
US,TENDON RUPTURE,53
US,TONGUE DISORDER,53
US,DEVICE DEFECTIVE,52
US,INJECTION SITE URTICARIA,52
US,OESOPHAGITIS,52
US,ORAL HERPES,52
US,TOOTH FRACTURE,52
US,ABSCESS,51
US,ANOSMIA,51
US,BRAIN INJURY,51
US,DECREASED INTEREST,51
US,HAIR TEXTURE ABNORMAL,51
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,51
US,LIVER FUNCTION TEST INCREASED,51
US,MALNUTRITION,51
US,ORAL MUCOSAL BLISTERING,51
US,OVARIAN CYST,51
US,PULMONARY PAIN,51
US,THERAPY NON-RESPONDER,51
US,TOTAL LUNG CAPACITY DECREASED,51
US,ATAXIA,50
US,BLOOD ALKALINE PHOSPHATASE INCREASED,50
US,BLOOD GLUCOSE ABNORMAL,50
US,DERMATITIS,50
US,ENURESIS,50
US,GINGIVAL BLEEDING,50
US,MOUTH SWELLING,50
US,NOCTURIA,50
US,ORTHOSTATIC HYPOTENSION,50
US,PULMONARY HAEMORRHAGE,50
US,SPLENOMEGALY,50
US,WALKING AID USER,50
US,ABDOMINAL HERNIA,49
US,CARDIAC MURMUR,49
US,DRUG SCREEN POSITIVE,49
US,FOREIGN BODY,49
US,FURUNCLE,49
US,GENITAL HAEMORRHAGE,49
US,LYMPHOEDEMA,49
US,MULTIPLE FRACTURES,49
US,PERIPHERAL COLDNESS,49
US,PRODUCT CONTAINER ISSUE,49
US,TACHYPNOEA,49
US,TREATMENT FAILURE,49
US,ARTERIAL OCCLUSIVE DISEASE,48
US,BREATH ALCOHOL TEST POSITIVE,48
US,DIABETES MELLITUS INADEQUATE CONTROL,48
US,DRUG DEPENDENCE,48
US,FAILURE TO THRIVE,48
US,FEELING DRUNK,48
US,GENERALISED TONIC-CLONIC SEIZURE,48
US,HAIR COLOUR CHANGES,48
US,MELAENA,48
US,PARALYSIS,48
US,ACUTE SINUSITIS,47
US,BLINDNESS UNILATERAL,47
US,BREAST PAIN,47
US,CARDIAC PACEMAKER INSERTION,47
US,EXERCISE TOLERANCE DECREASED,47
US,FOOT DEFORMITY,47
US,GENERALISED OEDEMA,47
US,JOINT EFFUSION,47
US,NASAL DRYNESS,47
US,PERIPHERAL VASCULAR DISORDER,47
US,REHABILITATION THERAPY,47
US,SCAB,47
US,TEMPERATURE INTOLERANCE,47
US,ARTERIOSCLEROSIS CORONARY ARTERY,46
US,ATYPICAL PNEUMONIA,46
US,DECUBITUS ULCER,46
US,HYPERCALCAEMIA,46
US,HYPERCHOLESTEROLAEMIA,46
US,HYPOPNOEA,46
US,INJECTION SITE WARMTH,46
US,METRORRHAGIA,46
US,MOUTH HAEMORRHAGE,46
US,PARANASAL SINUS HYPERSECRETION,46
US,PROSTATOMEGALY,46
US,ATRIAL SEPTAL DEFECT,45
US,BILIARY DYSKINESIA,45
US,DERMATITIS CONTACT,45
US,DISEASE RECURRENCE,45
US,ENDOMETRIOSIS,45
US,GAIT INABILITY,45
US,HEPATITIS C,45
US,INTERVERTEBRAL DISC DISORDER,45
US,INTRAOCULAR PRESSURE INCREASED,45
US,SKIN FISSURES,45
US,UPPER RESPIRATORY TRACT CONGESTION,45
US,ADVERSE REACTION,44
US,CATHETERISATION CARDIAC,44
US,CHOLECYSTITIS,44
US,DYSMENORRHOEA,44
US,EYE HAEMORRHAGE,44
US,FACIAL PAIN,44
US,GASTROINTESTINAL INFECTION,44
US,IMMUNODEFICIENCY,44
US,INCONTINENCE,44
US,MALIGNANT MELANOMA,44
US,PANCREATITIS ACUTE,44
US,PELVIC FRACTURE,44
US,RESPIRATORY RATE INCREASED,44
US,TONGUE DISCOLOURATION,44
US,VENTRICULAR EXTRASYSTOLES,44
US,BLADDER CANCER,43
US,BONE DENSITY DECREASED,43
US,INCORRECT DOSE ADMINISTERED BY DEVICE,43
US,ONYCHOCLASIS,43
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,43
US,PARKINSON^S DISEASE,43
US,PHARYNGEAL ERYTHEMA,43
US,TRANSAMINASES INCREASED,43
US,VENTRICULAR TACHYCARDIA,43
US,ARTHROPOD BITE,42
US,ATRIAL FLUTTER,42
US,BLOOD CALCIUM DECREASED,42
US,DEVICE LEAKAGE,42
US,ELECTROLYTE IMBALANCE,42
US,NASAL SEPTUM DEVIATION,42
US,ORTHOPNOEA,42
US,PHOTOSENSITIVITY REACTION,42
US,PLATELET COUNT INCREASED,42
US,SLUGGISHNESS,42
US,ULCER HAEMORRHAGE,42
US,VOCAL CORD DISORDER,42
US,AFFECT LABILITY,41
US,APPLICATION SITE ERYTHEMA,41
US,APPLICATION SITE PAIN,41
US,BLOOD GLUCOSE FLUCTUATION,41
US,GLUCOSE TOLERANCE IMPAIRED,41
US,HAEMORRHAGIC STROKE,41
US,INCREASED BRONCHIAL SECRETION,41
US,JAUNDICE,41
US,MANIA,41
US,PANCREATIC CARCINOMA,41
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,41
US,RENAL CANCER,41
US,SENSATION OF FOREIGN BODY,41
US,WOUND INFECTION,41
US,ACUTE RESPIRATORY DISTRESS SYNDROME,40
US,ANEURYSM,40
US,APNOEA,40
US,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,40
US,BONE LESION,40
US,COORDINATION ABNORMAL,40
US,DIZZINESS POSTURAL,40
US,GALLBLADDER INJURY,40
US,INJURY ASSOCIATED WITH DEVICE,40
US,ISCHAEMIC STROKE,40
US,LUMBAR SPINAL STENOSIS,40
US,METABOLIC ACIDOSIS,40
US,METASTASES TO LIVER,40
US,NEOPLASM,40
US,ORAL FUNGAL INFECTION,40
US,RENAL PAIN,40
US,RESPIRATORY SYNCYTIAL VIRUS INFECTION,40
US,ANAL INCONTINENCE,39
US,BREAST MASS,39
US,COMPRESSION FRACTURE,39
US,ELECTROCARDIOGRAM ABNORMAL,39
US,ERECTILE DYSFUNCTION,39
US,FACE OEDEMA,39
US,FACIAL BONES FRACTURE,39
US,MUSCLE ATROPHY,39
US,OVERWEIGHT,39
US,RALES,39
US,RENAL FAILURE CHRONIC,39
US,RHABDOMYOLYSIS,39
US,SINUS OPERATION,39
US,SKIN INFECTION,39
US,BARRETT^S OESOPHAGUS,38
US,EJECTION FRACTION DECREASED,38
US,FORMICATION,38
US,LIMB OPERATION,38
US,NON-CARDIAC CHEST PAIN,38
US,OSTEONECROSIS,38
US,PHYSICAL DISABILITY,38
US,RHINOVIRUS INFECTION,38
US,SARCOIDOSIS,38
US,VARICOSE VEIN,38
US,VITAMIN B12 DEFICIENCY,38
US,ANGIOPATHY,37
US,DEFORMITY,37
US,EXPIRED DRUG ADMINISTERED,37
US,EXPOSED BONE IN JAW,37
US,HOSPICE CARE,37
US,HYPERAESTHESIA,37
US,HYPOMAGNESAEMIA,37
US,INFUSION SITE PRURITUS,37
US,INJECTION SITE NODULE,37
US,LOWER RESPIRATORY TRACT CONGESTION,37
US,NARCOLEPSY,37
US,NO THERAPEUTIC RESPONSE,37
US,PHARYNGEAL DISORDER,37
US,PREMATURE BABY,37
US,RETINAL DETACHMENT,37
US,SPINAL PAIN,37
US,UMBILICAL HERNIA,37
US,BOWEL MOVEMENT IRREGULARITY,36
US,CARDIAC VALVE DISEASE,36
US,COMPLETED SUICIDE,36
US,DYSPAREUNIA,36
US,FOOD ALLERGY,36
US,HYPERKERATOSIS,36
US,LIBIDO DECREASED,36
US,NEUTROPHIL COUNT INCREASED,36
US,OSTEOSCLEROSIS,36
US,PROTEINURIA,36
US,VISUAL FIELD DEFECT,36
US,VITREOUS FLOATERS,36
US,AFFECTIVE DISORDER,35
US,BLOOD CALCIUM INCREASED,35
US,COLITIS ISCHAEMIC,35
US,DEVICE OCCLUSION,35
US,EYELID OEDEMA,35
US,GASTROINTESTINAL PAIN,35
US,MAJOR DEPRESSION,35
US,OESOPHAGEAL DISORDER,35
US,POLYP,35
US,PSYCHOLOGICAL TRAUMA,35
US,RAYNAUD^S PHENOMENON,35
US,SCRATCH,35
US,SKIN ATROPHY,35
US,UTERINE LEIOMYOMA,35
US,ANAPHYLACTIC SHOCK,34
US,APHAGIA,34
US,BREAST CANCER METASTATIC,34
US,BRONCHIAL HYPERREACTIVITY,34
US,BRONCHIAL SECRETION RETENTION,34
US,CARBON DIOXIDE INCREASED,34
US,CORONARY ARTERIAL STENT INSERTION,34
US,DIABETIC KETOACIDOSIS,34
US,FOOT OPERATION,34
US,FRACTURE,34
US,GROIN PAIN,34
US,HALLUCINATION_ VISUAL,34
US,HEPATOMEGALY,34
US,HYPERTHYROIDISM,34
US,MATERNAL EXPOSURE TIMING UNSPECIFIED,34
US,MIDDLE EAR EFFUSION,34
US,NICOTINE DEPENDENCE,34
US,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,34
US,PYELONEPHRITIS,34
US,RED CELL DISTRIBUTION WIDTH INCREASED,34
US,RENAL INJURY,34
US,SHOULDER OPERATION,34
US,THERAPY CHANGE,34
US,URINE OUTPUT DECREASED,34
US,APPETITE DISORDER,33
US,BRAIN NEOPLASM,33
US,CARDIAC FLUTTER,33
US,DIARRHOEA HAEMORRHAGIC,33
US,DIVERTICULUM INTESTINAL,33
US,EYE DISCHARGE,33
US,FAECAL INCONTINENCE,33
US,HUMERUS FRACTURE,33
US,INTERCEPTED DRUG DISPENSING ERROR,33
US,MADAROSIS,33
US,MUCOSAL INFLAMMATION,33
US,MYOCARDIAL ISCHAEMIA,33
US,PAINFUL RESPIRATION,33
US,PATHOLOGICAL FRACTURE,33
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,33
US,PERIPHERAL VENOUS DISEASE,33
US,PNEUMONIA STAPHYLOCOCCAL,33
US,PREMATURE DELIVERY,33
US,WHEELCHAIR USER,33
US,ADRENAL INSUFFICIENCY,32
US,BACTERAEMIA,32
US,BRUXISM,32
US,CAROTID ARTERY STENOSIS,32
US,DRUG ABUSE,32
US,DRUG SCREEN FALSE POSITIVE,32
US,EAR DISORDER,32
US,EMBEDDED DEVICE,32
US,EUPHORIC MOOD,32
US,GINGIVITIS,32
US,HAIR DISORDER,32
US,HEPATIC CYST,32
US,HYPERCAPNIA,32
US,HYPOCALCAEMIA,32
US,INJECTION SITE INDURATION,32
US,LIVE BIRTH,32
UY,ARRHYTHMIA,1
VN,ANAPHYLACTIC SHOCK,1
VN,CRYING,1
VN,DYSPNOEA,1
VN,HEART RATE INCREASED,1
VN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
VN,RASH,1
VN,URETEROLITHIASIS,1
